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The fact that Joint Protection Programs (JPP) can reduce pain and improve function is based 
on small, but definitive Randomized Controlled Trials (RCTs), conducted in the 1980s. 
However, changes over time in the nature of hand use, the rapid expansion of technology, and 
improvements in our understanding of health literacy mean that these programs are now 
outdated. Further, problems with adherence to JPP are well documented. The purpose of this 
thesis was 1) to conduct a scoping review to map all the available evidence around joint 
protection programs in published and unpublished studies 2) to evaluate the effectiveness of 
joint protection programs when compared to usual care/no joint protection/advice on pain 
reduction and improvement of hand function for individuals with hand arthritis 3) to conduct 
an overview of systematic reviews to establish the current state of evidence evaluating the 
effectiveness of joint protection for people with hand RA and OA 4) to investigate the barriers, 
facilitators, expectations and patient preferences regarding joint protection programs in people 
with hand arthritis 5) to evaluate the Content Validity Index (CVI) of Patient-Rated Wrist 
Evaluation (PRWE), Australian/Canadian Osteoarthritis hand Index (AUSCAN) and Thumb 
Disability Exam (TDX) in patients with hand arthritis and 6) to design a single center, 
investigator-blinded, randomized, 12-month, parallel-group, superiority study for the 
evaluation of the efficacy of a hand exercise and a joint protection program on pain Intensity 
levels in people with hand osteoarthritis. From the existing literature, we found evidence of 
very-low to low quality that the effects of joint protection programs compared to usual 
care/control on pain and hand function are too small to be clinically important at short -, 
intermediate- and long-term follow-ups for people with hand arthritis. We also found that 
awareness of the potential benefits of JP, and prior experience with JP program were very low. 
Common potentially modifiable patient-reported barriers to participate in future JP 
interventions, included: cost, work commitments distance from home to clinic and times that 
the JP intervention were provided. These barriers might be addressed with free and accessible 
forms of delivery of JP, which may lead to better uptake and participation in JP. Our findings 
also demonstrated very high content validity indices for the PRWHE, AUSCAN, and TDX; 
with strong consensus across reviewers. This augments prior statistical evidence supporting 
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Summary for Lay Audience 
The most common location for osteoarthritis (OA) is the hand. Hand OA is responsible for 
pain and limitations in hand function that can limit peoples’ ability to work or remain 
independent. As hand OA progresses, the joints become deformed. Joint Protection Programs 
(JPP) were developed in the 1980’s to help people with hand OA do tasks in daily life, alleviate 
pain, and prevent joint deformity. JPP teach people how to change, or pace tasks, and how to 
use devices that reduce joint loading. Although studies have shown these programs can be 
effective, many people do not fully understand or use JPP. The JPP in use today have not been 
updated to reflect the life tasks and tools of the 21st century. Much has changed - like how we 
use our phones.  
This thesis aimed to investigate the efficacy of JPP and to update the JPP to better address the 
important daily tasks that people do, by working with patients and engineers to find the best 
solutions. This study will lead to more useful, accessible and effective JPP that will help people 
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Chapter 1  
1 Introduction 
1.1 Osteoarthritis 
Osteoarthritis (OA) affects up to 18% of the population above 60.1 Prevalence of OA is 
steadily increasing as the average age and risk factors such as obesity increases. This 
painful condition is the main cause of disability in older individuals, and is thus, 
unsurprisingly, associated with lower quality of life and a higher risk of depression and 
mortality. The condition is characterized by loss of articular cartilage in synovial joints, 
accompanied by subchondral bone changes, osteophyte formation at the joint margins, 
thickening of the joint capsule, and mild synovitis. Conventional radiographs show joint 
space narrowing as a reflection of cartilage loss, osteophyte formation and, in some cases, 
subchondral bone changes, but these signs are not consistently associated with symptoms.2 
 
1.2 Rheumatoid arthritis 
Rheumatoid arthritis (RA) is a systemic auto-immune disease.3 RA prevalence and 
incidence rates are increasing globally and RA has become a major public health 
challenge.4,5 Quality of life for people with RA has been reported to be lower than in 
patients suffering from the four main non-communicable diseases.6 The primary clinical 
manifestation of RA is the symmetrical inflammatory polyarthritis that usually is starting 
in the small joints of the hands and the feet, and then expanding to the bigger joints.3 The 
condition is resulting in tender swelling joints, pain, limited range of motion and stiffness.7 
RA is often characterized by irreversible tissue damage and destruction of bone and of the 







1.3 Etiology and pathogenesis of hand osteoarthritis 
Joints have a layer of articular cartilage which helps to eliminate friction between the bones 
when movement is occurred.8 As a person gets older, the tissues of bone and cartilage are 
starting to degenerate progressively resulting in a compromise of the functional integrity 
of the joint. Ligaments and tendons may play also a potential role to aid the erosion of the 
joint and in the development of Heberden’s nodes.9 Joints from everyday movement are 
subjected to mechanical loading however, the stress from the movements is not enough to 
cause a healthy joint to develop osteoarthritis.8 On the other hand, injured or vulnerable 
joints such as misalignment  have a higher risk of developing osteoarthritis because of joint 
thickening and joint space narrowing respectively.8 OA has been reported as a form of non-
inflammatory arthritis however, many studies have indicated the upregulation of several 
inflammatory pathways.8 Onset to early OA has been linked with changes in the 
extracellular matrix of cartilage. A highly negative charged protein named aggrecan assist 
the cartilage to maintain its compressive stiffness with electrical repulsion which is 
enforced by collagen fibers.10 Typically, OA is classified either as primary or as secondary 
type. Primary type is defined when the joint develops OA and has no history of injury or 
trauma.11 Secondary type of OA is referred to the development of the disease after an injury 
or trauma in the joint that it is usually caused from physical injury, accident or any other 
condition or disorder.12,13  Bony abnormalities in the presence of hand OA are the 
Heberden’s and Bouchard’s nodes that affect part of the fingers. Heberden’s nodes are 
defined as bony abnormalities and are located in the distal interphalangeal joints while 
Bouchard’s are located in the proximal interphalangeal joints.11,14 The prevalence of these 
nodes has been extensively investigated and documented however, their etiology and 
pathogenesis have not been determined yet.15 The most commonly affected joint in the 
hand is the distal interphalangeal joints which often progresses after 40 to 50 years of age. 
The second most commonly affected joint is the carpometacarpal joint of the thumb and 
progress around the age of 50 years.16,17 The metacarpophalangeal joint of the thumb may 
be also affected from OA while other joints in the hand are more often affected from 





1.4 Osteoarthritis and risk factors 
Several risk factors have been associated with the development of osteoarthritis such as 
age, obesity, sex, smoking, race and environment, diet, occupation and genetics.18 Age has 
been linked with an increased risk after the age of 20, with most individuals at the age of 
40 will appear to have some damage in their joints whereas 50% of people aged greater 
than 65 will present characteristics of OA.19,20 The increased risk in hand OA, is during the 
average age of menopause for females approximately at 55 to 60 years whereas the risk is 
starting to decrease after that age period.21 When compared hand OA and knee/hip OA the 
risk is increased at the age of 50 years old and then the risk is starting to decrease after that 
age of 75 years old.21 Obesity has been reported as a risk factor however, studies in the 
literature have presented conflicting findings. Previous studies such as the Baltimore 
Longitudinal Study of Aging for men or the National Health Examination Survey for 
women found no relationship between OA and obesity respectively.18,19,22 On the other 
hand, subsequent studies have indicated that obesity is a risk factor for developing hand 
OA. Carman et al. found that obese individuals had a higher incidence of developing hand 
OA when compared to average weight individuals.23 A 10-years  study that was conducted 
in 1675 subjects indicated a weak association of hand OA and obesity.24 Reasons why 
obesity is a risk factor for OA is poorly understood however, it has been reported that the 
higher body weight may increase the mechanical loading in the joints, may affect the 
hormone composition, the metabolism of the cartilage as well as the muscles.24 Hormone 
production from the adipose tissue regulates inflammatory activity which has been linked 
to OA. Systemic factors such as (leptin, adiponectin, resistin, visfatin and chemerin) are 
probably more associated to the higher prevalence of hand OA in obese people than the 
mechanical loading factors.25-27 Sex has been reported as a risk factor for developing hand 
OA with women being at 2.6 times higher risk in comparison with men.23 The higher 
prevalence of OA in women after the age of 55 indicates that hormones (i.e. estrogen) may 
play a role for the development of hand OA.18,19 As with obesity, the literature around 
smoking as a risk factor of developing OA is very ambiguous. Several studies that 
conducted in the past were not able to establish a relationship between smoking and OA in 





back in 2005 indicated that smoking may have a beneficial effect in terms of lower the risk 
for developing hip or knee OA.31 In contrast, Amin and colleagues showed that smoking 
was associated with greater cartilage loss and pain in the knee.32 While the literature shows 
conflicting results for smoking as a risk factors it is important to note that this risk or 
benefitted relationship has not been thoroughly examined for people with hand OA. 33 
Prevalence of OA is very different depending on ethnicity and culture. For instance, an 
epidemiological study in China found that females had lower rates of radiographically 
confirmed OA in the hip and hand when compared with Caucasian females.34 This finding 
further supports the role of genetics in the risk of developing OA. The role of diet has not 
been clearly understood but studies have showed that there is a relationship between hand 
OA and vitamin K.35 Several studies have investigated the relationship between an 
individual’s occupation and hand OA. More specifically, people with high labor working 
occupations that required repetitive movements (i.e. clothing industry)  had a higher risk 
of developing hand OA.36 A subsequent study confirmed this finding and suggested that 
females with hand OA had jobs that required to push something with their joints.37 
 
1.5 Available treatments for osteoarthritis 
Osteoarthritis treatment is mainly symptomatic; there is no cure. Available treatments can 
be divided into subgroups for didactical reasons: advice and self-help, conservative 
treatments requiring supervision, and surgery.2 Advice and self-help includes patient 
education about OA, paracetamol, topical agents, physical agents, and food supplements 
such as glucosamine and chondroitin. Conservative treatments requiring supervision 
includes non-steroidal anti-inflammatory drugs (NSAIDs), weight loss, acupuncture, 
manual therapy, physical exercise, physical aids and supports, growth factor injections 
and/or platelet rich plasma, intra-articular corticosteroids, and intra-articular hyaluronic 
acids. Surgical treatments include arthroscopic surgery and total joint replacement. Recent 
clinical practice guidelines have reached somewhat conflicting conclusions regarding the 
usefulness of conservative treatment in osteoarthritis.38-41 Hand OA leads to reduction in 





work time and a decreased ability to perform manual activities.42,43 In the clinical setting, 
pain is a major symptom among patients with hand OA which also contributes to patient 
report of reduced joint function.44,45 Aspirational goals of hand OA treatment are to 
maximize long-term health-related quality of life through control of symptoms such as 
pain, prevention of structural damage and normalization of function. Management 
recommendations advise applying non-pharmacological and pharmacological treatments.46 
Medications include non-steroidal anti-inflammatory drugs (NSAIDs) and analgesics to 
relieve musculoskeletal signs and symptoms during all phases of treatment; however in 
general disease modifying drugs have not been effective.47-49 Tumor necrosis factor 
inhibitors such as adalimumab, etanercept, golimumab and infliximab have a positive role 
in inflammatory arthritis, and have been studied in OA.50,51 Previous studies on psoriatic 
arthritis50 and rheumatoid arthritis52 have supported the benefits of using anti-TNF drugs 
with respect to pain, swelling, function, quality of life, fatigue and radiographic 
progression. Literature is scattered with hypotheses and hopes for a positive effect of anti-
TNFs on hand OA. On the other hand, non-pharmacological treatments for hand OA may 
include joint protection, exercise therapy and muscle strengthening, paraffin bath therapy, 
electrotherapy or acupuncture mainly for the management of symptoms.46,53 
 
1.6 Joint protection programs 
Joint protection programs are a self-management strategy to help patients with hand 
arthritis reduce pain and improve hand function.54 This self-management approach usually 
involves training in safe movement patterns, the use of assistive devices and behavior 
modifications such as activity to avoid or pacing in active daily living.54,55 Joint protection 
programs were primarily developed for people with rheumatoid arthritis in the hand and 
later this approach was expanded for patients with hand OA.54,56 
 
1.7 The gap in the knowledge 





Arthritis) for joint protection programs was published back in 1988. The book has several 
examples of joint protection techniques however, it is evident that these programs are 
clearly outdated and have not considered recent adaptations in technology use or how daily 
tasks are performed. The American College of Rheumatology conditionally recommends 
joint protection techniques for the management of hand OA which indicates that there is 
lack of evidence to support their efficacy.39 More recent systematic review that investigated 
the effectiveness of joint protection programs provided strong evidence for people with 
rheumatoid arthritis in the hand but no evidence was presented for hand OA.57 This is an 
indication that more evidence is needed on updated joint protection programs for people 
with hand OA. Another potential problem is that the literature does not describe adequately 
what constitutes joint protection and how the different aspects of the programs are 
implemented. For example, description of joint protection is often mentioned as leaflet, 
educational sessions or written course material and no other details are presented.57,58 
Furthermore, intervention dosage parameters and what training tools are most effective are 
currently unknown. This makes it very difficult to transfer the best available evidence to 
clinical practice. Previous reports have indicated that adherence to joint protection has been 
suboptimal.59,60 Reasons for poor adherence have not been well documented and it is 
unclear what barriers may contribute to poor compliance in joint protection programs. 
Previous conducted trials have found that people with rheumatoid arthritis in the hand used 
joint protection approaches only when experienced pain symptoms.56 Patients may not 
fully understand that they need to practice joint protection techniques consistently in their 
daily life and develop new patterns of daily activity so the cumulative joint loading can be 
reduced.  
 
1.8 Objectives of this dissertation 
The fact that Joint Protection Programs (JPP) can reduce pain and improve function is 
based on small, but definitive Randomized Controlled Trials (RCTs), conducted in the 
1980s. However, changes over time in the nature of hand use, the rapid expansion of 





programs are now outdated. Further, problems with adherence to JPP are well documented. 
JPP can be enhanced by incorporating recent biomechanical and clinical evidence, 
technology innovations, and insights gained in collaboration with people with hand OA. 
JPP can be more salient, useful and effectively implemented. Therefore, the purpose of this 
thesis is to provide evidence to better understand the efficacy of JPP in patients with hand 
OA. More specifically, a series of studies were conducted: 
 
1. To conduct a scoping review to map all the available evidence around joint 
protection programs in published and unpublished studies 
2. To evaluate the effectiveness of joint protection programs when compared to usual 
care/no joint protection/advice on pain reduction and improvement of hand function 
for individuals with hand arthritis 
3. To conduct an overview of systematic reviews to establish the current state of 
evidence evaluating the effectiveness of joint protection for people with hand RA 
and OA 
4. To investigate the barriers, facilitators, expectations and patient preferences 
regarding joint protection programs in people with hand arthritis. 
5. To evaluate the Content Validity Index (CVI) of Patient-Rated Wrist Evaluation 
(PRWE), Australian/Canadian Osteoarthritis hand Index (AUSCAN) and Thumb 
Disability Exam (TDX) in patients with hand arthritis 
6. To design a single center, investigator-blinded, randomized, 12-month, parallel-
group, superiority study for the evaluation of the efficacy of a joint protection 
program on pain intensity levels in people with hand osteoarthritis 
 
1.9 Overview of this dissertation 
Chapter 2 is a scoping review which aims to map all the available evidence around joint 
protection programs. More specifically, the scoping review examined what are the sources 





protection studies, by whom the program is implemented, what are the current principles 
of joint protection and what is available in the “grey” literature for joint protection. Chapter 
3 is an evidence synthesis that aimed to investigate the effectiveness of joint protection on 
pain intensity and on hand function outcomes in people with hand arthritis. A meta-analysis 
of all the eligible RCTs was performed to pool all the extracted outcomes on pain and hand 
function. Chapter 4 is an overview of systematic reviews that critically appraise all the 
available evidence synthesis reviews and aims to explain why the different reviews provide 
different results. Chapter 5 is a cross-sectional survey that aimed to understand the barriers, 
facilitators, preferences and expectations in people with hand arthritis. Patients were 
recruited from a tertiary clinic in London, Ontario as well as with the help from The 
Arthritis Society of Canada social network. Chapter 6 is a measurement study that 
quantified the content validity of three self-reported outcomes in terms of their relevancy 
and clarity in people with hand arthritis. Chapter 7 is a design of superiority trial that 
integrates all the previous information from the previous studies of this thesis and aims to 
assess the efficacy of the updated joint protection and hand exercises programs in people 
with hand OA. Chapter 8 is a discussion section and overview of this thesis. In Chapter 8 
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Chapter 2  
2 A Scoping Review of Joint Protection Programs for People 
with Hand Arthritis 
Abstract 
Background: Joint protection (JP) can be enhanced by incorporating recent evidence and 
innovations in collaboration with people with hand arthritis to be salient, useful and 
effectively implemented.  
Objective: The purpose of this study is to map the current research on JP principles and 
guide future research on JP programs for the management of hand arthritis. 
Methods: A search was performed in 4 databases (PubMed, EMBASE, Google 
SCHOLAR, CINHAL) from January 1990 to February 2017. A Grey literature was also 
conducted through the Google web search engine. A combination of search terms was used 
such as hand osteoarthritis, rheumatoid arthritis, joint protection and/or self-management 
strategies.  
Results: Our search found 8,788 citations which 231 articles were deemed relevant and 
after duplication 111 articles were retrieved for a full-text review. In total, 40 articles were 
eligible for data extraction. The majority of the articles were (19) randomized controlled 
trials (RCTs), (6) systematic reviews and (3) overviews of reviews that investigated joint 
protection for hand arthritis. Joint protection was tested mostly in rheumatoid arthritis (RA) 
population and to a lesser extent on hand osteoarthritis and was provided mainly by an 
occupational therapist. 
Conclusion: This review synthesized and critically examined the scope of JP for the 
management of hand arthritis and found that RCTs, systematic reviews and overviews of 
reviews constituted two-thirds of the current body of literature. Furthermore, it identified 
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2.1 Introduction 
Hand osteoarthritis (h-OA) is one the most common type of osteoarthritis (OA), and it is a 
leading cause of disability in the elderly population around the world.1 Asymptomatic h-
OA is characterized by nodes and deformities in the finger joints. Symptomatic h-OA is 
usually associated with pain, stiffness and limited functional ability.2 Reports from “The 
Framingham study” in 2002 showed that the prevalence of symptoms in h-OA was higher 
than the symptoms in the knee.1 Management of h-OA typically includes pharmacological 
(medications) and/or non-pharmacological interventions such as joint protection programs, 
assistive devices, and hand exercises. Currently, there is no cure for h-OA and individuals 
with symptomatic h-OA need strategies and approaches on how to maintain their active 
daily living and functioning. 
Joint protection programs were primarily developed for people with Rheumatoid Arthritis 
(RA) and had been reported to be beneficial.3 Joint protection includes self-management 
strategies to alleviate pain, reduce inflammation and reduce the risk of deformities.4 Also, 
joint protection has been developed as an approach to improve the performance of daily 
tasks by enhancing the control perceptions and improve the psychological status of the 
patient.5 Joint protection is considered a multimodal intervention that aims to alter working 
methods by using proper body mechanics and by using assistive devices. It is often 
integrated with stretching and hand exercises .6 Individuals with RA can play an essential 
role in the management of their disease progression, but this requires their involvement. 
The American College of Rheumatology in 2012 guidelines7 suggested the use of joint 
protection for the management of h-OA however, no definite recommendations have been 
made so far. The European League Against Rheumatism (EULAR) evidence-based 





approach for the management of RA but whether this method can be generalized to h-OA 
remains unclear. A scoping review of joint protection programs will be a narrative 
synthesis that aims to map the basic principles of joint protection and identify the primary 
sources of the current scientific evidence. 
2.1.1 Purpose of the Study 
The purpose of this scoping review is to gather, synthesize and critically examine the scope 
of joint protection principles for the management of h-OA and guide future research on 
joint protection programs for the future management of h-OA. The following questions 
were generated: 
1. What are the main sources of scientific evidence of the current joint protection 
programs? 
2. What are the main outcome measures that are used for joint protection? 
3. What are the current approaches of the joint protection programs? 
4. What is available in “Grey Literature” for joint protection programs? 
 
2.2 Methods 
This study followed the steps of reporting guidelines by Arksey and O’ Malley’s.8 The 
steps were the following: identifying the research question (1), identifying relevant studies 
(2), study selection (3), charting the data (4) and synthesizing, summarizing and reporting 
the results.8 
  
2.2.1 Study identification 
The first author (PB) performed the literature search in 4 databases (PubMed, EMBASE, 
Google SCHOLAR and CINHAL) from January 1990 to February 2017. A combination 





protection and/or hand exercises and/or self-management strategies. A Grey literature was 
also conducted through the Google web search engine. The grey literature was investigated 
through google manual searches in the first 10 pages of results. Also, relevant articles from 
the scientific databases and the grey literature were selected from the title and entered into 
a word database file. 
 
2.2.2 Study Selection 
The title and the abstract from all the articles and the grey literature were independently 
screened by 2 investigators (PB) and (GN) and discrepancies were resolved by discussion 
with a 3rd investigator (JM). We included all articles and handbooks (grey literature) that 
contained information about joint protection programs for people with hand osteoarthritis 
and/or rheumatoid arthritis. Studies, where the primary language was not in English, were 
excluded from the review process. Also, studies and grey literature that focused exclusively 
on assistive devices or orthotic devices or hand exercises were excluded from our review. 
Articles with the same data presentation were prioritized as the ones that have the most 
details, and the others were eliminated. A flow diagram of the search results and selection 
process is shown in Figure 1.  
 
2.2.3 Data Charting  
Data were extracted from the first author (PB) from the included studies. Data information 
included Author(s) name or source, year of publication, type of research, study population, 
age, outcome measures, joint protection approaches, and by whom it was provided, and if 






2.2.4 Analyzing, synthesizing and reporting the results 
Description of the study design, the population that was examined and by whom the joint 
protection was delivered. The reported summarized findings were presented in a summary 
table (Table 1). To answer our research questions, we categorized each type of study by 
level of evidence. Current joint protection approaches/principles and outcome measures 
were listed and reported in separate tables (Table 2-3). Grey literature was reported in a 
different category (Table 4-6). 
 
2.3 Results 
Our search found 8,788 citations. After the duplication 231 articles were deemed relevant 
from the title and abstract. Review of abstracts identified 111 articles and were assessed 
for a full-text review. In total, 40 articles were eligible for inclusion in the scoping review 
(Figure 1). The most common reason that studies were excluded was that either they did 
not test joint protection on hand or they talked about patient education in general and not 
for joint protection. Approximately 72% of the included articles reported rheumatoid 
arthritis (RA) as a patient population and only 20% reported patients with hand 
osteoarthritis (h-OA). A small portion of studies (8%) included both populations for joint 
protection programs. The average age of the included population was ranging from 48.95 
to 67.2 years old. In terms of sex, more than 75% of the included sample size were females 
across the studies. 
 
2.3.1 Study Description  
The majority of the articles which consisted of 70% of the included articles were: (19) 
randomized controlled trials 5,9,18–25,10–17, (6) systematic reviews 26–31 and (3) overviews of 
reviews 32–34. The rest of the studies were critical review of the literature 35–37, cohort 
studies 38,39, surveys 4,40, mixed methods studies 41, pilot 42 and cross-sectional studies 43. 





2.3.2 Outcome Measures 
 The outcome measures that were used in the included studies are summarized in Table 2. 
Pain was the most evaluated outcome measure, and it was evaluated with Visual Analog 
Scale (VAS) or by pain subscale of Health Assessment Questionnaire (HAQ) or by 
Numeric Pain Rating Scale (NRS) and by Michigan Hand Questionnaire. Self-report 
measures for psychological domains were evaluated with the Arthritis Self-Efficacy Scale 
(ASES), Hospital Anxiety and Depression Scale (HADS), Arthritis Helplessness Index 
(AHI) and Sense of Coherence (SoC). Disease-specific activity outcome measures were 
evaluated with the Disease Activity Score 28 (DAS28), Rheumatoid Arthritis Disease 
Activity Index (RADAI), Arthritis Impact Measurement Scale (AIMS2). Quality of life 
was assessed with EUROHIS-QOL 8 and health status with SF-12 and EQ-5D-3L. 
Functional ability was evaluated with HAQ, Dreiser Functional Index (DFI), Australian 
Canadian Osteoarthritis Index (AUSCAN), and Functional Index for Hand Osteoarthritis 
(FIHOA). The adherence of joint protection programs was measured with the Joint 
Protection Behaviour Assessment (JPBA), and joint deformity was assessed with Hand 
Joint Alignment and Motion Scale. Efficacy was measured with general self-efficacy scale 
and with global change. Disability was assessed with HAQ and with Disabilities of the 
Arm, Shoulder, and Hand (DASH). Performance-based tests were performed to assess grip 
and pinch strength as well as hand dexterity. Clinician based outcomes included wrist range 
of motion and finger range of motion. 
 
2.3.3 Joint Protection Approaches 
In half of the studies, it was not clear who was primarily involved in delivering the joint 
protection program. Only two studies reported that the joint protection was provided by 
medical staff (nurse or physician) and by a research assistant. Joint protection and energy 
conservation were administered mostly with two methods such as an educational-
behavioral approach or as an approach that was focused on personal goals and available 
resources. The average time of a standardized joint protection education lasted from 1.5 to 





education was to educate the participants about the disease and how the joints are affected 
by h-OA or RA. The education sessions included information about the joint protection 
principles with short time demonstrations (15 to 30 minutes) of hand joint protection 
approaches usually for household activities. At the end of the joint protection education, 
there was a discussion about patients' needs and problems that were mostly supported by a 
leaflet. The joint protection tasks are summarized in detail in Table 3. Assistive devices 
were not reported in the vast majority of the studies.  
2.3.4 Grey Literature 
 Our grey literature search identified several online sources that are: (1) non-profit 
organizations (e.g. National Agricultural Safety Database (NASD), East Sussex Healthcare 
NHS, OASIS-Vancouver Coastal Health. Hand Osteoarthritis) (68) (2) educational e-
learning communities (e.g. Physiopedia) (69) that have available online material for joint 
protection for people with hand arthritis and (3) Thesis from post-graduate and doctoral 
studies. General joint protection principles for hand consideration included: avoid tight 
grasp, avoid pressure on back of knuckles, use both hands when possible, avoid repetitive 
hand activities, avoid stress to tip or pad of thumb, avoid to pressure against the radial side 
of each finger thumb side, avoid prolonged period of holding hands in the same position, 
use more prominent joints to complete a task, plan ahead, use orthotic devices to protect 
your joints and respect pain. , and further details are summarized in Table 4-6.  
 
2.4 Discussion 
This study aimed to summarize the extent of the evidence for joint protection principles for 
the management of RA / h-OA and identified randomized controlled trials, systematic 
reviews and overviews of reviews as the primary sources of scientific evidence for the 
current joint protection programs. Pain, function, psychological domains, adherence, 
quality of life and health-status were the main outcomes that were administered. More 
specifically, pain levels were mainly examined by Visual Analog Scale, Health Assessment 





Self-Efficacy Scale, Health Anxiety and Depression Scale, Arthritis Helplessness Index 
and Self of Coherence. Function was mostly examined by Australian Canadian 
Osteoarthritis index (AUSCAN), Michigan Hand Questionnaire (MHQ) and Health 
Assessment Questionnaire (HAQ). While the occupational therapist was primarily 
responsible for the delivery of joint protection, in half of the included studies, it was unclear 
who was mainly involved in delivering the joint protection program. Also, the current joint 
protection programs primarily focused on tasks associated with home care and kitchen, and 
the review of the grey literature yielded principles such as avoiding tight grips, awareness 
of pain, limiting prolonged periods of holding and use of larger joints.  
This scoping study did not evaluate the effectiveness of Joint protection programs but 
identified 18 RCTs that can be synthesized to investigate their effectiveness. The two most 
recent systematic reviews 26,27 provided recommendations from 8 RCTs in total leading to 
the exclusion of 10 additional trials. Therefore, an update of the most recent evidence is 
highly recommended. 
Joint protection as a multimodal intervention includes the following components (1) 
altering working methods, (2) use of proper joint and body mechanics through applying 
ergonomic principles, (3) use of assistive devices, and (4) modifying functional 
performance and environments.6 It is often integrated with fatigue management, working 
splints and flexibility and strengthening exercises.6 We were unable to extract all the 
components mentioned above of joint protection because either there was a lack of 
reporting or either the joint protection intervention was not fully implemented. Joint 
protection programs may include specific principles and techniques such as avoiding tight 
grips or use of larger joints or utilize particular exercises or energy conservation methods. 
Therefore, it is crucial to ensure comprehensive reporting of all the components of such 
programs when used in clinical studies. In this review, we were unable to extract specific 
information on what exactly included in joint protection programs from most of the clinical 
studies because the information was not available.  
Future research needs to focus on clear and concise reporting of different principles 
included in joint protection programs utilized in clinical studies and ensure adequate 





protection programs in large-scaled well-designed randomized controlled trials by 
incorporating all the components of joint protection and not only parts of joint protection.  
The strengths of this review are that we summarized all the reported joint protection 
principles in peer-reviewed and grey literature. We highlighted the main outcome measures 
that were used in most of the studies to help future clinical studies to select the most 
commonly used self-report outcome measures and performance-based tests. We identified 
a lack of clarity and lack of detailed description on the components of joint protection that 
were tested. Finally, we indicated that many RCTs (n=10) have been published that have 
not been considered in a recent evidence synthesis.  
Despite the authors’ efforts to follow rigorous guidelines from Arksey and O’Malley 8, this 
scoping study is subjected to several limitations. A thorough literature search was 
performed; however, we may have missed research articles that were under development 
during the study period. Also, a search of the grey literature was conducted through google 
search web engine, but we have decided to stop after the first ten pages of google web. 
Therefore, online material that addresses joint protection strategies may have been missed 
during the search process. 
 
2.5 Conclusions 
This review synthesized and critically examined the scope of joint protection programs for 
management of h-OA and found that RCTs, systematic reviews and overviews of reviews 
constituted two-thirds of the current body of literature. Furthermore, it identified a lack of 
clarity regarding the specific elements of joint protection programs used in studies. 
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Table 2-1. Characteristics of the included studies 
Author or Source 
Year  Study Population Provider 
1. Siegel26 
2017 
SR RA N/A 
2. McGee43 
2017 
CS OA N/A 
3. Carandang27 
2016 
SR RA N/A 
4. Williams44 
2015 
RCT RA N/A 
5. Hammond45 
2015 
Book OA OT/PT 
6. Oppong46 
2015 
RCT OA N/A 
7. Dziedzic47 
2015 
RCT OA N/A 
8. Spaans28 
2015 
SR OA OT 
9. Ekelman32 
2014 
Overview RA N/A 
10. Dilek12 
2013 
RCT OA OT 
11. Niedermann13 
2012 
RCT RA Researcher 
12. Beasley35 
2012 
Review Both OT 
13. Swann36 
2011 
Review RA N/A 
14. Niedermann14 
2011 
RCT RA N/A 
15. Niedermann41 
2010 
Mixed RA OT 
16. Valdes29 
2010 
SR OA OT 
17. Boustedt48 
2010 
Cohort OA N/A 
18. Vlieland33 
2009 
Overview RA OT 
19. Hammond15 
2008 
RCT RA OT) 
20. Steultjens30 
2008 
SR RA OT 
21. Masiero16 
2007 
RCT RA OT 
22. Quintrec24 
2007 
RCT RA N/A 
23. Christie49 
2007 
Overview RA PT/OT/MD 
24. O’Brien50 
2006 







CPG RA N/A 
26. Steultjens 31 
2005 
SR RA N/A 
27. Veitiene40 
2005 
Survey Both N/A 
28. Hammond37 
2004 
Review RA N/A 
29. Hammond18 
2004 
RCT RA N/A 
30. Stamm19 
2002 
RCT OA N/A 
31. Hammond52 
2002 
RCT RA OT 
32. Hammond20 
2001 
RCT RA OT 
33. Hammond5 
1999 
RCT RA OT 
34. Hammond39 
1999 
Cohort RA N/A 
35. Scholten25 
1999 
RCT RA N/A 
36. Hammond4 
1998 
Survey RA N/A 
37. Lindroth21 
1997 
RCT RA OT/PT/MD/Nurse 
38. Lindroth23 
1995 
RCT RA N/A 
39. Hammond53 
1994 
Pilot RA N/A 
40. Neuberger54 
1993 
RCT RA OT 
RCT, randomized controlled trial; SR, systematic review; CPG, clinical practice 
guidelines; CS, cross-sectional study; OA, osteoarthritis; RA, rheumatoid arthritis; OT, 





Table 2-2. Outcome measures that were reported 
Author(s) Year Outcome Measures 
Siegel 2017 Joint protection behavior, function, pain, fatigue, self-efficacy, stiffness 
McGee 2017 Grip Strength, Numeric Rating Scale (NRS), Arthritis Impact Measurement Scale 2 (AIMS2) 
Carandang 2016 Joint protection behavior 
Williams 2015 
The Arthritis Self-Efficacy Scale (ASES), Grip Strength, Finger Range of Motion (ROM), Michigan 
Hand Questionnaire (MHQ), Hand Dexterity, European Quality of Life 5 (EQ-5D-3L), Wrist Range of 
Motion (ROM), Short-Form 12 (SF-12), Self-Efficacy, Global Change, Pain (MHQ), Adherence 
Oppong 2015 European Quality of Life 5 (EQ-5D-3L), Osteoarthritis Research Society International (OARSI) 
Dziedzic 2013 
The Arthritis Self-Efficacy Scale (ASES), Grip Strength, Short- Form 12 (v2), AUSCAN, Numeric 
Rating Scale (NRS), Pinch Strength, Global Change, functional performance using the grip ability test 
(GAT) 
Ekelman 2014 morning stiffness, pain, and functional capacity 
Dilek 2013 
Visual Analog Scale (VAS), Grip Strength, AUSCAN, Pinch Strength, Dreiser Functional Index, Wrist 
Range of Motion (ROM) 
Niedermann 2012 
The Arthritis Self-Efficacy Scale (ASES), Joint Protection behavior Assessment (JPBA), Health Anxiety 
and Depression Scale (HADS), Visual Analog Scale (VAS), Disease Activity Score (DAS 28), Grip 
Strength, EUROHIS-QUOL 8, JP-specific self-efficacy (JP-SES) 
Niedermann 2011 
The Arthritis Self-Efficacy Scale (ASES), Joint Protection behaviour Assessment (JPBA), Health 
Anxiety and Depression Scale (HADS), Visual Analog Scale (VAS), Disease Activity Score (DAS 28), 
Grip Strength, Hand Joint Alignment and Motion Scale (H-JAM), Health Assessment Questionnaire 
(HAQ), Sense of Coherence (SOC), EUROHIS-QUOL 8, Wrist Range of Motion (ROM), JP self-
efficacy scale (J-SES), 
Niedermann 2010 Disease Activity Score (DAS 28), Health Assessment Questionnaire (HAQ) 
Boustedt 2010 Visual Analog Scale (VAS), Grip Strength, Pinch Strength, DASH 
Quintric 2009 Health Assessment Questionnaire (HAQ) 
Hammond 2008 
The Arthritis Self-Efficacy Scale (ASES), the Visual Analog Scale (VAS), Health Assessment 
Questionnaire (HAQ), RA Self-efficacy (RASE) Scale, the Arthritis Stages of Change Questionnaire 
Steultjens 2008 
Pain, fatigue, functional abilities (including dexterity), physical independence, qua lity of life (including 
well-being and depression). knowledge about disease management, compliance, self -efficacy, range of 
motion, muscle strength 
Masiero 2007 
Visual Analog Scale (VAS), Health Assessment Questionnaire (HAQ), Arthritis Impact Measurement 
Scale 2 (AIMS2) 
Christie 2007 Pain, function, and patient global assessment. 
O’Brien 2006 
Grip Strength, Hand Dexterity, Pinch Strength, Arthritis Impact Measurement Scale 2 (AIMS2), finger 
flexion ROM goniometry, Jebsen–Taylor hand function test 
Hammond 2004 
The Arthritis Self-Efficacy Scale (ASES), Joint Protection behavior Assessment (JPBA), Visual Analog 
Scale (VAS), Grip Strength, Rheumatoid Arthritis Disease Activity Index (RADAI), Wrist Range of 
Motion (ROM), Arthritis Impact Measurement Scale 2 (AIMS2), EULAR 28, 






The Arthritis Self-Efficacy Scale (ASES), Joint Protection behavior Assessment (JPBA), Visual Analog 
Scale (VAS), Grip Strength, Health Assessment Questionnaire (HAQ), Self -Efficacy, Patient Knowledge 
Questionnaire, Rheumatology Attitudes Index (RAI) 
Hammond 2001 
Joint Protection behavior Assessment (JPBA), Visual Analog Scale (VAS), Grip Strength, Hand Joint 
Alignment and Motion Scale (H-JAM), Arthritis Impact Measurement Scale 2 (AIMS2), Self -Efficacy, 
EULAR 28 tender, Rheumatoid Attitudes Index (RAI) 
Hammond 1999 
The Arthritis Self-Efficacy Scale (ASES), Joint Protection behaviour Assessment (JPBA), Visual Analog 
Scale (VAS), Grip Strength, Hand Joint Alignment and Motion Scale (H-JAM), Health Assessment 
Questionnaire (HAQ), Arthritis Helplessness Index (AHI), Hand Joint Count, Joint Protection 
Knowledge Assessment ( JPKA ) 
Hammond 1999 
Joint Protection behavior Assessment (JPBA), Visual Analog Scale (VAS), Health Assessment 
Questionnaire (HAQ), Hand Joint Count, knowledge questionnaire 
Scholten 1999 
Stanford Health Assessment Questionnaire, German version of the Freiburg Questionnaire of Coping 
with Illness (FQCI), Beck Depression Inventory (BDI) 
Hammond 1998 Health Assessment Questionnaire (HAQ) 
Lindroth 1997 
Visual Analog Scale (VAS), Arthritis Helplessness Index (AHI), Stanford Health Assessment 
Questionnaire 
Lindroth 1995 Health Assessment Questionnaire (HAQ), Pain (VAS 
Hammond 1994 Joint Protection behavior Assessment (JPBA) 





Table 2-3. Joint protection Principles/Approaches that were reported 
Author(s)  
Year 
Joint Protection Principles 
Siegel 2017 the session was ranging from 45 minutes to 120 minutes 
McGee 2017 
In a standing position, participants maintained standardized glenohumeral and elbow joint positions as well as 
hand placements to control for the distal kinetic variance that might result from non -standardized posturing. 
Carandang 2016 
Uses guidelines that include techniques such as balancing rest and activity and the use of large joints Stresses 
education about disease, symptoms, and prognosis (especially effects of synovitis); incorporates family and 
routine 
Williams 2015 
The Number of sessions dependent on clinical need up to a maximum of three sessions or 1.5 hours in total. 
Rheumatoid Arthritis, a  booklet providing general information about the disease and its management; Looking 
After Your Joints When You Have Arthritis, describing various self-management techniques and JP advice; 
and Keep Moving – How a few Simple Exercises can Make You Feel Better About Yourself and Your 
Arthritis, a  booklet providing general exercise information along with suggestions as to specific exercises that 
could be performed for all parts of the body 
Hammond 2015 
Joint protection: Respect pain; distribute the load over several joints; use the strongest, largest joint to perform 
an activity; avoid working in positions of potential deformity; reduce effort by using assistive devices and 
avoiding lifting and carrying and avoid prolonged periods of working in the same position. • Energy 
conservation: Pace by balancing rest and work and alternate heavy and light activities; use work 
simplification; use correct working positions and postures. 
Dziedzic 2013 
 distributing the weight of what you lift over several joints (e.g., spread the load over two hands) ▸ avoiding 
putting strain on the thumb and repetitive thumb movements ▸ avoiding prolonged grips in one position ▸ 
using as large a grip as possible ▸ reducing the effort needed to do a task (e.g., use labor-saving gadgets; 
avoid lifting heavy objects, and reduce the weight of what you lift) ▸ energy conservation (activity pacing and 
planning) 
Ekelman 2014 
Training includes movement training to promote daily manual work by reducing pain and joint strain, 
preventing deformity, and maintaining functional capacity; self-exercise programs for hands; and provision of 
information on assistive devices, methods to adapt the environment, and the value, use, and handling of 
orthoses. 
Niedermann 2012 
Demonstrations and supervised practice of hand JP methods, mostly in kitchen activities, and demonstration of 
appropriate assistive devices. The interventions consisted of five 45-minute sessions, four over a three-week 
period and one booster session two months later 
Beasley 2012 
Respect pain, balance rest and activity, perform the exercise in a pain-free range, avoid positions of deformity, 
reduce the effort and force, use larger/stronger joints 
Swann 2011 
The main techniques for joint protection are to (Arthritis Research UK, 2010): Use larger, stronger joint s, 
Spread the load over several joints, reduce effort by using labor-saving gadgets, Avoid gripping things tightly, 
Avoid positions that push joints towards 
Boustedt 2010 
Joint protection consists of information about hand anatomy, osteoarthritis, and theoretical and practical 
information about pain and how to cope with it [6]. To introduce alternate working methods to reduce 
difficulties of daily activities the women tried grip assistive devices and elastic thumb splints during the day 
both at the clinic and at home. 
Hammond 2008 
joint protection (including 45min demonstration and practice), managing fatigue, aims of splinting, managing 
stress and relaxation (45 min practice) 
Masiero 2007 
Principles of JP and energy conservation, including a demonstration of various hand-JP techniques, plus a 
homework task to identify problem activities and find solutions based on the imparted principles, work 
difficulties, etc. 
O’Brien 2006 
basic principles of joint protection, energy conservation, ‘top tips’ relating to personal and household 
activities, 
Hammond 2004 Both education programs consisted of four 2-hour weekly meetings. 
Stamm 2002 
joint protection instruction: the need for balance between movement and resting a joint; dividing stress 
between as many joints as possible; using larger and stronger joints; using each joint in its most stable plane to 






principles of joint protection and energy conservation; demonstration of some hand -joint protection methods; 
and a homework task to identify problem activities and to find solutions using the principles taught.  
Hammond 1999 Arthritis and Rheumatism council leaflets 
Hammond 1998 Altering ways of moving hands during daily activities to reduce joint strain  
Hammond 1994 
Four JP principles were assessed: (1) distributing the load over several joints; (2) using each joint in its most 
stable position; (3) reducing effort by use of aids and avoiding lifting; and (4) avoiding positions of possible 
joint deformity 





Table 2-4. Joint protection principles from Physiopedia 
1. AVOID TIGHT GRASP 
• Use a relaxed grip. 
• Enlarge handles. 
• Place the palm on the jar lid, and using the weight of the 
body, turn arm at the shoulder to open the jar. A sponge 
or wet towel under the jar prevents sliding 
• Hold the knife or mixing spoon like a dagger, with the 
handle parallel to knuckles. Cutting is then changed from 
sawing to pulling 
• Don't carry heavy handbags, pails, and bags by the 
handle. 
• Hold everything no tighter tha n necessary. 
• Release tight grasp frequently if you must use it. 
• Use built-up handles on writing utensils, pot handles, 
tools, etc. 
• Use adaptive equipment such as jar openers 
2. AVOID PRESSURE ON BACK OF KNUCKLES 
• Avoid all pressures against the backs of fingers: this 
type of pressure contributes to dislocation of the large 
joints between the palm and the fingers (metacarpal-
phalangeal joints). 
• This occurs while pushing up from a chair using a 
closed fist or resting chin on the backs of fingers. 
• Use palms while holding fingers straight. 
3. USE BOTH HANDS WHEN POSSIBLE • Not specified how 
4. AVOID REPETITIVE HAND ACTIVITIES 
• Take breaks 
• Change activity, i.e., using screwdriver, crocheting 
5. AVOID PRESSURE TO TIP OR PAD OF THUMB 
• The thumb is necessary for 40 percent of hand 
activities 
• Example: opening car doors, ringing doorbells 
• To protect thumb joints, open milk containers with 
heels of the hands rather than thumbs. 
6. AVOID PRESSURE AGAINST THE RADIAL SIDE 
OF EACH FINGER THUMB SIDE 
• Don't rest chin on the side of fingers. 
• Add levers to keys, handles, and knobs. 
• Hold handles straight across the palm. 
7. AVOID PROLONGED PERIODS OF HOLDING 
HANDS IN THE SAME POSITION 
• Sit if the task takes more than 10 minutes. 
• Stand up after sitting for 20-30 minutes. 





Table 2-5. OASIS-Vancouver Coastal Health - Protecting Your Hands 
1. Use your bigger joints to complete a 
task 
• Carry your handbag with your shoulder or forearm. Carry only what you 
need. 
• Push or pull items rather than carry them, e.g., use a wheeled cart for 
groceries 
• Carry large or heavy items with two hands. Hug the object close to your 
body. 
• Close drawers/doors with your hip or choose automatic doors when 
possible 
• Push up from a chair using the palm of your hand, not your fingers. 
Choose higher chairs or use a firm cushion on your chair. 
2. Plan ahead 
• Vary tasks and change your hand position often. Take breaks every 20-30 
minutes. 
• Spread heavier tasks throughout the week 
• Rest your hands before they are tired or sore 
• Organize your workspace to ensure hands and wrists are in a neutral 
posture 
3. Use splints to protect your joints, 
either at rest or during activity 
• Talk to your care team to determine if a  hand or thumb splint would be 
helpful for you 
4. Change your grip and use adapted 
equipment to avoid tight 
gripping/squeezing and force 
through the thumb 
Writing, gardening 
Buy large-handled tools or make your handles 
larger with foam tubing  
Cooking 
Adapted kitchen aids, e.g., finger vegetable 
peeler, ergonomic salad spinner  
Opening jars and cans Jar seal-opener, non-slip grip, electric can opener 
Twisting tops,  
squeezing tubes 
Products with pumps 
Wringing out clothes 
Use the heel of your hand; sponge or washing 
brush 
Driving Foam steering wheel cover 
Pumping gas 
Use the lever on the handle to avoid squeezing 
for a long time 
Pinching a key Keyholder  
Reading Bookholder, books on tape, e-books  
Opening mail Easy-to-squeeze scissors 
Dressing Button hook, zipper pull 
Opening doors, turning taps Lever taps and door handles 
Gripping slippery items, e.g., 
removing credit cards from a 
wallet 
Use a piece of non-slip mat, e.g., Dycem; 
accordion-style wallet  
Self-care, e.g., cutting nails, 
washing hair, etc. 
Adapted equipment from a pharmacy or medical 
supply store 
 
5. Follow the exercises given to you by 
your health care team to keep your 
joints moving and your muscles 
strong 





Table 2-6. East Sussex Healthcare NHS 
1. Use joints in a stable 
position 
• Sit or stand as close as you can when working at a  table or bench as this reduces stretching 
• and bending. 
• Use a grip that keeps the wrists straight and the fingers in line with the wrist as much as 
• possible. 
2. Avoid activities that 
do not allow for a 
change of position 
• Be mindful of how long you have been doing specific activities, joint and muscles do not like to be held 
in the same position. They become stiff and work less effectively which leads to pain, damage and 
further deformity. When writing, doing hand work, release your grip every 10 to 15 minutes. On long 
car trips, get out of the car, stretch and move around at least every  one to two hours. 
3. Respect pain 
• If you have arthritis, you may always have some pain. If pain continues for hours after the activity has 
stopped, this indicates that the event was too much and should have been changed or stopped sooner. 
4. Avoid tight grips or 
gripping for long periods 
• Gripping tightly increases pain and can cause further joint damage. Gripping small objects require 
greater force 
5. Avoid deforming 
positions 
• When opening new or tight jars consider using a gripping aid and direct the force through the palm of 
your hand rather than just through the fingers. There are several types of jar opening devices. Ask others 
to undo the lids, while you close them. 
• Use a flat hand when possible for cleaning, wiping, dusting. 
• Try using cups with larger, straighter handles than cups with curved handles. 
• In general, finger motions should be in the direction of the thumb whenever possible. 
6. Use one large joint or 
many joints 
• Carry objects with your palm open to distribute weight equally over your forearms. 
• Slide objects along a counter or workbench rather than lifting and carrying them. 
• Carry light bags on your shoulders rather than with your hands. 
• When standing up from a chair or bed, rock forward and use your leg muscles rather than pushing up 
from your knuckles or wrists. 
• Use your hip or lower leg to close drawers. 





Table 2-7. Energy conservation and joint protection from NASD 
1. Respect PAIN as a signal to STOP the activity.  
2. Make a  SCHEDULE of daily activities. Write down when PAIN and FATIGUE occur and schedule in REST 
BREAKS as needed.  
3. Avoid POSITIONS OF DEFORMITY and FORCES in their direction. Finger motions should be in the direction of 
the thumb whenever possible. When getting up from a chair or holding a magazine, use the palms of the hands rather 
than the knuckles.  
4. Use the LARGEST and STRONGEST joints available for a job. Save weaker joints for the specific tasks that only 
they can handle. For example, carry bags on the shoulder instead of at the elbow, wrist, or fingers. 
5. Avoid staying in ONE POSITION for a  LONG PERIOD OF TIME. Don't give your joints the chance to become 
stiff. When writing or doing handwork, release your grip every 10 to 15 minutes. On long car trips, get out of the car, 
stretch and move around at least every hour. While watching television get up and walk around every 30 minutes.  
6. Use a CART to carry heavy items. If no cart is available, it is better to take several trips to  get a job done than to 
overload and make one trip. 
7. SLIDE or PUSH items whenever possible.  
8. Avoid making a  TIGHT FIST or PINCHING objects tightly. Instead, use a grasp that places your KNUCKLES 
PARALLEL to the handle of the tool or utensil being used.  
9. DO NOT start an activity that cannot be STOPPED IMMEDIATELY if pain or fatigue should occur.  











Chapter 3  
3 The Effectiveness of Joint Protection Programs on Pain, 
Hand Function and Grip Strength Levels in Patients with 
Hand Arthritis. A Systematic Review and Meta-Analysis 
Abstract 
Study Design: Systematic review with meta-analysis 
Introduction: Joint protection (JP) has been developed as a self-management intervention 
to assist people with hand arthritis to improve occupational performance and minimize 
joint deterioration over time.  
Purpose of the Study: We examined the effectiveness between JP and usual care/control 
on pain, hand function and grip strength levels for people with hand osteoarthritis (OA) 
and rheumatoid arthritis (RA). 
Methods: A search was performed in 5 databases from January 1990 to February 2017. 
Two independent assessors applied Cochrane’s risk of bias tool, and a GRADE approach 
was adopted. 
Results: For pain levels at short-term, we found similar effects between JP and control 
standardized mean difference (SMD) -0.00, 95% CI: -0.42 to 0.42, I2=49%, at mid and 
long-term follow-up JP was favored over usual care SMD: -0.32, 95% CI: -0.53 to -0.11, 
I2=0 and SMD -0.27, 95% CI: -0.41 to -0.12, I2=9% respectively. For function levels at 
mid and long-term follow-up JP was favored over usual care SMD -0.49, 95% CI: -0.75 to 
-0.22, I2=34% and SMD -0.31, 95% CI: -0.50 to -0.11, I2=56% respectively. For grip 
strength levels, at long term JP was inferior over usual care Mean Difference (MD) 0.93, 
95% CI: -0.74 to 2.61, I2= 0%. 
Conclusions: This systematic review provides the most updated evidence on the 
effectiveness of joint protection programs vs. usual care/control in patients with 
rheumatoid arthritis and hand osteoarthritis on clinical outcomes. Evidence of very-low to 
low quality indicates that the effects of joint protection programs compared to usual 
care/control on pain and hand function are too small to be clinically important at short -, 
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3.1 Introduction 
Osteoarthritis (OA) is a degenerative joint disease that affects approximately 27 million 
adults and is ranked in the top three causes of disability in the United States1. The economic 
burden for OA, rheumatoid arthritis (RA), and other rheumatoid conditions in the United 
States were estimated to be approximately 128 billion dollars which represent 1.2% of the 
2003 U.S. gross domestic product 2. Today, more than 272,000 people are living with RA, 
comprising 0.9% of the Canadian adult population, which will increase to 1.3% over the 
next 30 years3. In Canada between 2008 and 2009, the socioeconomic cost of arthritis was 
over 4.4 billion dollars. About 80% of these costs were attributed to the unemployment and 
underemployment 4. Pain from OA has a significant impact on the quality of life, work 
productivity and in the usage of healthcare resources among workers 1. Recent evidence 
from a systematic review suggests that the reduction in health care costs for services to 
manage arthritis is as necessary as the improvement of the quality of life of this patient  
population 5.  
The most common site of OA is in hand, and the most commonly described symptoms are 
pain, joint deformity, loss of grip strength and loss of hand function 6. RA can also affect 
small joints in the hands and may cause painful swelling, joint deformity, loss of joint 
function and increased disability 4. Conservative management of hand arthritis includes 
both pharmacological (e.g., NSAIDs) and non-pharmacological interventions, such as joint 
protection programs, assistive devices, and exercises 7,8. Currently, there is no cure for hand 





maintain functional performance with activities of daily living (ADLs), mediate symptoms, 
and prevent deformities. 
 Joint protection programs were initially developed for people with RA and had been 
expanded to treat patients with hand OA 9. Joint protection intervention includes education 
in altering working habits, use of proper joint and body mechanics by applying ergonomic 
principles, use of assistive devices and orthotics, and modifying functional performance 
and environments. It is often integrated with fatigue management and flexibility and 
strength hand exercises10. It has been suggested that joint protection for people with RA 
may reduce load and effort during daily activities of daily living. Therefore, it is 
theoretically resulting in strain reduction on joint structures which have been weakened by 
the disease, pain mediation, irritation prevention of the synovial membrane and reduction 
of local inflammation and fatigue. Also, it has been suggested that joint protection for 
people with hand OA is aiming to reduce loading on articular cartilage, strengthen muscle 
support, and improve shock-absorbing capabilities of joints10,11. 
Two recent systematic reviews (SRs) 7,12 examined the effectiveness of joint protection on 
people with RA. Each study examined joint protection and provided recommendations 
from 5 RCT’s and 3 RCT’s respectively7,12. Those 2 SRs reported strong evidence that 
joint protection may improve function 7 and pain 7,13. For people with hand OA, a SR found 
that programs of joint protection, advice, and home exercises are effective at improving 
grip strength and hand function14. While those reviews provide valuable insights, they have 
important limitations. Both studies reported effects mostly as statistical differences and not 
as magnitude of the effects. Also, both reviews did not interpret and discussed the potential 
impact of risk of bias when they provide recommendations. Given the limited number of 
RCT’s that were included for joint protection for people with hand OA and RA, an 
appraisal of the most recent evidence is needed. Therefore, the objective of this systematic 
review is to evaluate the effectiveness of joint protection programs when compared to usual 
care/no joint protection/advice on pain reduction and improvement of hand function for 








3.2.1 Search Strategy 
An electronic search was performed to identify RCT’s in PubMed, Google Scholar, 
CINAHL, PEDro and EMBASE from January 1990 to February 2017. Several different 
combinations of keywords were used such as: “rheumatoid arthritis” or “osteoarthritis” 
and/or “joint protection” or “hand osteoarthritis” or “self-management and osteoarthritis”. 
The complete search strategy is summarized in Appendix 1. The references of systematic 
reviews and overviews found in the electronic search were then hand searched to retrieve 
further RCT’s. 
 
3.2.2 Inclusion/Exclusion Criteria 
Only randomized controlled trials (RCT’s) were eligible for inclusion by fulfilling the 
following criteria: (1) RCT’s included people with RA or hand OA, (2) patients received 
joint protection10,11 (3) outcome measures were adequately reported. Studies were excluded 
if: (1) were not written in English, (2) they only examined a specific component of joint 
protection such as an assistive device or orthosis or they did just hand exercises without 
joint protection advice. 
 
3.2.3 Study Selection 
Two independent reviewers (PB and MS) performed the electronic search to screen 
relevant articles based upon title and abstract. After duplications were removed, inclusion 
criteria were applied to retrieve the articles for a full-text review. Disagreements were 







3.2.4 Data Extraction 
Two independent researchers (BP and MS) extracted the data from the included RCT's. A 
third person checked the data extraction (JM). Data extraction included the following 
information: (1) author, (2) year, (3) study population, (4) sample size (5) intervention 
method, (6) primary outcome measures, (7) secondary outcome measures (8) results, and 
(9) recommendations made by authors (if any). We categorized the follow-up periods as 
short-term (3-4 months or less), mid-term (6-8 months) and long-term (12 months or more). 
 
3.2.5 Missing data from Included Studies 
When values (Mean and SD) were not available an attempt was made to contact the 
corresponding authors to request the data. Additionally, we searched other tables from 
previous SR's to identify Means, and SD's of the included RCTs to facilitate our data 
analysis. 
 
3.2.6 Risk of Bias Assessment 
Two reviewers (PB and MS) independently assessed the risk of bias of each RCT. If there 
was a disagreement, consensus came from a third reviewer (JM). Risk of bias assessment 
was performed with Cochrane Collaboration’s tool 15 which contains seven domains 
(random sequence generation, allocation concealment, blinding of participants and 
personnel, blinding of outcome assessment, incomplete outcome data, selective reporting 
and other bias)  to score sources of bias. Each domain can be rated as "low risk of bias," 
"unclear risk of bias" or "high risk of bias." The interpretation of this tool is as follows: 1) 
low risk indicates that if bias is present, results will be unlikely to be altered, 2) unclear 





bias indicates that bias may change the results seriously 15. Publication bias was planned to 
assess with funnel plots if more than ten studies were pooled 16. 
3.2.7 Assessing the quality of individual RCTs 
The GRADE guidelines for systematic reviews were used to evaluate the quality of 
individual RCTs related to five outcomes: hand function/functional ability, grip strength 
and pain/hand pain levels 17–22. GRADE approach includes the rating of the quality of 
evidence such as study limitations, risk of bias, publication bias, imprecision and 
indirectness 17–21. The rating of the quality of individual RCTs per outcome across trials 
was carried out to summarize the extent of our confidence that the estimates of the effect 
were correct. This GRADE approach resulted in an assessment of the quality of each RCT 
for each outcome across trials as high, moderate, low, or very low 17–21. The domains of 
GRADE approach that may decrease the quality of evidence are: 1) imprecision, 2) 
indirectness, 3) limitations in study design, 4) inconsistency and 5) reporting bias. An 
optimal information size (OIS) was calculated to define the minimum amount of sample 
size needed for precision in the meta-analysis. 
 
3.2.8 Summary Measures 
To interpret our data a standard deviation of 0.5 points for pain and function was used to 
indicate clinical importance23.  We analyzed outcomes at short-term (3 – 4 months), mid-
term (6 – 8 months) and long-term (12 months) follow-ups.  
 
3.2.9 Subgroup Analysis and Exploring Heterogeneity 
In the presence of clinical or statistical heterogeneity (i.e., Chi2 with p<.05 and I2>50%)15, 
we planned to perform the following subgroup analyses (a priori): trials at low risk of bias 
(low risk of bias in allocation concealment and blinding of outcome assessor if objective 






3.2.10 Synthesis of Results 
We performed six meta-analyses of trials comparing joint protection programs vs. usual 
care/control in patients with rheumatoid arthritis using the outcomes function, pain, and 
grip strength at short-, mid- and long-term follow-ups. When necessary, data direction was 
adjusted appropriately to reflect improvements in pain reduction and functional ability. We 
used the Review Manager 5.3 (RevMan 5.3) software to conduct our review and a random-
effects model to pool outcomes. For outcomes of the same construct that were measured 
using a different metric, we used the standardized mean difference (SMD). If all eligible 
trials measured an outcome using the same metric, we used a weighted mean difference 
(WMD).   
 
3.3 Results 
3.3.1 Characteristics of Included studies 
Initially, 8,837 articles were identified (Pubmed: 4,161 EMBASE: 1,403 Google Scholar: 
3,016 CINAHL: 104 PEDro: 49). After removal of duplicates, 6,027 articles were then 
excluded (4,420 non-hand wrist population, 1,376 not talking about joint protection). Of 
the 29 studies were deemed relevant from the abstract, 17 met our inclusion criteria and 
were included in the analysis (Figure 1). Joint protection programs were examined in 3 
RCT’s for hand OA and in 14 RCT’S for patients with RA. The characteristics of the 
included RCT’s are summarized in Table 1.  
 
3.3.2 Excluded Studies 
Of the 29 studies that were deemed relevant for a full-text review, 12 articles were excluded 





1. Ineligible study design – Non-randomized studies (n=1, Boustedt et al. 200924)  
2.  Used same data/participants with included RCT (n=1, Oppong et al. 201525) 
3. Ineligible population – RCT (n=1, Maggs et al. 199626)  
4. Ineligible intervention – RCT (n=7, Grønning et al. 201427, Grønning et al. 201228,  Lorig 
et al. 200929, Barlow et al. 200830, Brus et al. 199831, Riemsma et al. 199732, Fries et al. 
199733) 
5. Both groups examined the same JP intervention with a different approach – RCT (n=2, 
Niedermann et al. 201234, Niedermann et al. 201135) 
 
3.3.3 Risk of bias and Quality assessment  
Overall, all the 17 studies were judged to be high risk of bias (Table 2); (Figure 2). 
Selection bias, performance bias, and reporting bias were the main contributors that 
influence our results (Figure 2). Funding sources were reported in the majority of the 
included RCTs. Quality assessment was ranging from very low to low, and most of the 
studies were downgraded for imprecision and high risk of bias. The summary of the 
findings is presented in Table 3. 
 
3.3.4 Selection Bias 
Randomization and allocation concealment were not reported appropriately in many of the 
studies and was the main reason that studies were rated as high risk. More specifically, 
randomization sequence generation and allocation concealment were rated as high risk in 








3.3.5 Performance Bias 
Blinding of participants and personnel was rated as high risk in 12 studies because the 
blinding procedure was not performed adequately. Only five studies were rated as low risk, 
and they managed to blind the participants and providers effectively (Table 2). 
 
3.3.6 Detection Bias 
The majority of the studies (10 RCTs) were rated as low risk, and they managed to blind 
the outcome assessor effectively.  Seven studies rated as high risk because the blinding of 
the outcome assessor could not be achieved (Table 2). 
 
3.3.7 Attrition Bias 
Sixteen studies were rated as low risk of bias for attrition bias, and only one was rated as 
high risk. The RCT that was rated at high risk did not report any dropouts and did not report 
if all the participants were analyzed after randomization (Table 2). 
 
3.3.8 Reporting and Other Bias 
Most of the studies (16 RCTs) reported the timing of outcome assessment. Description of 
co-interventions was unclear in 16 studies because of poor reporting and only 2 RCTs36,37 
performed trial registration and published their protocol. Seven studies38–44 did not report 








3.3.9 Publication Bias 
We assessed publication bias for the meta-analysis of pain and function outcomes (Figure 
3-4). The asymmetrical funnel plot (Figure 4) demonstrates that the smaller RCTs produced 
exaggerated treatment effects. 
 
3.3.10 Participants 
Data from a total of 1,847 participants with hand arthritis were included in this systematic 
review. The majority of them (n=1,504) have been clinically diagnosed with RA and only 
343 participants with hand OA. The average age of the participants with hand OA was 61 
years old, and 70% or more were females. The average age of the participants with RA was 
62.8 years old, and more than 70% of the sample was females. 
 
3.3.11 Interventions 
Studies that included in this systematic review compared joint protection programs that 
had an exercise component, or the participants received instruction on exercise, joint 
protection education and either was administered individually or to a group and was mostly 
delivered by an occupational therapist. Comparisons consisted of no treatment, advice, 
usual care, patient education. Treatment dose and frequency were varied a lot across the 
studies but typically was on average 3-5 times per week from 45 minutes to 1.5 hours. A 
summary of the interventions and the comparators is presented in Table 1.   
 
3.3.12 Outcomes  
Outcomes of interest that were extracted from the included studies were: pain levels36,42,54–





Outcome Questionnaire pain subscale (MHQ) (0-100) with lower scores indicating better 
pain scores, (2) Numerical Rating Scale (0-10) higher score is worse and (3) Visual Analog 
Scale (VAS) (0-100mm) higher score is worse. Self-report hand function42,43,54,56–58,44–
48,50,52,53 was assessed with the following outcome measures: (1) Michigan Hand 
Questionnaire (MHQ) (0-100) higher scores indicating better performance, (2) 
Australian/Canadian (AUSCAN) Osteoarthritis Hand Index (0-36), (3) Health Assessment 
Questionnaire (HAQ) (range from 0-3) higher is worse and (4) Arthritis Impact 
Measurement Scales II (AIMS II; upper limb, and hand and finger function subscales) 
Subscales range score of 5–25 (25 indicating severe functional difficulties).  Grip 
strength45,46,49–53,56 levels were assessed with a Jamar hand-held dynamometer and with a 
Smith and Nephew Rolyan Digital Dynamometer. 
 
3.3.13 Effects of interventions on RA 
Short-term effects of interventions on pain levels 
Three studies were pooled to examine the short-term effect of a joint protection program 
vs. usual care on pain levels. We found similar effects between joint protection programs 
and usual care/control (very low quality, 3 RCTs, 548 participants with RA, standardized 
mean difference (SMD) -0.00, 95% CI: -0.42 to 0.42, I2=49%). The analysis is illustrated 
in Figure 5.  
Mid-term effects of interventions on pain levels 
Three studies were pooled to investigate the mid-term effects of a join protection programs 
vs. usual care/ control on pain levels. We determined that joint protection was favored over 
control (very low quality, 3 RCTs, 358 participants with RA, SMD: -0.32, 95% CI: -0.53 








Long-term effects of interventions on pain levels 
Four studies were pooled to examine the long-term effects of joint protection programs vs. 
usual care/control on pain levels. We determined that joint protection was superior when 
compared with control (low quality, 4 RCTs, 857 participants with RA, SMD -0.27, 95% 
CI: -0.41 to -0.12, I2=9%. The analysis is presented in Figure 5.  
Short-term effects of interventions on function levels 
Only one study reported values of the function that we could calculate the SMD. We found 
that the JP intervention was superior when compared to usual care (very low quality, 1 
RCT, 451 Participants with RA, SMD 0.18, 95% CI: -0.01 to 0.36). 
Mid-term effects of interventions on function levels 
Three studies were pooled to investigate the mid-term effects of joint protection vs. control 
on function levels. We determined that intervention groups were superior over control 
(very low quality, 3 RCTs, 358 participants with RA, SMD -0.49, 95% CI: -0.75 to -0.22, 
I2=34%. The forest plot is illustrated in Figure 6. 
Long-term effects of interventions on function levels 
Six studies were pooled to investigate the long-term effects of joint protection vs. control 
on function levels. We determined that intervention groups were superior over control 
(very low quality, 6 RCTs, 1,077 participants with RA, SMD -0.34, 95% CI: -0.50 to -0.11, 
I2=56%. The forest plot is illustrated in Figure 6. 
Short-term effects of interventions on grip strength levels 
One study reported the short-term effects of joint protection vs. control/usual care on grip 
strength levels. We determined that joint protection programs were inferior when compared 
to usual care/control (very low quality, 1 RCTs, 400 participants with RA, MD 1.38, 95% 






Mid-term effects of interventions on grip strength levels 
One study investigated the mid-term effects of joint protection programs vs. usual 
care/control on grip strength levels. We found that join protection programs were superior 
over usual care/control (very low quality, 1 RCTs, 121 participants with RA, MD -1.39, 
95% CI: -5.02 to 2.24). Analysis and the strength of evidence are presented in Figure 7. 
Long-term effects of interventions on grip strength levels 
Two studies were pooled to examine the long-term effects of join protection programs vs. 
usual care/control on grip strength levels. We determined that joint protection programs 
were inferior when compared to control (very low quality, 2 RCTs, 478 participants with 
RA, MD 0.93, 95% CI: -0.74 to 2.61, I2=0). Analysis and the strength of evidence are 
presented in Figure 8. 
 
3.3.14 Effects of interventions on hand OA 
From the three studies that included participants with hand OA only 1 RCT46 reported clear 
means and SD. For short-term effects on pain levels, we found similar effects when joint 
protection compared to no joint protection (high risk of bias, relatively small sample size; 
257 participants with hand OA, MD -0.10, 95% CI: -0.60 to 0.40) for function levels, we 
found that joint protection was no better than no joint protection (high risk of bias, 
relatively small sample size; MD -0.20, 95% CI: -1.59 to 1.99). For midterm effects on 
pain and function levels, we found similar effects when joint protection compared to no 
joint protection (high risk of bias, relatively small sample size; MD -0.30, 95% CI: -0.23 
to 0.83), (high risk of bias, relatively small sample size; MD 0.50, 95% CI: -1.38 to 2.38) 
respectively. For midterm effects on grip strength levels, we determined that joint 
protection was superior when compared to no joint protection (high risk of bias, relatively 
small sample size; MD -2.20, 95% CI: -7.53 to 3.13). For long-term effects on pain and 





intervention (high risk of bias, relatively small sample size; MD 0.10, 95% CI: -0.45 to 
0.65), (high risk of bias, relatively small sample size; MD 1.20, 95% CI: -0.68 to 3.08) 
respectively. 
 
3.3.15 Unknown Treatment Effects on Extracted Outcomes 
There were five studies for participants with RA and two studies for people with hand OA 




O'Brien et al. 200657 (n=67) investigated the effectiveness of 3 different joint protection 
groups on function and pain at 1, 3 and 6 months follow-up (high risk of bias, relatively 
small sample size; low quality). Hammond et al. 200449 (n=127) examined the 
effectiveness of educational-behavioral joint protection programme vs. a standard 
programme on pain, functional ability and grip strength at 24 months follow-up (high risk 
of bias, relatively small sample size; low quality). Hammond et al. 200250 (n=30) examined 
the effectiveness of joint protection first vs. joint protection second on pain functional 
ability and grip strength at 3 and 6 months follow-up (high risk of bias, relatively small 
sample size; very low quality). Helliwell et al. 199940 (n=77) examined the effectiveness 
of a joint protection programme vs. control on functional ability at 1 and 12 months follow-
up (high risk of bias, relatively small sample size; very low quality). Lindroth et al. 199754 
(n=100) examined the effectiveness of a joint protection programme vs. control at 3 and 








Hand OA  
Dilek et al. 201356 (n=46) examined the effectiveness of paraffin bath therapy and joint 
protection vs. joint protection on pain, self-report function and grip strength levels in 
patients with hand OA at 3 weeks and 3 months follow-up (high risk of bias, relatively 
small sample size; very low quality). Stamm et al. 200259 (n=40) assessed the effectiveness 
of a joint protection program plus hand exercises vs. a control group (information only), 
on grip strength levels, pain and functional ability, in patient with osteoarthritis, at 3 months 
follow up (high risk of bias, relatively small sample size; very low quality) 60. We were 
unable to calculate effect sizes or report between-group (mean/median difference) 
improvements for pain and functional levels due to lack of reporting in group means, 
standard deviations, standard errors of means, confidence intervals or p-values. Only grip 
strength values were reported, and we found similar effects between joint protection 
intervention and control with an MD -0.01, 95% CI: 0.12-0.10 (Units: bar) between the 
joint protection and control at 3 months follow-up. 
 
3.4 Discussion 
We aimed to summarise the current evidence of the effects of joint protection programs vs. 
usual care/control in patients with rheumatoid arthritis and hand osteoarthritis on clinical 
outcomes of pain, functional ability, and grip strength. Based on the results of this study, 
we found no clinically important differences in function, grip strength or pain levels at 
short-, mid- and long-term follow-ups. Our study provides more definitive estimates of 
joint protection treatment effects for people with rheumatoid arthritis based on our meta-
analysis. Imprecision and high risk of bias were the main reasons that the quality of 
evidence was downgraded. 
Nine different studies reported comparable outcomes and had multimodal JP interventions 





between treatment groups and usual care/control. The wide confidence intervals that 
crossed the vertical line imply that the studies’ results d id not find a statistically significant 
between the tested groups and also, that the sample size was low. While JP as multimodal 
intervention reduced pain for people with RA at mid and long-term follow-up, the 
magnitude of the pooled estimates was smaller than the predefined clinically important 
difference (SMD>0.5). At long-term follow-up, the number of pooled participants (n=857) 
exceeded the estimated optimal information size (OIS) (n=685) which it indicates that we 
had adequate sample size to be precise in our pain level estimates. The effect sizes of the 
pooled estimates regarding function levels were improved from short-term to mid-term 
(SMD -0.49, 95% CI: -0.75 to -0.22) and at long-term follow-up slightly declined (SMD -
0.34 95% CI: -0.50 to -0.11). While these estimates are lower than the predefined clinically 
important difference, it is evident that the hand function at mid-term was improved (SMD 
-0.49) very close to the clinically important margin. The upper bound of the 95% CI 
indicates an SMD of -0.70 however, due to imprecision issues (n=358<OIS) we cannot be 
confident for the treatment effect if it can be clinically worthwhile or not. Regarding grip 
strength, our short and long-term effect estimates indicated that joint protection programs 
were inferior to usual care/control. At mid-term JP programs were superior to usual 
care/control in terms of grip strength levels. However, the tested power was very low 
because of the wide confidence intervals and also, that the studies’ results did not observe 
a statistically significant difference. Generally, the measurement of grip strength as a 
performance-based test provide very useful information in clinical practice because it’s an 
indication of hand function. Previous studies have indicated a negative correlation between 
grip strength and disease activity for people with RA and showed that the grip strength 
becomes worse when the disease is more active61,62. While joint protection principles 
indicate to maintain your muscle strength and range of movement, it is unclear if the 
instructed exercises are optimal to improve hand grip strength. Given the disease activity 
and the lack of clarity of joint protection programs, the results of grip strength are even 
more ambiguous. For patients with hand OA, only one study reported means and SDs for 





protection. However, this study was rated as high risk of bias with a relatively small sample, 
and therefore, we have very little confidence about the treatment effects.  
Previous recent systematic reviews (SR) reported strong evidence that joint protection may 
improve function 7 and pain 7,13. Our findings are not in concordance with those 2 SR, and 
this can be attributed to the following main reasons. First, we included more studies (14 
RCT’s and 3 RCT’s) in our analysis for people with RA and hand OA respectively. We 
reported treatment effects of MD, SMD and 95% confidence intervals to indicate the 
magnitude of the effects. Second, we took a more conservative approach while 
synthesizing the evidence by using the Cochrane risk of bias tool and using GRADE 
approach to rate the quality of the evidence.  
Publication bias was assessed with two different funnel plots (Figure 3-4). While an 
asymmetry was detected in both figures, we deem that they do not indicate publication 
bias. In our meta-analysis, we pooled less than ten studies to examine the effects of 
interventions. However, the tested power was low, and it was very difficult to distinguish 
from the real asymmetry16. A statistical heterogeneity was detected at long-term function 
levels (p=0.05, I2=56%). For that reason, we downgraded the quality of the evidence by 1 
level for long-term function levels. A potential explanation for the causes of statistical 
heterogeneity it may be due to variations in the treatment effects of a particular study from 
the pooled studies. This study43 favors control over the experimental group when 
examining the function levels at long-term follow-up which was not consistent with the 
other studies. The contributing percentage in the I2 value when this trial added in the 
analysis was an additional 36% which it may be attributed to a false variation from the real 
treatment effect. 
Strengths of this SR are that we used the most conservative approach to assess risk of bias 
with Cochrane risk of bias tool. We interpreted our results by summarizing the results by 
providing GRADE rating. We calculated effect sizes and we presented confidence intervals 
to indicate the magnitude of the effects and whether the effects were meaningful or not. 
We estimated the optimal information size (OIS) to demonstrate whether our results had 







3.4.1 Future Implications 
While this is beyond the scope of this systematic review, the current state of the literature 
is not clear about the dosage, intensity, and frequency of joint protection programs and 
when other aspects are incorporated (e.g., assistive devices, orthotic devices, exercises) 
when this therapeutic approach is delivered to people with hand arthritis. We were unable 
to extract instructions on joint protection in a specific and measurable way because of lack 
of reporting. Future research should aim to be more specific for all the components of joint 
protection programs for better head to head comparisons.  
 
3.4.2 Limitations 
Our study has some limitations that need to be addressed. While a thorough literature 
review was conducted, trials that were under development may have been missed. Also, 
we were unable to calculate the effect sizes from some of the included studies, and 
therefore, we are uncertain of their effect. We extracted outcome measures for pain, hand 
function, grip/pinch strength and we did not analyze further outcomes for the effectiveness 
of joint protection. 
 
3.5 Conclusions 
This systematic review provides the most updated evidence on the effectiveness of joint 
protection programs vs. usual care/control in patients with rheumatoid arthritis and hand 
osteoarthritis on clinical outcomes. Evidence of very-low to low quality indicates that the 
effects of joint protection programs compared to usual care/control on pain and hand 
function are too small to be clinically important at short-, intermediate- and long-term 
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Table 3-1. Summary of the included studies 
Study 
Population Groups Outcomes Follow ups Experimental group Comparison group 




Age (yr.) = exp. 
61.3 (SD 12), con. 






usual care  
-overall hand 
function subscale 
of the Michigan 
Hand Outcome 
Questionnaire 
(MHQ), (0 – 100) 
higher indicating 
better performance 
-Pain sub-scale of 
MHQ (0–100; high 
score is worse) 
-grip strength 
(Newton) 
4 and 12 
months 
-assessment and advice session plus five 30- to 
45-minute exercise sessions spread over 12 
weeks l content of usual care arm treatment.  
-an exercise programme aiming to improve 
strength, mobility and dexterity (including four 
strength 
-exercises for the hand and seven mobility 
exercises of all the upper limb joints)  
-a home exercise plan with exercises performed 
daily 
-a standardised protocol for progression or 
regression 
-strategies to improve programme adherence 
including exercise diaries 
-no resting orthotic devices, no manual therapy 
or electrotherapy, assessment and treatment  
documented using a standardised log. 
-individual appointment(s) with a therapist 
(number of sessions dependent on clinical 
need up to a maximum of three sessions or 
1.5 hours in total) 
-JP advice 
-provision of Arthritis Research Campaign 
(ARC) booklets containing further advice and 
-exercise information 
-functional splinting as deemed necessary by 
the therapist  
-assistive devices as required  
-no resting orthotic devices provided, no 
explicit exercise prescription, no manual 
therapy (i.e. joint mobilisations) or 
electrotherapy assessment and treatment 
documented using a standardised log 
Dziedzic 
2013 




Age (yr.) = leaflet 
& advice 67.2 (SD 
9.5), Joint 
protection (JP) 
65.5 (SD 8.6), 
Hand exercises 
(Hex) 64.5 (SD 9), 














severity over the 





-Grip strength (kg) 
3, 6 and 12 
months 
For the remaining 75% of participants, in 
addition to receiving the leaflet, they received 
one of three interventions: joint protection, 
hand exercises, or a combination of the two. 
The interventions were all delivered over four 
group sessions (held once a week) by nine 
occupational therapists (OTs) in two hospital 
centres. OTs were rotated every 3 months to 
minimise the potential for bias. The rotation 
order was determined by the OTs availability to 
deliver the specific intervention. 
Groups included up to six participants and 
lasted for a maximum of one hour (1.5 h for the 
combined intervention). Treatment session 
duration and participant attendances were 
recorded by the OTs on case report forms  
(CRFs). Attendance adherence was audited by 
the study coordinator (SH), and was defined (a 
priori) to be per protocol if participants 
attended: session 1, 2, 3 and 4; sessions 1, 2 and 
4; sessions 1, 3 and 4; or sessions 1 and 4. Any 
participant unable to attend week 1 was booked 
on to the following course. 
All participants were given standardised 
written information on self-management  
approaches for hand osteoarthritis (OA) 
including general information on looking 
after hand joints and using analgesia 
(reproduced with permission from the 
Arthritis Research UK leaflets ‘Looking after 
your joints when you have arthritis’ and 
‘Osteoarthritis’, respectively 
(http://www.arthritisresearchuk.org/), and 
the National Institute of Health and Care 
Excellence (NICE) good practice guidelines. 
Participants were advised to continue with 
any self-management approaches they were 
currently using and were given advice to 
consult their general practitioner if symptoms 
continued to be troublesome. For 25% of 
participants this was the sole intervention. 
 
Dilek 2013 N=46 (40 females) 
Hand 
Osteoarthritis 
Age (yr.) = exp. 
58.87 (SD 9.47), 















- Grip strength 
(Jamar) (kg) 
 
3 weeks and 
3 months 
Experimental group treated with dip-wrap 
paraffin bath therapy and Joint protection. The 
temperature of the paraffin bath was 50C. 
Patients dipped both hands into the paraffin, 
removed them, and waited for the layer of 
paraffin to harden and become opaque. Then 
they redipped both hands. These steps were 
repeated 10 times. When the last layer 
hardened, their hands were wrapped within a 
plastic bag and covered with a towel. They then 
waited for 15 minutes until the paraffin cooled. 
A physiotherapist in the Department of Physical 
Medicine and Rehabilitation in the university 
hospital conducted these treatments 5 days per 
week for a period of 3 weeks. 
Control group received joint protection 











Age (yr.) = exp. 
55.56 (SD 13.10), 



















6 and 12 
months 
The LMAP included two modules, each with 
four 2.5h meetings, and one 2-h review 
meeting. To standardize programme delivery, a 
two-day training course for each module (led by 
A.H.) was completed by therapists. This 
explained: evidence for programme 
interventions; patient education and 
behavioural change methods; tips for good 
teaching practice (e.g. voice modulation, eye 
contact, open questions, reflecting back,  
positive feedback); programme structure; and 
role play of sessions emphasizing group 
processes, teaching techniques and skills 
teaching. A.H. delivered a programme observed 
by the therapists. The therapists were then 
observed delivering a programme and given 
feedback on performance. Module manuals  
enabled adherence to programme content. 
Participants could attend the two LMAP 
modules and review meeting over a 3- to 9-
month period, as convenient to them. Six people 
could attend module 1 (‘Looking After Your 
Joints’), 7–10 module 2 (‘Keeping Mobile and 
Managing Pain and Mood’) and up to 12 the 
review meeting. Each meeting included self-
monitoring, skills training with individualized 
feedback and advice, goal-setting and action 
planning to follow individually determined 
home activity and exercise programmes  
working towards recommended frequency 
targets. 
Standard programme consisted of five 2-h 
meetings including talks each week from a 
different member of the team and group 
discussion. Meeting 1 included: what is 
arthritis, how it affects joints and other parts 
of the body, drug treatments and tests, 
managing arthritis (rheumatology nurse and 
consultant rheumatologist); Meeting 2: 
exercise (including stretch programme with 
30 min demonstration and practice), rest, 
posture and pain management [using heat and 
cold, transcutaneous electrical stimulation 
(TENS), massage] [physiotherapist (PT)]; 
Meetings 3 and 4: joint protection (including 
45 min demonstration and practice), 
managing fatigue, aims of splinting, 
managing stress and relaxation (45min 
practice), foot care [occupational therapist 
(OT)]; Meeting 5: healthy diet, 
complementary therapies, Social Security 
benefits and open discussion (nurse, OT, PT, 
social worker). Usually the same OT attended 
each week to facilitate discussion and 
programme management. Relevant Arthritis 
Research Campaign and Arthritis Care 
booklets were provided. Eight to 12 people 
were invited to attend each programme. 




Age (yr.) = exp. 
55.32 (SD 11.80), 










(HAQ) (0-3), 0 (no 
functional 
limitation) to 3 
(serious functional 
limitation 
12 months  An intensive education program was proposed 
to deliver a large quantity of information about 
the disease and the treatment, but also to point 
the possibilities to reduce pain and stress at 
home, to understand how to use nonchemical  
treatment (e.g., physical activities or sports, 
social and professional behaviors, nutritional 
advice). The interactive multidisciplinary 
education program consisted of passive 
information on the disease, on medical 
treatment, and on lifestyle advice concerning 
diet, but also included information on active 
coping strategies, joint protection, relaxation, 
and physical exercise, with the teaching of an 
exercise program to be followed at home. 
Sessions were conducted on Thursdays for 6 
hours for 8 consecutive weeks. 
Usual care 




Age (yr.) = exp. 
54.2 (SD 9.8), con. 





















using the Health 
Assessment 
Questionnaire 
(HAQ), which is 
an ordinal score 
measure (range 0–
3) 
8 months The Experimental Group continued with their 
usual drug treatment (with infliximab) in the 
follow-up months, but additional educational–
behavioral JP training was provided. This 
training consisted of four meetings based on 
approximately 3-h sessions, every 3 weeks, for 
groups of 4–6 patients at a time, with one or 
more family member (the patients were 
encouraged to bring a partner). The education 
methods used were group discussion, problem 
solving, guided practice, and lectures designed 
to facilitate understanding of the program. At 
the beginning of each session, feedback was  
provided, and the results of and problems with 
home practice were discussed. At the end of 
each meeting, patients received an illustrated 
brochure on the program meeting with a home 
guide. 
The Control Group patients received only 
anti-TNFα drugs (infliximab) and continued 
with their usual drug monitoring and medical 
management regimen in the follow-up 
months, but no physiotherapy, occupational 
therapy, or other additional treatments were 
performed or permitted 




Age (yr.) = group1 
62.3 (SD 9.95), 









Scales II (AIMS II; 
upper limb, and 
hand and finger 
function subscales) 
Subscales range 
1, 3 and 6 
months 
Group 1 received JP and additional instruction 
on how to perform a total of eight simple 
strengthening and mobilizing (stretching) 
‘tendon gliding’ exercises. These encouraged a 
maximum range of movement of all small joints 
of the fingers, thumb and wrist, as well as radial 
finger walking (fingers moving towards the 
Joint protection leaflet which covered the 
basic principles of joint protection, energy 
conservation, ‘top tips’ relating to personal 
and household activities, postural advice, 
























score was then 
normalized so that 
the potential range 
of scores was 0–10 
where higher 
scores indicate 
more problems  
-Grip Strength 
(Jamar) lbs 
radius only thus avoiding exacerbating ulnar 
deviation), pinch grip exercises, strengthening 
the intrinsic, and thenar eminence muscles 
(using a towel) and wrist extensor muscle 
groups with a ‘Theratubes’ resistive band 
(Promedics, UK). Group 2 participants received 
the joint protection leaflet together with a set of 
eight stretching exercises, without any specific 
strengthening exercises. Exercises included 
wrist flexion, extension and circumduction, 
pronation and supination, radial deviation as  
well as global flexion and abduction of all 
finger joints, thumb opposition and 










Age (yr.) = exp. 
















Scales2) was used 
to assess activities 
of daily living 
(ADL) (0-10, 0 
indicates good 
function) 
-Grip Strength (kg) 
24 months The educational behavioural JP consisted of 
four 2-hour weekly meetings. The Educational-
behavioural joint protection programme applied 
educational, behavioural, motor learning and 
self-efficacy enhancing strategies to increase 
adherence. 
The education consisted of four 2-hour 
weekly meetings. The standard programme 
included talks from the rheumatology teams 
on:  RA, drug treatments, diet, exercise, pain 
management, relaxation and joint protection. 
Hammond 
2002 




Age (yr.) = 52.3 
(SD 12.08 




















3 and 6 
months 
The ‘Looking After Your Joints’ programme 
included: information about RA and disease 
management, joint protection and energy 
conservation education. About 5 hours of joint 
protection practice was included, using motor 
learning, mental rehearsal, problem-solving and 
behavioural methods, with the setting of weekly 
goals to practise joint protection methods at 
home. It also included self-efficacy and 
adherence-enhancing strategies. Structured 
teaching methods were used to enhance recall,  
such as explicit categorisation, repetition, 
checking understanding by asking regular 
questions and structured visual aids. An 
information pack and a workbook were 
provided, containing summaries of the four 
sessions and a home programme, as well as  
other information about the disease, its 
management (including drug therapy), exercise,  
rest, energy conservation and splinting; these 
were also briefly discussed in the programme. 





Stamm 2002 N=40 (40 females) 
Hand 
Osteoarthritis 
Age (yr.) = exp. 
58.87 (SD 9.47), 
























3 months The JPE group received oral and written 
instruction for joint protection and a home hand 
exercise program, which was to be performed 
daily throughout a study period of 3 months. 
The following principles were explained during 
the joint protection instruction: the need for 
balance between movement and resting a joint; 
dividing stress between as many joints as  
possible; using larger and stronger joints; using 
each joint in its most stable plane to reduce 
pressure on the joint; avoiding staying in one 
position; and avoiding vibrations for the finger 
joints. In addition, patients were trained to 
protect their joints, using assistive devices if 
necessary to perform Activities of Daily Living 
(ADL). Patients were trained to do the 
following activities in a protective way:  
wringing a cloth; using enlarged grips for 
writing; opening jars, cans, or boxes with 
Dycem; using a book holder for reading; and 
using a rocker or angled knife for cutting food. 
Patients were encouraged to find exam- ples for 
application of these principles in their own daily 
activities, which were discussed. Oral and 
written information was provided. The joint 
protection instruction and ADL training took 30 
minutes for each patient. The exercise program 
consisted of 7 exercises: making a fist, making 
a small fist (flexing the PIP and DIP joints 
only), flexing the MCP joints while keeping the 
PIP and DIP joints stretched, touching the tip of 
each finger with the tip of the thumb while 
keeping each finger flexed, spreading the 
fingers as far as possible with the hand lying flat 
on a table, pushing each finger in the direction 
of the thumb with the hand lying flat on a table, 
and touching the MCP V joint with the tip of the 
thumb. 
The control group was given oral and written 
information about hand OA to ensure that 
these persons also received proper attention. 
The information about hand OA included 
information on joint anatomy and 
pathogenesis of OA. During this session, 
each control person also received a piece of 
Dycem (nonslip matting), which they were 
told to use for opening jars throughout the 
period of 3 months. Duration of this session 
was 20 minutes. 
Hammond 
2001 




Age (yr.) = exp. 
51.56 (SD 9.73), 


















Scales) 0 to 10, 




6 and 12 
months 
The joint protection programme was based on 
the health belief model and the theories of social  
learning and self-management and was con- 
ducted by an experienced rheumatology 
occupational therapist. Between three and six 
participants usually attended and, with partners  
included, numbers were between four and eight. 
Participants were provided with an information 
pack and workbook detailing the principles of 
joint protection, with photographs of a range of 
joint protection methods. The programme 
applied educational, behavioural, motor 
learning and self-efficacy enhancing strategies  
to increase adherence to the joint protection 
programme, as well as a range of educational  
methods to match different group members’ 
learning styles. Two-thirds of the programme 
was spent practising hand-joint protection 
methods in small groups with feedback on 
performance from each other and the group 
leader. People were shown a range of options 
for task performance, so that they could select 
which methods worked best for them. 
Education programmes was of 8 h duration over 
four afternoon or evening sessions of 2 h each 
The standard programme included short talks 
from nursing, medical, occupational therapy 
and physiotherapy staff on the following: 
RA; drug treatments; alternative therapies, 
diet; exercise, rest and positioning; energy 
conservation; joint protection; assistive 
devices; splinting; pain and relaxation; and 
other methods of controlling pain (e.g. heat 
and ice). Some demonstration and practise of 
exercise, joint protection and relaxation was 
included (15–45 min for each). Meetings 
allowed time for discussion and information 
leaflets were provided. Education 
programmes was of 8 h duration over four 









Age (yr.) = exp. 










1 and 12 
months 
The education classes took place over 4 weeks  
in four afternoon sessions lasting 2 h. Subjects 
were encouraged to bring a partner, although 
this happened infrequently. For people who 
were still working or who preferred to come 
with a partner, evening sessions were arranged.  
The format of the sessions was a talk from a 
non- medical health professional using 
overhead projection, a discussion period and the 
distribution of supporting literature. The 
content of the sessions included the 
pathophysiology of rheumatoid arthritis, drug 
treatments, local treatments, mechanisms and 
control of pain, stress, exercise and rest, joint 
protection, task allocation, splinting and 
assistive equipment. 
Not reported/No details 

















12 months The following fields were covered:  
pathogenesis and mechanisms of RA, benefits  
and limitations of drug therapy, the impact of 
physiotherapy, practical exercise in remedial  
gymnastics aimed at relieving pain and muscle 
tension, use of joint protection devices, 
orthopedic perspectives including methods and 
indications of joint replacement, psychological 
counseling including coping strategies, 
Jacobson stress management and relaxation 
exercise, 20 dietetics, information about 
unproven cures, and social assistance to 
improve the patients’ utilization of public social 
resources. Psychological counseling 
emphasized a general sense of control or 
efficacy, and skill in coping with variability of 
the disease and its sequelae. Training in the 
proper execution of remedial gymnastics was  
offered and advice on joint protection was  
included in the program. The aim of the exercise 
practice sessions was to keep the patients 
mobile by feasible therapeutic exercises  
preserving the axis of the joints destroyed by 
RA and by reinforcing the weakened muscles. 
Within a daily l0-minute training program 
nearly every joint had to be moved in the right 
position and direction. The patients were taught 
performance of everyday activities and how to 
use auxiliary devices like special scissors or 
knives. The importance of wearing orthotic 
devices at night or during manual activities was 
emphasized. 
Control/No additional details 
Hammond 
1999 




Age (yr.) = 55.17 
(SD 9.39) 
 -Pain (visual 
analogue scale) (0–












3 and 6 
months 
The JP group education programme consisted 
of four weekly 2-h sessions, plus an optional 
home visit within 2 weeks of the end of the 
programme. It was led by an experienced 
rheumatology occupational therapist. Partners  
or significant others were invited to attend. 
Between four and eight people attended each 
programme. A teaching manual was followed 
throughout to standardise the programme 
content and delivery. Patients were provided 
with a workbook ‘Managing Your Arthritis: 
Joint Care Workbook’, ‘Coping with 
Rheumatoid Arthritis’ and patient education 
leaflets produced by the Arthritis and 
Rheumatism Council (ARC) such as 
‘Rheumatoid Arthritis’, ‘Your Home and Your 
Rheumatism’, ‘Exercise and Arthritis’, ‘Drug 
Therapy’, ‘Gardening and Arthritis’, and ‘Diet  
and Arthritis’. The ARC videotape ‘Help is at 
Hand— getting the better of your arthritis’ is 
shown at the first meeting to promote 
discussion of members’ own alternate methods 
and gadgets they found useful, as well as on the 
impact of living with arthritis. 

















100; high score is 
worse) 
 
3 and 12 
months 
A handbook for patients presented facts about 
each session. During 8 sessions, 2.5 hours once 
a week, group discussions were led by a team of 
health professionals. The group members were 
encouraged to understand the terms of the 
disease process such as inflammation, 
seropositive, erosion, and anemia. In the session 
on therapy a nurse led discussions about 
medication, surgery, and alter- native 
treatments. Diet, fasting, and basic nutrition 
were discussed with a dietitian. The session led 
by a physiotherapist concentrated on pain 
management by rest, exercise, and relaxation.  
Acupuncture and other forms of 
nonpharmaceutical pain relief procedures were 
discussed. Home exercise was explained by ad- 
dressing the topics of why, how, when, and how 
much. The occupational therapist discussed 
problems related to hand function, hand 
program, and technical aids used to alleviate 
hand problems.  
Control/No further details 
Lindroth 1995 n=92 (84 females) 
Rheumatoid 
Arthritis 
Age (yr.) = exp. 
64.8 (SD 13.6), 















and 5 years 
Six sessions 2/h each focused on medical  
aspects, pain management, available 
treatments, stress management, self-awareness  
and communication skills, exercise, joint 




































scale) (0–10; high 
score is worse) 
 
4 months The self-instructional program LARA was used 
in this study. Practice time consisted of 10-20 
min time periods, in which a subject gave a 
return demonstration of ROM exercises to the 
Investigator. Another 10-20 min time period, on 
a different clinic visit, was provided for the 
subject to give (3 return demonstration of tasks 
using JPPs. The effectiveness of the unit on 
joint protection was further tested by asking 
subjects to perform four tasks: drinking from a 
coffee mug, carrying a handbag, moving a pot 
with a handle from one flat surface to another 2 
feet away, and transferring a book from one flat  
surface to another 2 feet away. One point was  
assigned to each task performed satisfactorily, 
with a possible sum total of four points. These 
tasks were performed by the experimental  
group and after reading the third unit of the 
instructional program on rest, pacing, and joint 
protection.  
Did not read the instructional program but 







Table 3-2. Risk of bias summary: Review authors’ judgements about each risk of 
bias item for each included study 
 





Abbreviations: VAS; visual analogue scale, NRS; Numerical Rating Scale, MHQ; Michigan Hand Outcome Questionnaire, HHD; 
hand held dynamometer, SMD;  
   standardized mean difference, MD; mean difference, CI; confidence interval. 
   1
We downgraded by two levels due to high risk of bias. 
   2
We downgraded by one level due to a relatively small sample size. 
   3
We downgraded by one level due to indirectness (surrogate outcomes). 
   4We downgraded by one level due to publication bias. 
   5
We downgraded by one level due to inconsistency. 
 
GRADE quality of evidence: 
High quality: We are very confident that the true effect lies close to that of the estimate of the effect. 
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the 
effect, but there is a possibility that it’s substantially different. 
Low quality: our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the 
effect. 
Very low quality: we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the 
estimate of effect. 
Table 3-3 Summary of Findings - Joint Protection Programs vs Usual care/control in Patients with Rheumatoid Arthritis (short-term) 
Population: patients with rheumatoid arthritis 
Settings: inpatient clinics. 
Intervention:  joint protection programs 
Comparison:  usual care/control 
Follow up: short-term (3 – 4 months). 
Outcomes 
SMD / MD 
(95% C.I.) 
No of participants 
(studies) 
Quality of the evidence (GRADE) 
Pain: 
- MHQ (0-100)  
Lower scores indicating better pain scores. 
- NRS (0-10)  
Higher score is worse  
-VAS (0-100)  
Higher score is worse. 
 
SMD -0.00 








- MHQ (0-100)  
Higher scores indicating better performance.  
 
SMD 0.18 







Grip strength:  
-HHD (kg) 
Higher values indicate better strength 
 
MD 1.38 











Abbreviations: VAS; visual analogue scale, NRS; Numerical Rating Scale, MHQ; Michigan Hand Outcome Questionnaire, HHD; 
hand held dynamometer, HAQ; Health  
   Assessment Questionnaire, SMD; standardized mean difference, MD; mean difference, CI; confidence interval. 
   1
We downgraded by two levels due to high risk of bias. 
   2
We downgraded by one level due to a relatively small sample size. 
   3
We downgraded by one level due to indirectness (surrogate outcomes). 
   4
We downgraded by one level due to publication bias. 
   5
We downgraded by one level due to inconsistency. 
 
GRADE quality of evidence: 
High quality: We are very confident that the true effect lies close to that of the estimate of the effect. 
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the 
effect, but there is a possibility that it’s substantially different. 
Low quality: our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the 
effect. 
Very low quality: we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the 
estimate of effect. 
Table 3-4. Summary of Findings - Joint Protection Programs vs Usual care/control in Patients with Rheumatoid Arthritis (mid-term) 
Population: patients with rheumatoid arthritis 
Settings: inpatient clinics. 
Intervention:  joint protection programs 
Comparison:  usual care/control 
Follow up: mid-term (5 – 8 months). 
Outcomes 
SMD / MD 
(95% C.I.) 
No of participants 
(studies) 
Quality of the evidence (GRADE) 
Pain: 
- MHQ (0-100)  
Lower scores indicating better pain scores. 
- NRS (0-10)  
Higher score is worse  
-VAS (0-100)  
Higher score is worse. 
 
SMD -0.32 








- HAQ (0-3) 
Higher is worse. 
-AIMS2 (0 to 10) 











Grip strength:  
-HHD (kg) 
Higher values indicate better strength 
 
MD -1.39 











  Abbreviations: VAS; visual analogue scale, NRS; Numerical Rating Scale, MHQ; Michigan Hand Outcome Questionnaire, AIMS2; 
Arthritis Impact Measurement Scales, HHD;  
  hand held dynamometer, HAQ; Health Assessment Questionnaire, SMD; standardized mean difference, MD; mean difference, CI; 
confidence interval. 
   1
We downgraded by two levels due to high risk of bias. 
   2
We downgraded by one level due to a relatively small sample size. 
   3
We downgraded by one level due to indirectness (surrogate outcomes). 
   4
We downgraded by one level due to publication bias. 
   5
We downgraded by one level due to inconsistency. 
 
GRADE quality of evidence: 
High quality: We are very confident that the true effect lies close to that of the estimate of the effect. 
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the 
effect, but there is a possibility that it’s substantially different. 
Low quality: our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the 
effect. 
Very low quality: we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the 
estimate of effect. 
Table 3-5. Summary of Findings - Joint Protection Programs vs Usual care/control in Patients with Rheumatoid Arthritis (long-term) 
Population: patients with rheumatoid arthritis 
Settings: inpatient clinics. 
Intervention:  joint protection programs 
Comparison:  usual care/control 
Follow up: long-term (12 – months). 
Outcomes 
SMD / MD 
(95% C.I.) 
No of participants 
(studies) 
Quality of the evidence (GRADE) 
Pain: 
- MHQ (0-100)  
Lower scores indicating better pain scores. 
- NRS (0-10)  
Higher score is worse  
-VAS (0-100)  
Higher score is worse. 
 
SMD -0.27 








- MHQ (0-100)  
Higher scores indicating better performance.  
- HAQ (0-3)  
Higher is worse. 
-AIMS2 (0 to 10)  
Lower scores represent better function 
 
SMD -0.34 







Grip strength:  
-HHD (kg) 
Higher values indicate better strength 
 
MD 0.93 






























































Chapter 4  
4 Joint Protection Programmes for People with Osteoarthritis 
and Rheumatoid Arthritis of the Hand: An Overview of 
Systematic Reviews 
Abstract 
Purpose: Joint protection has been introduced as a self-management strategy for people 
with rheumatoid arthritis (RA) and osteoarthritis (OA) of the hand. The purpose of this 
study was to conduct an overview of systematic reviews (SRs) and critically appraise the 
evidence to establish the current effectiveness of joint protection for people with hand RA 
and OA.  
Method: A comprehensive search was conducted of six databases from January 2008 to 
May 2018. SRs that evaluated the effectiveness of joint protection for people with hand 
arthritis were eligible for inclusion. The A MeaSurement Tool to Assess systematic 
Reviews (AMSTAR) 2 checklist was used to assess the methodological quality of each SR.  
Results: Nine SRs were included: two were rated as high quality, and seven were rated as 
low quality. Seven of the nine did not take into account risk of bias when interpreting or 
discussing their findings, six did not assess publication bias, and five did not register their 
protocol. The high-quality reviews found no clinically important benefit of joint protection 
for pain, hand function, and grip strength levels. The low-quality reviews reported 
improvements in function, pain, grip strength, fatigue, depression, self-efficacy, joint 
protection behaviours, and disease symptoms in people with RA.  
Conclusions: High-quality evidence from high-quality reviews found a lack of any 
clinically important benefit of joint protection programmes for pain, hand function, and 
grip strength outcomes, whereas low-quality evidence from low-quality reviews found 
improvements in these outcomes. 
Reproduced with permission from Bobos P, MacDermid JC, Nazari G, Lalone EA, 
Ferreira L, Grewal R. Joint Protection Programmes for People with Osteoarthritis and 
Rheumatoid Arthritis of the Hand: An Overview of Systematic Reviews. Physiother 






Clinical manifestations of rheumatoid arthritis (RA) can be unpredictable, but pain, 
disability, fatigue, joint deformities, and poor quality of life are common features.1 
Although medications such as biological agents and drugs are increasingly effective,1,2 
arthritis currently has no cure. Conservative management aims to prevent or control joint 
deformities, reduce pain and swelling, increase hand function, and improve quality of life.3 
Numerous studies investigating various hand pathologies have demonstrated that hand 
function is an important factor.4–8 Joint protection was first introduced in the 1960s as a 
self-management strategy for people with RA, and the indications were later extended to 
other arthritic conditions, such as hand osteoarthritis (OA) and soft-tissue rheumatic 
disorders.9 Joint protection consists of a wide range of strategies such as education for 
strengthening or stretching exercises, joint protection education for activity and pacing, use 
of proper body mechanics, and assistive devices to improve pain, reduce inflammation, 
lower additional risk of deformities, and enhance performance.9,10 
Systematic reviews (SRs) are a recognized approach to synthesizing research evidence on 
the effectiveness of therapeutic interventions.11 Because the number of SRs is rapidly 
increasing, there is a need to summarize the evidence and inform health care professionals 
about conflicting or inconsistent evidence. Although the aim of these SRs in facilitating 
evidence-based practice is commendable, poor-quality SRs may contain significant bias 
that can mislead readers. An overview of SRs can summarize a large body of evidence and 
identify conflicting or inconsistent results and the potential reasons for them. For example, 
a 2007 overview that examined non-pharmacological and non-surgical joint protection 
interventions for people with hand RA reported high-quality evidence for a positive effect 
on function and no difference in pain.12 A subsequent overview in 2009 that examined non-
pharmacological and non-surgical interventions for people with hand OA found 
insufficient high-quality evidence for these types of intervention.13 Still another overview 
published in 2014 that examined the effectiveness of occupational therapy interventions 






These overviews had some limitations that justify the need to conduct another overview of 
SRs. The first limitation is that those reviews are outdated because they are based on SRs 
that were published between 2000 to 2013. The second relates to how the SRs were 
evaluated. Ekelman and colleagues based their quality assessment on guidelines that had 
been described by Stern,14,15 and they categorized the included SRs according to the levels 
of evidence for SRs established by the Oxford Centre for Evidence-Based Medicine in 
2009.16 Although SRs and randomized controlled trials (RCTs) are considered high-quality 
evidence in that categorization, this way of rating methodological quality is imprecise 
because it does not consider how an SR or RCT was conducted. Christie and colleagues 
assessed the quality of SRs using a nine-item checklist that had been developed from 
Oxman and Guyatt in 1991.12,17 Moe and colleagues assessed the methodological quality 
of the first version of the A MeaSurement Tool to Assess systematic Reviews (AMSTAR) 
checklist.13 Although these instruments do assess SR methods, they have been superseded 
by tools that more thoroughly consider risk of bias.12,13 Therefore, we set out to conduct an 
overview of SRs to establish the current state of evidence evaluating the effectiveness of 
joint protection for people with hand RA and OA. 
 
4.2 Methods 
4.2.1 Study design 
We followed a standard methodology for overviews.18–21 This study was registered in the 
International Prospective Register of Systematic Reviews (PROSPERO) database 
(Registration No. CRD42018094725). 
 
4.2.2 Eligibility criteria 
We included SRs of RCTs in our overview if they met the following criteria: 





• Interventions: joint protection programme with other treatments or joint protection 
alone 
• Comparison: other treatment or no treatment 
• Outcomes: pain, function, and grip and pinch strength. 
 
4.2.3 Search strategy 
A search for SRs that had been published between January 2008 and May 2018 was 
conducted on May 15, 2018, in the following databases with no language restriction set: 
MEDLINE, Embase, CINAHL, Cochrane Library, Physiotherapy Evidence Database 
(PEDro), and Latin American and Caribbean Health Sciences Literature (LILACS). The 
search strategy was designed to locate SRs that addressed the effectiveness of joint 
protection programmes on pain, function, and grip and pinch strength in patients with hand 
RA and hand OA. In addition, the PROSPERO database was searched to identify ongoing 
studies of joint protection. Reference lists of included studies were searched to identify and 
retrieve other eligible SRs. Our search strategy, which includes words and Boolean 
operators, is summarized in the Appendix. 
 
4.2.4 Study selection 
Two independent reviewers (PB and GN) screened relevant titles and abstracts. Relevant 
studies (SRs) were then screened at full-text review and included if the following criteria 
were met: (1) SR of the effectiveness of joint protection programmes (defined by 
Hammond9) plus other treatments or joint protection programmes compared with other 
treatment or no treatment; (2) studied population included patients with hand RA or hand 
OA; and (3) SR of RCTs. Studies were excluded if they (1) were narrative, critical, or 
scoping reviews; (2) were not written in English; or (3) described joint protection not as a 





4.2.5 Quality assessment 
Three reviewers (PB, GN, and EAL) independently applied the AMSTAR 2 risk-of-bias 
tool to assess the risk of bias of each SR.22 Disagreements on the AMSTAR 2 rating were 
resolved by consensus with the help from a fourth reviewer (JCM) if needed. AMSTAR 2 
is composed of 16 items and has adequate interrater reliability for measuring the risk of 
bias of SRs and for rating overall confidence in the results of an SR.22 For each SR, we 
considered the 16 items included on the AMSTAR 2 checklist along with the checklist 
guidelines and scored the SR as “yes,” “partial yes,” “no,” or, for some domains, “not 
applicable.” The AMSTAR 2 rating is based not on an overall score but on identification 
of the following critical domains: 
• Protocol registered before commencement of the review (Item 2) 
• Adequacy of the literature search (Item 4) 
• Justification for excluding individual studies (Item 7) 
• Review includes risk of bias of individual studies (Item 9) 
• Appropriateness of meta-analytical methods (Item 11) 
• Consideration of risk of bias when interpreting the results of the review (Item 13) 
• Assessment of presence and likely impact of publication bias (Item 15). 
The overall AMSTAR 2 rating of confidence are as follow:22 
• High – no or one non-critical weakness: the SR provides an accurate and 
comprehensive summary of the results of the available studies that addresses the question 
of interest. 
• Moderate – more than one non-critical weakness: the SR has more than one 
weakness but no critical flaws. It may provide an accurate summary of the results of the 
available studies that were included in the SR. 
• Low – one critical flaw with or without non-critical weaknesses: the SR has a 
critical flaw and may not provide an accurate and comprehensive summary of the available 
studies that address the question of interest. 
• Critically low – more than one critical flaw with or without non-critical 
weaknesses: the SR has more than one critical flaw and should not be relied on to provide 





4.2.6 Data extraction 
Two review authors (PB and JCM) were trained and calibrated on the use of the data 
extraction form. Data extraction was performed by one author (PB) and checked by a 
second (JCM). The following descriptive characteristics were extracted from the eligible 
SRs: (1) author and year, (2) number of primary studies, (3) population, (4) risk-of-bias 
assessment, (5) quality-of-evidence assessment, (6) outcomes reported in the SR, and (7) 
conclusions drawn by the authors of the SR. 
 
4.2.7 Data analysis and synthesis 
A qualitative synthesis was conducted to summarize the findings across the multiple SRs. 
We synthesized the results on the basis of quality of evidence and on the populations 
studied. The risk of bias and the quality assessment of primary studies were extracted as 
reported in the included SRs. Rather than re-scoring the data from the primary studies 
included in each SR, we relied on the judgment and reporting of the SR authors. 
 
4.3 Results 
4.3.1 Selection process 
Our literature search identified 14 SRs for a full-text review. Of these, 4 were excluded 
because they evaluated the effect of hand exercises,23,24 splints,25 or Web-based multi-
modal interventions with no mention of joint protection.26 One SR was excluded because 
it did not include any study that had evaluated joint protection as an intervention or 
control.27 Overall, nine SRs met our inclusion criteria and were included in our analysis. A 






4.3.2 Characteristics of the included systematic reviews 
Five reviews evaluated the effectiveness of joint protection for people with hand OA,28–32 
and three evaluated its effectiveness for people with hand RA;33–35 one review (Bobos and 
colleagues36) included studies for both hand OA and RA. Risk of bias was evaluated in six 
reviews: five used the Cochrane risk-of-bias tool,29,30,33,34,36 and one used a list 
recommended by VanTulder and colleagues.35 Quality of evidence was assessed in six 
reviews: two using the Grading of Recommendations Assessment, Development and 
Evaluation (GRADE) guidelines,29,36 one using the Jadad scoring checklist,28 one using the 
PEDro scale,31 one using the Structured Effectiveness for Quality Evaluation Scale 
(SEQES) and levels of evidence,32 and one using a list recommended by VanTulder and 
colleagues.35 One review rated the evidence as strong, moderate, mixed, or limited on the 
basis of consistent or conflicting results from the RCTs,33 and Carandang and colleagues 
rated the evidence as low, unknown, or high quality to reflect the language used in the 
quality assessment (i.e., high risk, unknown risk, and low risk of bias).34 Six reviews 
assessed pain levels and function,29,30,32,33,35,36 four reviews examined grip strength as an 
outcome of interest, 29,31,32,36,37 and two reviews assessed behavioural change.33,34 The 
characteristics of the included reviews are summarized and presented in Table 1. 
 
4.3.3 Description of joint protection programmes 
Most joint protection programmes used guidelines that included an educational component 
that addressed disease and symptom severity (RA or OA) and techniques to influence 
behavioural change such as energy conservation, coping skills for pain management, 
assistive devices, and the use of large joints.36 Interventions included on average three to 
four 2-hour, face-to-face interventions and home programmes.33,36 In the majority of 









4.3.4 Quality assessment 
Two SRs29,36 were rated as high quality, seven as low quality.28,30–35 Regarding the critical 
domains of AMSTAR 2, five reviews did not perform a priori registration,28,31–34 two did 
not perform a comprehensive search,32,34 and three partially met this criterion.28,30,33 Three 
reviews did not provide justification for excluding studies,28,30,31 and four did not use a 
satisfactory technique to assess the risk of bias of the primary studies.30–32,35 Seven reviews 
did not take into account the risk-of-bias assessment in their interpretation or 
discussion,28,30–35 and six reviews28,30-34 did not assess publication bias of the included 
studies. The summary of AMSTAR 2 ratings is presented in Table 2. 
 
4.3.5 Findings from high-quality reviews for hand osteoarthritis and 
rheumatoid arthritis 
Two high-quality SRs reported the effects of joint protection versus usual care or control 
and hand exercises versus joint protection for pain, hand function, and grip strength 
outcomes for patients with hand RA and OA.29,36 The review by Bobos and colleagues 
reported results from 14 RCTs for people with hand RA and three RCTs for people with 
hand OA for pain, grip strength, and hand function.36 This review found very-low- to low-
quality evidence (according to GRADE guidelines) that, compared with usual care or 
control, the effects of joint protection programmes on pain and hand function for people 
with hand arthritis are too small to be clinically important at short-, intermediate- and long-
term follow-up. Pain levels were quantified by pooling the results from five low-quality 
primary studies for the short, mid-, and long term for people with hand RA. Pooling the 
results indicated that joint protection is no better than usual care or control at short -term 
follow-up (3–4 mo). For the mid- (6 mo) and long term (12 mo), joint protection was 
favored over usual care or control but did not exceed the cutoff scores for minimal 
clinically important difference. For hand function, joint protection was favored over usual 
care or control with small effects at mid- and long-term follow-up. The Cochrane review 
by Østerås and colleagues29 reported the effects of hand exercise versus no exercise (joint 





favor of hand exercises for the short, mid-, and long term for hand pain and function and 
for grip and pinch strength. No specific recommendation was made for joint protection, 
only for hand exercises. 
 
4.3.6 Findings from low-quality systematic reviews for hand 
osteoarthritis 
Four SRs summarized findings of reported outcomes for pain, hand function, and grip 
strength for people with hand OA.28,30–32 Lue and colleagues reported the results from two 
high-quality RCTs (Jadad score > 3) for people with hand OA.28 This review did not report 
the effect on outcomes specifically for joint protection studies but concluded that joint 
protection was conditionally recommended. Aebischer and colleagues reported findings 
from one RCT (risk of bias not reported) for pain and function and found that joint 
protection improved solely pain, not function.30 Ye and colleagues reported findings from 
one high-quality RCT (PEDro scale > 6) and found that joint protection improved grip 
strength and hand function.31 Valdes and Marik32 reported findings from one high-quality 
RCT (SEQES scores for quality of research ) and found that the evidence to support joint 
protection for increased hand function was moderate. 
 
4.3.7 Findings from low-quality reviews for hand rheumatoid arthritis 
Three SRs provided summarized findings on reported outcomes of function, pain, fatigue, 
depression, self-efficacy, behavioural change, and knowledge.33–35 Siegel and colleagues 
reported the results from five high risk-of-bias RCTs and found strong evidence to support 
the use of psychoeducational interventions (joint protection) to improve function, pain, 
fatigue, depression, self-efficacy, and disease symptoms in people with RA.33 Carandang 
and colleagues reported findings from three RCTs (one with low risk of bias, two with high 
risk of bias) and found that the evidence for joint protection and energy conservation 





colleagues reported findings from four RCTs and found strong evidence to support the 
efficacy of joint protection.35 
 
4.4 Discussion 
Our overview shows that the majority of the evidence supporting the effects of joint 
protection for patients with hand arthritis is of low quality. The summarized findings from 
the high-quality reviews indicate that, when compared with usual care or control, joint 
protection does not improve pain by a clinically important amount at 6- and 12-month 
follow-up. Joint protection was superior to usual care or control in improving hand function 
but did not exceed the predefined cut-off scores. The majority of the included SRs had very 
poor overall methodological quality in the critical domains of AMSTAR 2. Seven of the 
nine reviews did not take risk of bias into account in the interpretation and discussion of 
findings, six reviews did not assess publication bias, and five reviews did not register their 
protocol. Another important finding is that differences in the risk-of-bias and quality 
assessment tools seemed to affect the SRs’ overall recommendations (Table 3).  
Seven of the nine SRs were rated as low quality, and the majority of the included SRs did 
not follow the recommended Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines.38 Six of the nine SRs were published between 2015 and 
2018, and only two followed the PRISMA guidelines. Not following these predefined 
guidelines may be diminish the usefulness of the results when they are interpreted by 
clinicians or policymakers. It is important to note that low-quality evidence implies not that 
joint protection has no effect but that the low-quality evidence is insufficient to draw 
definite conclusions. 
Our included SRs used a variety of risk-of-bias and quality assessment tools. The authors 
of the included reviews seemed to lack an understanding of what constitutes risk-of-bias 
and quality assessment. Authors have at their disposal a wide variety of tools to critically 
appraise and synthesize evidence, and which one they use is a matter of personal 
preference. However, the methodological quality of the included reviews may have a very 





conclusions.39 For instance, a primary study (RCT) that had been rated with four separate 
approaches was reported as being high quality when using the PEDro scale, high quality 
when using SEQES, high risk when using only the Cochrane risk-of-bias tool, and very 
low quality when using the Cochrane risk-of-bias tool and the GRADE approach 
combined. 
This overview had several limitations that need to be taken into account when interpreting 
our findings. First, the included SRs did not differ significantly in their eligibility criteria.20 
Second, they did not clearly report potential harms. Third, there was minor overlap among 
the primary studies, although this is common for reviews.19,20,28 Next, we focused on SRs 
of RCTs and did not include SRs that included other study designs (i.e., prospective or 
retrospective observational designs), and it is possible that such inclusion criteria could 




This overview provided high-quality evidence (AMSTAR 2) from two SRs that, compared 
with usual care or control, the effects of joint protection programmes on pain and hand 
function are too small to be clinically important at short-, intermediate- and long-term 
follow-up. It is important to note that the primary studies included in these SRs were graded 












What is already known on this topic 
Several systematic reviews (SRs) have been published on the effectiveness of joint 
protection programmes for patients with osteoarthritis or rheumatoid arthritis of the hand, 
but the quality of the evidence synthesized by these SRs varies. 
What this study adds 
Our review shows that the majority of the current evidence from systematic reviews that 
supports the effects of joint protection for patients with osteoarthritis or rheumatoid 
arthritis of the hand is of low quality. The summarized findings from the high-quality 
reviews indicate that, when compared with usual care or control, joint protection does not 
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Risk-of-bias tool Quality of evidence 
Reported outcomes 
for joint protection 
Bobos et al.36 OA and RA 
14 for RA, 3 
for OA 
Cochrane GRADE 
Pain, function, grip 
strength 
Siegel et al.33 RA 5 Cochrane 
Evidence was considered 
strong, moderate, mixed, 
and limited on the basis of 
consistent or conflicting 





Lue et al.28 OA 2 Not assessed 
Jadad’s scoring checklist (0–
5) 
Unclear 
Østerås et al. 
(2017)29 
OA 1 Cochrane GRADE 
Pain, hand function, 




RA 3 Cochrane 
Low, unknown, and high 
quality; adapted to reflect 
the language used in the 
quality assessment (e.g., 
high risk, unknown risk, low 




OA 1 Cochrane Unclear Pain, function 
Ye et al.31 OA 1 Not assessed PEDro scale 




OA 1 Not assessed SEQES and LOE 
HAQ; VAS for pain 






by VanTulder and 
colleagues (1997) 
Methodological quality of 
RCTs and CCTs rated using 
a list recommended by 
VanTulder et al. (1997) 
Pain, functional 
ability, knowledge 
OA = osteoarthritis; RA = rheumatoid arthritis; GRADE = Grading of Recommendations Assessment, 
Development and Evaluation; RCT = randomized controlled trial; PEDro = Physiotherapy Evidence 
Database scale; SEQES = Structured Effectiveness for Quality Evaluation of Study; LOE = levels of 






Table 4-2. AMSTAR 2 Rating 

































– + + 
2. A priori 
protocol used* 
+ – – + – + – – + 
3. Study design 
selection 
explained 


































+ + + + + + – + + 






































+ + – – – – 










+ N/A N/A + N/A + N/A N/A + 
12. If meta-
analysis, risk of 
bias of included 
studies taken 
into account 










+ – – + – – – – – 
14. Satisfactory 
explanation 
given for any 
heterogeneity 
+ N/A N/A + N/A + N/A N/A – 
15. Publication 
bias in included 
studies 
assessed* 
+ – – + – – – – + 
16. Review 
authors reported 
on any of their 
own conflicts of 
interest 
+ – + + – + + + + 
Overall quality High Low Low High Low Low Low Low Low 
* Indicates a critical domain. 
AMSTAR 2 = A MeaSurement Tool to Assess systematic Reviews; – = no; + = yes; ? = partial yes; 











Bobos et al.36 High Very-low- to low-quality evidence that the effects of joint protection programmes 
compared with usual care or control on pain and hand function are too small to be 
clinically important at short-, intermediate- and long-term follow-ups for people 
with hand arthritis 
Siegel et al.33 Low Strong evidence to support the use of physical activity and psychoeducational 
interventions (joint protection) to improve function, pain, fatigue, depression, self-
efficacy, and disease symptoms in people with RA 
Lue et al.28 Low Joint protection conditionally recommended 
Østerås et al.29 
(2017) 
High No specific recommendation made for joint protection, only for hand exercises 
Carandang et 
al.34 
Low Moderate evidence for joint protection and energy conservation interventions 
improving joint protection behaviours 
Aebischer et 
al.30 
Low Main finding: moderate to high evidence that multimodal physiotherapy and 
occupational therapy–related interventions have beneficial effects on pain; no 
statistical evidence for improvement of function, only narrative; joint protection 
improved pain but not function 
Ye et al.31 Low Evidence suggests that programmes of joint protection, advice, and home 
exercises are effective at improving grip strength and hand function 
Valdes & 
Marik32 
Low Moderate evidence to support joint protection education and providing adaptive 
equipment to increase hand function and reduce pain  
Steultjens et 
al.35 
Low Results of best-evidence synthesis show that there is strong evidence for the 
efficacy of instruction on joint protection (an absolute benefit of 17.5 to 22.5, 
relative benefit of 100%)  











Chapter 5  
5 Barriers, Facilitators, Preferences and Expectations of Joint 
Protection Programs for Patients with Hand Arthritis. A 
Cross-sectional Survey 
Abstract 
Objectives: The objective of this survey is to investigate the barriers, facilitators, 
expectations and patient preferences regarding joint protection (JP) programs in people 
with hand arthritis. 
Design: Cross-sectional survey 
Setting: Tertiary clinic 
Participants: Patients with hand arthritis: osteoarthritis (OA), rheumatoid arthritis (RA), 
psoriatic arthritis (PsA) and other forms of arthritis. 
Primary and secondary outcome measures: This study utilized a survey among people 
with hand arthritis. Descriptive statistics and percentages were reported for all the data 
about the barriers, facilitators and preferences around JP. 
Results: A total of 192 patients consented to participate. Most of the patients (82%) were 
unaware of JP. Factors that may act as barriers to participation and were regarded as “a 
very big concern” were: cost of the program (44%), time of offering the program (39%), 
work commitments (36%) and having a centre/clinic close to the house (28%). Factors that 
may act as facilitators and rated as “extremely helpful” were: research that shows that JP 
works (26%) and having the centre/clinic close to the house (25%). An online format for 
JP was the most preferred option (54%). Half (46 %) preferred a timeframe of 1 hour, 3 
times per week and 44 % preferred a 2-hour program, for 3 times per week. 
Conclusions: Awareness of the potential benefits of JP, and prior experience with JP 
program were very low. Common potentially modifiable patient-reported barriers to 
participate in future JP interventions, included: cost, work commitments, distance from 
home to clinic and times that the intervention were provided. These barriers might be 
addressed with free and accessible forms of delivery of JP, which may lead to better uptake 





Reproduced with permission from Bobos P, MacDermid JC, Ziebart C, Boutsikari EC, 
Lalone EA, Ferreira L, Grewal R. Barriers, Facilitators, Preferences and Expectations of 
Joint Protection Programs for Patients with Hand Arthritis. A Cross-sectional Survey. BMJ 
Open 2021; Copyright © BMJ Open® 
Strengths and limitations of this study 
• The survey was adapted to people with hand arthritis from a validated questionnaire 
developed to assess the barriers, facilitators and preferences to exercise used in 
other clinical populations. 
• A small sample of people with experience of JP prevented us from adequately 
exploring the perceptions of patients who had completed the program. 
• The survey was designed for English speakers with hand arthritis therefore, people 
speaking other languages were not represented. 
5.1 Introduction 
Osteoarthritis (OA) is characterized as a degenerative joint disease that affects 
approximately 27 million adults in the USA and is one of the leading causes of disability. 
1 Osteoarthritis affects 60-70% of the population above the age of 65 years, and is likely to 
increase further in the future, due to the aging population. 2,3 The most common site of OA 
is the hand and it typically involves the interphalangeal (proximal and distal) and first 
carpometacarpal joints. 4 In a clinical setting, pain is a major symptom among patients with 
hand OA as it contributes to a reduction in joint function.1,4 Currently there is no cure for 
hand OA, but  goals of treatment  include  maximizing long-term health-related quality of 
life, by controlling symptoms such as pain, prevention of structural damage and 
normalization of function.5 
Joint protection (JP)  is a self-management strategy for patients living with arthritis to help 
preserve joint function and reduce pain.6 JP involve training on “safer movement patterns, 
the use of adaptive devices (e.g. built up handles, hands free technologies) and behavior 





be implemented in many different ways, and  patient preferences are rarely reported as 
being considered in program design. There are many unknown barriers that may reduce 
participation in JP programs, and these may be related to personal beliefs, preferences or 
circumstances. For example, patients may believe that JP will not slow joint damage, may 
not like engaging in groups or may have life/location issues that make it difficult to attend 
clinics. Identifying these barriers at group and individual levels may be a strategy to design 
and customize future JP to increase participation in JP programs. 
Considering preferences and customizing JP may be critical to improving adherence. Prior 
reports suggest that adherence is a major concern. Previous systematic review and meta-
analysis indicated that only 6 out of the 17 trials used strategies to maximize adherence for 
JP.7 Although the evaluation of adherence from these trials was ranging from low to 
moderate adherence has not been properly studied in the published literature yet. The 
purpose of this cross-sectional survey is to investigate the barriers, facilitators, expectations 
and patient preferences regarding joint protection programs in people with hand arthritis. 
 
5.2 Methods 
5.2.1 Patient and Public Involvement 
Patients or the public were not involved in the design, or conduct, or reporting, or 
dissemination plans of our research. 
 
5.2.2 Study Design 
This study utilized a cross-sectional survey among people with hand arthritis that was open 
for response from March 2019 to February 2020. Ethical approval was granted by Hamilton 
Research Ethics Board (HiREB) at McMaster University, Hamilton, Canad a (Project 






5.2.3 Inclusion criteria and exclusion criteria 
Participants were eligible to complete the anonymized survey if they were able and willing 
to provide informed consent, were between 18 to 85 years old, they have been diagnosed 
with hand arthritis and they could read and write English. Participants which have not been 
diagnosed with hand arthritis or they could not answer the survey questions, or they did 
not understand English were excluded from the study. 
 
5.2.4 Setting and recruitment 
Participants were recruited through advertisements in the main website of The Arthritis 
Society of Canada and from the Roth McFarlane Hand and Upper Limb Centre (HULC) at 
St. Joseph’s Health Care Hospital in London, Ontario. Research assistants and research 
coordinators from HULC contacted people with hand arthritis who had previously 
expressed interest in participating in research. Also, an informative poster was setup at 
HULC patient waiting area providing details about the study. Two separate approaches 
were used for data collection. An online form to complete the survey and a paper-based 
version of the survey form at HULC clinical research lab.  
 
5.2.5 Data protection 
No participant identifying information was collected in this anonymized survey. Data were 
kept at the HULC clinical research laboratory where only authorized personnel have 
access, and all paper-based files were stored in a locked cabinet. Electronic files were 
stored in encrypted file and apart from the study investigators no other person had access 







The survey was adapted to people with hand arthritis based on previous experience of the 
study investigator (JCM) with JP, from a validated questionnaire initially developed to 
assess the barriers, facilitators and preferences to exercise for people with osteoporosis  and 
for shoulder arthritis.8,9 The survey consisted of 31 questions with sections related to 
barriers, facilitators, expectations and patient preferences for joint protection programs in 
people with hand arthritis. The survey questions are presented in the Web Appendix. 
 
5.3 Data analysis 
5.3.1 Quantitative 
Descriptive statistics and percentages were reported for all the data about the barriers, 
facilitators and preferences around JP programs. In 2014 (Statistics, Canada), 16.5% of 
Canadians (around 4.8 million people) reported that they had been diagnosed with any form 
of arthritis by a health professional. The Ontario province represents the 18.5% of 4.8 
million which is 888,000 individuals with arthritis approximately. Sample size calculation 
was based on a population size of 888,000 individuals, a confidence level of 95% and with 
7% margin of error and it was determined that 196 individuals were needed to complete 
the survey.10 Data analyses were completed using STATA 16.0 version. 
 
5.3.2 Qualitative 
Some of the survey questions (Questions 7, 8, 10, 11, 12, 13) were written responses. For 
these questions qualitative data analyses techniques were used. Data were analyzed by 
response line to identify emerging codes. Relationships and similarities among codes were 
discussed leading to the formation of themes. Themes were particularly identified to 
provide new information to the quantitative responses, in an effort to better understand the 






A total of 192 patients consented to participate and completed our survey. They provided 
information about JP barriers and facilitators regarding their possible prospective 
participation in a JP program, the impact of JP programs on domains of their everyday life 
and their preferred frequency of use of JP.  Out of the 192 survey respondents, 92 (50%) 
were diagnosed with Rheumatoid Arthritis (RA) in the hand, 38 (21%) with hand OA, 29 
(16%) with Psoriatic Arthritis (PsA), 13 (7%) had a diagnosis other than hand arthritis, and 
10 (5%) reported none from the options provided. The majority of participants were aged 
between 34 to 54 years old representing the 53% of the sample of this survey. Thirteen 
(n=13) people disqualified from the survey, because three of them were under 18 years old 
and ten of them had arthritis in lower extremities and therefore, they were deemed 
ineligible to participate. The demographic description of the included sample is presented 
on Table 1. 
 
5.4.1 Awareness of joint protection programs 
Regarding patients’ awareness of JP programs, from the 164 patients in total who had hand 
arthritis, most (82%) had never heard about JP programs before, 11% had heard about JP 
but had never taken part in such a program. A small percentage of respondents (5%) had 
previously taken part in a JP and only 4% were currently participating in a JP program. 
Amongst the 13 participants who took part in JP, 5 people participated in a program in an 
outpatient hospital department, 3 at a family’s physician office, 2 in an inpatient unit, 2 in 
a rehabilitation center and 1 home.  The JP program was provided most commonly by an 
occupational therapist (46%), a family physician or specialist (38%), and to a lesser extent 






5.4.2 Use, frequency and perceived impact of joint protection programs 
on outcomes 
Out of 13 patients who participated in a JP program, five of them continued using the 
principles of the program at least once a week, four of them kept using them always, one 
participant applied them less than once a week while 3 of them while 3 of them did not use 
them at all. In Table 2, four patients that participated in the joint protection provided 
examples what joint protection principles they used. Within this small subsample of ten 
patients’ experiences (Figure 1), eight patients reported “no change” to “very much better” 
in terms of impact on stiffness, pain, grip strength, hand function and swelling. Two 
patients reported feeling slighting worse to much worse in stiffness, pain, grips strength, 
hand function and swelling (Figure 1).   
 
5.4.3 Information and awareness of the existence of joint protection 
programs 
The majority of the respondents have never heard about joint protection programs until 
they undertook this survey, according to their comments in an open-ended question within 
the survey. None were informed about the existence of the joint protection programs by a 
family physician or a local community center. A small percentage of 14% were informed 
by a specialist about the existence of the JP programs, 10% of them heard it from television, 
5% by their therapist and 3% from family or friends.  
 
5.4.4 Factors affecting prospective participation in joint protection 
Factors reported by 87 participants that were reported as important barriers to participation 
in a future JP are described in Figure 2. Factors that may act as barriers to participation and 
were regarded as “a very big concern” included: cost of the program (44%), time of offering 
the program (39%), work commitments (36%) and having a centre/clinic close to the house 
(28%). Factors that may act as facilitators to participation and rated as “extremely helpful” 





close to the house (25%). All the barriers and facilitators that may affect participation are 
presented in Figure 2. 
 
5.4.5 Qualitative Data 
A total of 73 participants provided additional information in open-ended responses to 
describe their barriers and facilitators to engaging in a joint protection program. Three 
major themes emerged: personal factors; environmental factors; and health factors. For the 
personal factors, common barriers were energy, other personal or work commitments, and 
fear of further injury. Environmental factors included having a centre close to the house, 
transportation, cost of the program, building accessibilities and social support from family 
or friends to participate with. Health condition factors included comorbidities associated 
with the disease, complications related to the disease, flare ups, and depression. For 
example, one participant noted that arthritis-related health issues limited participation: RA 
said “[permanent] RA voice loss, [permanent] RA lung damage”, and another patient 
mentioned “flare ups”. 
Facilitators mentioned in open-ended responses included: having the centre/ clinic close to 
my house, transportation to the centre where program is provided, cost of the program, 
time when the program was offered, my work commitments, my personal commitments, 
support from family/ friends, having a friend to participate with, research that shows joint 
protect works and another patient finding joint protection helpful. A number of the barriers 
mentioned in open-ended responses related to health factors not specifically identified on 
the survey: flare ups, fear of further injury, and comorbid conditions were not listed as 
potential barriers in the survey. 
 
5.4.6 Preference on method of delivery of Joint protection 
An online format for JP was the most preferred option representing slightly over half of 





home (20%), clinic (17%), videos (6%) and printed material (2%). Patient were open to a 
variety of health providers for JP programs, and stated preference for occupational 
therapists (22%), physiotherapists (20%), family physician or specialists such as 
rheumatologists(19%), hand therapists (17%), other patients with arthritis (13%), and 
kinesiologists with the other choices comprising 2%.  
 
5.4.7 Preference of frequency of joint protection 
Participants reported their top preference in terms of frequency and their possible 
prospective participation in a JP. Half of them (46 %) preferred a timeframe of 1 hour, 3 
times per week for 10 weeks and 44 % preferred a 2 hour, 3 times a week for 5 weeks 
program.  
 
5.4.8 Usefulness of joint protection components 
Patient preferences for content in JP suggest that information about joint loading, reduction 
of joint stress, feedback on correctness and carefulness in tasks, information about pacing 
activities, advice from health professionals or other patients and demonstration of how to 
do things in ways that minimize effort and maximize efficiency, a JPP were considered as 
moderately to extremely useful (Figure 3). Respondents indicated that the following 
information would be moderately or extremely useful: activity pacing and how joint 
positions affect joint loading, ways to reduce joint loading and feedback on task 
performance. They indicated preference as “moderately” or “extremely useful” the 
following approaches: advice from health professionals, demonstrations/feedback on task 
performance, and advice from other patients (Figure 3).  
 
5.4.9 Perceived importance of joint protection programs 
Patients rated the following potential outcomes of JP as “extremely important”: pain 





(75%). On average 84 out of 192 of patients reported how often they use one or more of 
the following rehabilitation modalities such as heat, cold, exercise, joint protection, splints 
and modified equipment (Figure 4). Modalities such as heat, exercise and splints were 
reported that were used “very frequently” by 15% of the respondents. Heat (32%), exercise 
(25%) and cold modalities (19%) were used as “frequently” by the participants. On the 
other hand, modalities such TENS/electrical devices (68%), splints (46%), joint protection 
(48%) and modified equipment (43%) were never used by the respondents (Figure 4).  
 
5.5 Discussion 
This study found that very few patients with arthritis were aware of or had participated in 
a JP program, yet slightly more than half favored a JP program which could be offered 3 
times per week at 1-2 hours of engagement in an online format.  This suggests a profound 
need for better accessibility to JP programs for people with arthritis as a component of their 
overall self-management strategy.  
It is also clear one single method of delivery is unlikely to meet all needs since variation in 
preferences was clear. An online format for JP was the most preferred option representing 
slightly over half of the respondents (54%).  Other preferred options were JP programs that 
could be completed at home (21%) or at a clinic (16%). Our findings need to be tempered 
by two considerations. Firstly, some of the other preferred options overlap, for example 
preferences like “at home” or “videos” could include virtual components. Secondly, since 
the majority of the respondents (82%) were unaware of JP and were rarely using it, their 
preferences were based on a priori assumptions not on experience with such programs. 
However, preferences prior to participation are important since this is the time when 
patients make decisions about participation.  
It was remarkable that so few respondents had participated in JPP, given that there is 
systematic review evidence demonstrating the effectiveness of these programs both for 
patients with RA and OA.14 The included trials in this meta-analysis were of low 
methodological quality however, the effects of JP on function outcomes for people with 





survey the experiences were mostly positive in terms of perceived benefit in symptom 
control and very limited perceived harm. Lack of awareness of JPP was greater than 
anticipated and may reflect a lack of access to programs, a lack of awareness in clinicians 
who should be recommending JPP or a lack of interest in participating. Self-management 
strategies are important for patients with arthritis since is it a chronic disease. In fact, many 
of the patients in this survey were participating in some aspect of self -management. JP 
effectiveness has been supported by systematic reviews.6,7,14 Therefore, our finding that 
only 10 had participated in suggests that there is a substantial gap in awareness, delivery 
and accessibility of these programs. 
Respondents identified several challenges to participate in JP programs. This suggests that 
flexibility in how/when programs are offered is a critical factor in program planning. 
Patients placed high importance on participation in JP if research findings show that this 
program actually works. Pain reduction outcomes, joint deformity prevention, hand 
function and grip strength outcomes were all judged as being “extremely important” by the 
patients. Since all of these outcomes are important to patients it may be that adherence 
could to JP could be improved by clear explanations of how JP can benefit each of these 
outcomes both a conceptual level and with the current research evidence that suggests 
benefits to these outcomes. 
The level of participation preferred by potential participants in JP in this study equates to 
3-6 hours/week, and is  similar to that performed in clinical trials of JP in patients with 
osteoarthritis and rheumatoid arthritis in the hand.15–17 Half of the respondents ranked the 
online format as the first choice over all the other methods of delivery of JP with home 
program being the second most preferred choice. This finding is consistent with a recent 
study where patients with RA reported that a home version of a hand exercise program, 
which was held online was very  useful and authors suggested that this might contribute to 
better adherence in long term.18 Data from an RCT of behavioral and hand exercises 
interventions in women with arthritis also suggested home programs may increase 
participation.19 The recent pandemic has forced many  countries to re-evaluate how care is 
delivered to maintain social distancing or self-isolation.20 The pandemic has heighted the 





the same time, it has opened up the pathway for innovation and acceptance of alternative 
delivery models that provide remote accessibility. Since our data was collected pre-
pandemic, we can only assume that preference for online programs would have increased. 
While the efficacy of JP interventions with hand exercises has been evaluated it is difficult 
for patients with hand arthritis to have confidence that an online or remote intervention is 
equally effective method to control their symptoms without being tested in future trials.7 
This underlines the importance of trials and post-trial implementation studies to provide 
more definitive evidence on the impact of virtual JP programs.  
The third most preferred choice of JP delivery was at the clinic. Our previous studies of 
information access preferences in patients with fibromyalgia21,22 indicated that face-to face 
interaction with health care providers was the most preferred way of getting information 
and it likely that this is the positive aspect for attending a clinical site. Previous review has 
indicated that patient-centered interaction styles related to the provision of emotional 
support and allowing patient involvement in the consultation process may enhance the 
therapeutic alliance between clinician and patient.23 Effective communication between the 
clinician and the patient is relied on verbal but also on non-verbal factors, and this can 
usually be achieved in an in-person encounter.24 The value of face-to-face interaction may 
mean that online interventions although theoretically more accessible, may not instigate 
the same level of engagement or adherence.  
Another key finding of this study is that the cost of the JP program, working commitments, 
the time that JP is offered as well as the distance from home to clinic were regarded as the 
main barriers and could substantially decrease participation in JP. Financial burden, time 
has been previously described for patients with rheumatoid arthritis as a perceived 
barrier.25,26 From the qualitative analysis barriers associated with health factors were novel, 
and not well captured in the survey. 
Respondents identified a variety of perceived important outcomes with pain reduction, 
joint deformity prevention and hand function being the main predominant ones. This is 
consistent with the core set outcome measures that has been proposed from OMERACT- 
Osteoarthritis Research Society International (OMERACT-OARSI) set of responder 





measured performance and function have been recommended by patients.28,29 Based on 
patients’ perceived benefit, JP programs appeared to have neutral to positive impact on 
stiffness, pain, grip strength, hand function and swelling. While this is consistent with a 
recent meta-analysis7,14 there was a very low number of respondents that used JP in our 
sample. 
Our study has several limitations that need to be taken into account when interpreting our 
study findings. Since the survey was designed for English speakers with hand arthritis, 
people speaking other languages were not represented. Potentially cultural, language and 
health system issues could affect preferences. The survey responses were recorded online, 
and patients did not have access to electronic devices could not participate in the survey. 
However, we offered a paper version survey for individuals as an alternative. Finally, the 
small sample of people with experience of JP prevented us from adequately exploring the 
perceptions of patients who had completed the training. 
 
5.6 Future research and clinical implications 
While this survey is a first step to understand what factors affect participation rates in 
people who are candidates for JP, studies that collect patient perceptions of draft programs 
in a co-design process are needed to create a patient-preference based JP program. It is 
possible that preferences will change or become more specific through a co-design process. 
A future trial to compare alternative delivery models is highly needed. Our survey 
identified principles of JP that the patients perceived as extremely important and it is 
unclear if these components were present in the published efficacy trials, since these studies  
have inadequate reporting.7 Adherence to guidelines such as Template for Intervention 
Description and Replication (TiDIER) and presentation of theoretical assumptions for the 
content of programs would improve fidelity across studies and in converting current JP 
programs to online formats.30 One of the most important findings of our work is the lack 
of awareness about, and participation in JP in a sample of people for who current best 
evidence suggest this would be effective. Education of health care professionals about this 






Awareness of the potential benefits of JP, and prior experience with JP program were very 
low. Common potentially modifiable patient-reported barriers to participate in future JP 
interventions, included: cost, work commitments distance from home to clinic and times 
that the JP intervention were provided. These barriers might be addressed with free and 
accessible forms of delivery of JP, which may lead to better uptake and participation in JP. 
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Table 6-1. Sample characteristics 
Variable 
% n 
Age (years)     
18 – 24 3% 5 
25 – 34 11% 19 
35 – 44 26% 45 
45 – 54 26% 45 
55 – 64 23% 39 
65 – 74 7% 12 
75 – 84 1% 2 
Diagnosis (hand)   182 
Osteoarthritis 22% 38 
Rheumatoid arthritis 51% 92 
Psoriatic arthritis 16% 29 
Other form of arthritis 7% 13 
None of the above 5% 10 
Joint Protection     
I am currently taking part in a joint protection program 4% 6 
I have previously taken part in a joint protection program 5% 7 
I have heard about joint protection but have not taken part in a program 10% 17 
I have not heard about any joint protection programs 82% 134 
Setting     
Inpatient- rehabilitation unit 8% 1 
Inpatient- hospital 8% 1 
Outpatient- hospital 38% 5 
Home care 8% 1 
A rehabilitation centre/ clinic 15% 2 
Family Physician 23% 3 
Joint protection provider     
Family physician or specialist 38% 5 
Occupational therapist 46% 6 






Table 6-2. Examples provided of joint protection from patients that used them 
Example 1 “Learned how to do things safer for my hands, re-enforced pacing” 
Example 2 
“Wearing thumb caps for working in the garden, wrist guards while using my hands. 
Splints for hands and feet” 
Example 3 
“I choose to use larger muscles and joints to aid me in completing day to day tasks, 
and I use splinting to reduce pain, weakness, and fatigue” 
Example 4 
“I wore resting splints for 30 years. I have a key turner and a right-angled knife. I try 
to always use the largest joints. My taps and light switches are modified. I changed my 







Figure 6-1. Individuals who took part into joint protection (n=10) where to asked to 
what extent did the joint protection (JP) affect stiffness, pain, grip strength, hand 
function and swelling. Only 2 out of 10 individuals that participated in JP 







Figure 6-2. Factors perceived either as facilitators or barriers that may affect 






Figure 6-3. Participants were asked to rate the following components of joint 






Figure 6-4. Individuals were asked how often they used the following modalities to 






Chapter 6  
7 Evaluation of the Content Validity Index of the 
Australian/Canadian Osteoarthritis hand Index, the Patient-
Rated Wrist/Hand Evaluation and the Thumb Disability 
Exam in people with hand arthritis 
Abstract 
Background 
The Australian/Canadian Osteoarthritis Hand Index (AUSCAN), the Patient -Rated 
Wrist/Hand Evaluation (PRWHE) and the Thumb Disability Exam (TDX) are patient-
reported outcome measures (PROM) designed to assess pain and hand function in patients 
with hand arthritis, hand pain and disability, or thumb pathology respectively. This study 
evaluated the content validity of AUSCAN, PRWHE and TDX in people with hand 
arthritis.  
Methods 
This study enrolled participants with hand arthritis to rate the items of all 3 PROM in terms 
of relevance and clarity.  The Content Validity Index (CVI) was computed for each item 
in each scale (I-CVI) as well as for the overall scale (S-CVI). Kappa was used to determine 
the inter-rater agreement among the raters.  
Results 
Overall, 64 individuals with hand arthritis (27% with OA, 67% with rheumatoid arthritis 
and 6% with psoriatic arthritis) participated in the study. The I-CVI for all items and all 
scales were very high (I-CVI > 0.76) and the modified Kappa agreement among the raters 
demonstrated excellent agreement (k>0.76).The S-CVI for all PROMs was very high for 
relevance (AUSCAN = 0.92, 95% CI 0.90 to 0.94; PRWHE = 0.85, 95% CI 0.82 to 0.88 
and TDX = 0.87, 95% CI 0.85 to 0.89) and for clarity (AUSCAN = 0.99, 95% CI 0.98 to 







This study demonstrated very high content validity indices for the AUSCAN, PRWHE and 
TDX; with strong consensus across raters. This augments prior studies demonstrating 
appropriate statistical measurement properties, to provide confidence that all three 
measures assess important patient concepts of pain and disability. 
Keywords: osteoarthritis, rheumatoid arthritis, psoriatic arthritis, content validity, hand 
arthritis 
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Ferreira L, Grewal R. Evaluation of the content validity index of the Australian/Canadian 
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7.1 Introduction 
Hand osteoarthritis (OA) is one of the most common musculoskeletal diseases and a 
leading cause of disability with an increasing prevalence mainly attributed to increased life 
expectancy.1,2 Clinical characteristics of hand OA typically involve pain, reduced hand 
function, decreased hand grip strength, poor quality of life3,4 joint degeneration, bony 
enlargements and joint swelling.5Rheumatoid arthritis, although leading to bone tissue 
abnormalities, loss of joint function and impact on quality of life similarly to OA, is a 
distinct pathology that mainly targets synovial and soft tissue structures.6 
Patient-reported outcome measures (PROMs) are often administered to assess any health-
related changes that may have occurred as a consequence of health-management 
interventions.7,8 Many properties are important9–13 during an instrument development such 
as reliability and validity but a key property is considered to be content validity.14  Content 





adequate reflection of the construct being measured.15 Based on the Consensus-based 
Standards of the selection of health Measurement Instruments (COSMIN) initiative content 
validity is considered as one of the most important measurement properties.14 While 
reliability, responsiveness and other types of validity can be pivotal for an outcome 
assessment they may be insufficient to establish the validity of a PROM.16 When PROMs 
include irrelevant items and lack of clarity they  are inefficient, and may have weaker 
measurement properties.14 Most importantly, if key aspects are missing or the questions 
are not relevant responses, they may not reflect patient status or concerns, and may be 
biased because patients may get frustrated.17 
The Australian/Canadian Osteoarthritis Hand Index (AUSCAN) 18, the Patient-Rated 
Wrist/Hand Evaluation (PRWHE)18and the Thumb Disability Exam (TDX)19 are clinical 
tools designed to assess pain and hand function in hand arthritis. 18–21 Both AUSCAN and 
PRWHE have demonstrated construct validity with verbal rating scale, had high internal 
consistency, and correlated with each other at baseline and follow-up time points in patients 
with early thumb carpometacarpal OA.18 However, previous studies have reported 
inconsistent results about construct validity of AUSCAN.22–24 Haugen et al showed that 
AUSCAN total index lacks construct validity with items contributing to separate scales of 
pain, stiffness, and physical functioning.24 Also, a recent update of PRWHE was performed 
to improve the clarity and applicability of items, but this version has not been compared to  
the AUSCAN and it is important to assess the content validity of the revised scale. The 
TDX is a more recently developed scale that has not been compared to either the PRWHE 
or AUSCAN.  Although, previous studies have demonstrated appropriate statistical 





constructs being evaluated are those intended, and that items are interpreted probably by 
potential respondents. Limited investigation of content validity has been reported for any 
of these three questionnaires. Therefore, we aimed to investigate the quantification of 
content validity index by asking patients with hand arthritis to rate each of the instruments 
items in terms of relevance and clarity. 
  
7.2 Primary Objective 
To evaluate the Content Validity Index (CVI) of the Australian/Canadian Osteoarthritis 
Hand Index (AUSCAN), the Patient-Rated Wrist/Hand Evaluation (PRWHE), and the 
Thumb Disability Exam (TDX) in patients with hand arthritis.  
 
7.3 Methods 
7.3.1 Study Design  
This study was a cross-sectional design that investigated the content validity of patient-
reported outcomes (AUSCAN, PRWHE and TDX) for hand arthritis. Ethical approval was 
granted from the Hamilton Integrated Research Ethics Board (HiREB). 
 
7.3.2 Inclusion criteria: 
1. The participant was able and willing to provide informed consent 





4. The participant had hand arthritis. 
5. The participant can read and write English. 
 
7.3.3 Exclusion criteria 
1.  Hand pathologies or conditions other than arthritis  
2.  Inability to answer the survey questions in English. 
 
7.3.4 Setting and Recruitment 
Participants were recruited through poster advertisements at The Roth McFarlane Hand 
and Upper Limb Centre (HULC) at St. Joseph’s Health Care Hospital in London, Ontario 
and through The Arthritis Society main website. The patients that expressed interest to 
participate in the study received a letter of information about the survey.  Both electronic 
and paper versions of the survey were available for participants. An email with the link of 
the online survey was sent out to the participants that were interested to complete the 
electronic version. The electronic version was hosted on Qualtrics from May 2019 till 
February 2020 which is a secure data collection platform.25 Participants were asked to 
provide consent to proceed into the survey questions. Allthe items were rated for relevance 
and clarity in an order (AUSCAN, PRWHE, TDX). Participants were asked to rate the 






7.3.5 Patient-reported Outcome Measures 
The Australian/Canadian Osteoarthritis Hand Index (AUSCAN) is a 15-item self-reported 
disease specific questionnaire measuring pain (5-items), function (9-items) and stiffness 
(1-item) in the hand on a scale from 0 – none to 4 – extreme for all items.18,20 The Patient-
Rated Wrist/Hand Evaluation (PRWHE)is a self-administered questionnaire which has 2 
subscales of pain (5-items) and function (10-items). The PRWHE was originally developed 
and tested for people with distal radius fracture (DRF)21,26,27 and later validated as 
applicable to the wrist/hand for multiple conditions including arthritis as the PRWHE. 18,28 
Each item is scored from 0 to 10 scale which 10 indicates the worst possible pain or 
disability. The Thumb Disability Exam (TDX) is composed of 20 questions divided into 3 
sections: hand function (11-items), pain (5-items) and satisfaction (4-items). Each item for 
hand function is scored from 1 – not difficult to 5 – unable, for level of pain 1 – never to 5 
– always and for satisfaction from 1 – very satisfied to 5 – very dissatisfied. 19 
 
7.3.6 Data Analysis 
Descriptive statistics were used to capture the demographics characteristics (age, diagnosis, 
medications and whether they had surgery or not) of the included sample.  A Content 
Validity Index (CVI) value was computed for each item on the AUSCAN, PRWHE and 
TDX (I-CVI) as well as for the overall scale (S-CVI). To calculate an item-level CVI (I-
CVI), patients with hand arthritis were asked to rate the relevance of each item, on a 4-
point scale. Four ordinal points were used foreach scale which was 1=not relevant, 





was computed as the number of patients giving a rating of either 3 or 4, divided by the 
number of raters—that is, the proportion in agreement about relevance and clarity which is 
between 0 and 1. The S-CVI was calculated by averaging across the I-CVIs of each PROM. 
To calculate the modified kappa statistic, the probability of chance agreement (Pc) was first 
calculated for each item by the following formula: Pc= [N! /A! (N -A)!] *0.5N with N being 
the number of raters (patients with arthritis) and A is the number of patients that agree that 
the item was clear or relevant.29 Then Kappa was calculated of entering the probability of 
chance agreement (Pc) and content validity index of each item (I-CVI) in the following 
formula: K= (I-CVI - PC) / (1- PC).29 Kappa values of 0.74 and above were considered as 
excellent, 0.60 to 0.74 as good and 0.54 to 0.59 as fair.30 We performed a Shapiro-Wilk as 
the omnibus test for assessing univariate normality of each S-CVI distribution, in both 
relevance and clarity subscales of PROMs. Then, the S-CVI scores were compared with a 
paired student’s t-Test if normality assumption was met or with Wilcoxon paired signed-
ranks test, if assumptions of normality were violated. 31 We conducted all the analyses with 




Overall, 64 individuals with hand arthritis (27% with hand OA, 67% with rheumatoid 
arthritis in the hand and 6% with psoriatic arthritis) participated in the study. Four 





hand. The majority of the participants (66%) were taking pain medication on a daily basis 
(Table 1). All individuals completed the electronic version of the survey. 
 
7.4.1 Content Validity Index and Modified Kappa agreement of 
the AUSCAN  
The I-CVI and the S-CVI supported the content validity of the hand pain, stiffness and 
function items and subscales of the AUSCANs (Table 2). Five items of pain subscale were 
rated for relevancy and clarity with I-CVI scores ranging from 0.86 to 0.96 and from 0.92 
to 1.00 respectively. For 1-item in stiffness subscale the I-CVI was found 0.93 for 
relevancy and 1.00 for clarity. For function subscale, 9-items were rated for relevancy and 
clarity with an I-CVI ranging from 0.88 to 0.97 and from 0.98 to 1.00 respectively. The S-
CVI for AUSCAN was found 0.92,95% CI: 0.90 to 0.94 for relevance and 0.99, 95% CI: 
0.98 to 1.00 for clarity. The modified Kappa agreement for every item of the AUSCAN 
demonstrated excellent agreement (K ranging from 0.86 to 1.00) 
 
7.4.2 Content Validity Index and Modified Kappa agreement of 
the PRWHE  
The I-CVI and the S-CVI of the PRWHE for pain subscale and function subscales all 
supported the content validity of the PRWHE (Table 3). Five items of pain subscale were 
rated for relevancy and clarity with I-CVI values ranging from 0.79 to 0.89 and from 0.87 
to 0.94, respectively. For function subscales, 10 items were rated for relevancy and clarity 





CVI for PRWHE was 0.85, 95% confidence intervals (CI): 0.82 to 0.88 for relevance and 
0.95,95%CI: 0.93 to 0.97 for clarity. The modified Kappa agreement for every item of 
PRWHE demonstrated excellent agreement (K ranging from 0.79 to 1.00). 
 
7.4.3 Content Validity Index and Modified Kappa agreement of 
the TDX 
The I-CVI and the S-CVI supported the content validity of the TDX for hand function, pain 
and satisfaction subscales (Table 4). Eleven items of hand function were rated as relevant 
and clear with I-CVI values ranging from 0.82 to 0.93 and from 0.94 to 0.98 respectively. 
For pain subscale, five items were rated as relevant and clarity with I -CVI scores ranging 
from 0.78 to 0.85 and from 0.77 to 0.86 respectively. For the satisfaction subscale, four 
items were rated as relevant and clear based on I-CVI demonstrating scores from 0.83 to 
0.95 and from 0.88 to 0.91. The S-CVI of TDX was rated as relevant and clear based on 
scores of 0.87,95% CI: 0.85 to 0.89 for relevancy and 0.91, 95% CI: 0.89 to 0.94 for clarity. 
The modified Kappa agreement demonstrated excellent inter-rater agreement on item 
ratings (K ranging from 0.77 to 0.98). 
 
7.5 Discussion 
This study established a high level of content validity for AUSCAN, PRWHE and TDX 
for patients with hand arthritis. The content validity index was very high for all the 
individual items for each questionnaire (I-CVI> 0.77) and for the overall score (S-CVI > 





respectively.29 The Kappa inter-rater agreement of  >0.75 was excellent across all the 
individual items for all PROMs (AUSCAN, PRWHE and TDX) among the raters.29 
Together these data provide confidence in our assessment since multiple raters agreed on 
the high content validity scores obtained. 
For the AUSCAN the content validity was established  during development using a formal 
clinimetric process where patients in a tertiary care centre rated items by importance and  
frequency to establish relevance.20 This study provides additional support for the content 
validity in a community sample of people living with hand arthritis, and by adding new 
data on the clarity of the items.  
Content validity of PRHE was established during the development of the PRWHE by using 
semi-structured interviews in patients with distal radius fracture and expert opinion. 32 
Later the extension to the PRWHE compared relevance to DASH, based on a comparative 
trial in a mixed clinical population with hand problems.  However, neither were quantified, 
described specific findings in-depth or focused on patients with arthritis. Thus, this study 
provides novel information on the content validity of the items of the PRWHE, with 
specific reference to those with hand arthritis. All items of PRWHE were found with very 
high content validity index in terms of relevance (I-CVI > 0.79) and clarity (I-CVI > 0.87). 
It might have been expected that the AUSCAN would have more relevance to our sample, 
than the PRWHE since it a disease-specific PROM. Both point estimate and CI 
comparisons indicate that AUSCAN had slightly higher overall scores in terms of 
relevancy (S-CVI = 0.92, 95% CI: 0.90 to 0.94) and clarity (S-CVI = 0.99, 95% CI: 0.98 





CVI=0.95, 95% CI: 0.93 to 0.97 for clarity). Although the CIs of the respective S-CVIs 
indicate that there was a small statistically significant difference (Table 5) between 
compared S-CVI values (AUSCAN vs TDX and AUSCAN vs PRWHE), all PROMs met 
standards of very high content validity.  Further, since 6 to 8 additional raters assessed the 
PRWHE that did not assess the AUSCAN, the small differences may reflect differences in 
rater pools rather than an actual difference in perceptions. 
The TDX is relatively new developed PROM (Noback et al. 2017)19 that was tested in 
patients with basal joint arthritis. The TDX demonstrated very high content validity index 
when assessed in terms of relevancy (S-CVI = 0.87, 95% CI: 0.85 to 0.89) and clarity (S-
CVI = 0.91, 95% CI: 0.89 to 0.94). All the individual items of the TDX had a very high 
content validity index (I-CVI >0.77). No previous studies have reported the content validity 
index of TDX. The item generation of TDX included the review of items from relevant 
scales (Michigan Hand Questionnaire (MHQ)33, Disabilities of the Arm, Shoulder, and 
Hand (DASH)34, AUSCAN20, PRWHE27 and McGill Pain questionnaire35). Then, the 
development process included item reduction and pilot testing and then final item 
reduction.19 Thus the items may have benefited from content validity efforts made in 
developing the scales.  Since the thumb is so important for overall hand function, it is not 
surprising that this thumb questionnaire was found to have validity for patients with hand 
arthritis. 
Our kappa statistics indicated excellent agreement between patient raters after correcting 
for chance agreement. (K> 0.77). The assessment from a large pool of patients (n> 60) 





described in the literature when the number of raters increasing and the probability of 
chance (Pc) decreases the K agreement and I-CVI values tend to converge.29 
This study provided novel data on the content validity index in 3 different PROMs in 
patients with hand arthritis. Since few studies address content validity, this is important to 
support the conceptual foundations of these measures and support their use in clinical 
practice. While the computation of CVI is relatively easy, its major weakness is the failure 
to adjust for chance agreement. However, the authors tried to mitigate this problem by 
calculating a modified kappa agreement.29,36 A potential limitation is that the items of the 
PROMs were not randomized but the items were rated for relevance and clarity in an order 
(PRWHE, AUSCAN, TDX).  Since all three scales were brief, we would think it is unlikely 
that there was an order effect, especially since the highest scores were found in the 
questionnaire administered in the middle.  CVI is one method of assessing content validity 
and as a quantitative process are ideally suited to rating existing items, not to identification 
of potential gaps in important constructs.  Ideally CVI should be augmented by qualitative 
techniques like cognitive interviewing or understanding the dimensions of the underlying 
construct to be measured. Also, all three questionnaires demonstrated high content validity, 
and existing evidence confirms that all three provide strong psychometric properties then 
practical considerations might be the predominant difference that would guide selection. 
For example, the AUSCAN requires that a licensee fee be paid to the developer, whereas 







This study demonstrated evidence of very high content validity index for all the individual 
items and for the overall scale of AUSCAN, PRWHE and TDX for patients with hand 
arthritis, with high agreement across raters. This augments prior statistical evidence 
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Table 7-1 Demographics of study participants 
Variable 












































Table 7-2. Content Validity Index of item relevancy and clarity, and Modified 
Kappa agreement of the Australian and Canadian Osteoarthritis Index (AUSCAN) 
Item 
Relevance Clarity Interpretation 
Agreement I-CVI* Pc** K*** Agreement I-CVI* Pc** K***  
Rate your pain          
At rest 49/57 0.86 < 10 -5 0.86 49/50 0.98 < 10 -5 0.98 Excellent 
Gripping 55/57 0.96 < 10 -5 0.96 49/49 1.00 < 10 -5 1.00 Excellent 
Lifting 55/57 0.96 < 10 -5 0.96 49/50 0.98 < 10 -5 0.98 Excellent 
Turning 54/57 0.95 < 10 -5 0.95 46/50 0.92 < 10 -5 0.92 Excellent 
Squeezing 55/57 0.96 < 10 -5 0.96 50/50 1.00 < 10 -5 1.00 Excellent 
Rate your stiffness          
After first wakening in the morning 52/56 0.93 < 10 -5 0.93 48/48 1.00 < 10 -5 1.00 Excellent 
Rate your difficulty when          
Turning taps/faucets on 51/58 0.88 < 10 -5 0.88 51/51 1.00 < 10 -5 1.00 Excellent 
Turning a round doorknob or handle 54/59 0.92 < 10 -5 0.92 53/53 1.00 < 10 -5 1.00 Excellent 
Doing up buttons 52/59 0.88 < 10 -5 0.88 52/52 1.00 < 10 -5 1.00 Excellent 
Fastening jewellery 52/59 0.88 < 10 -5 0.88 53/53 1.00 < 10 -5 1.00 Excellent 
Opening a new jar 57/59 0.97 < 10 -5 0.97 53/53 1.00 < 10 -5 1.00 Excellent 
Carrying a full pot with one hand 56/59 0.95 < 10 -5 0.95 52/53 0.98 < 10 -5 0.98 Excellent 
Peeling vegetables/fruits 56/59 0.95 < 10 -5 0.95 53/53 1.00 < 10 -5 1.00 Excellent 
Picking up large heavy objects 55/59 0.93 < 10 -5 0.93 51/51 1.00 < 10 -5 1.00 Excellent 
Wringing out wash cloths 52/59 0.88 < 10 -5 0.88 50/51 0.98 < 10 -5 0.98 Excellent 
S - CVI 0.92 (95% CI: 0.90 to 0.94)  0.99 (95% CI: 0.98 to 1.00)   
NOTE: *I-CVI: item-level content validity index, **pc (probability of a chance occurrence) was computed using the 
formula: pc= [N! /A! (N -A)!] *.5N where N= number of experts and A= number of experts who agree that the item is 
relevant or clear, ***K(Modified Kappa) was computed using the formula: K= (I-CVI- PC)/(1- PC). Interpretation 
criteria for Kappa, using guidelines described in Cicchetti and Sparrow (1981): Fair=K of 0.40 to 0.59; Good=K of 0.60 







Table 7-3. Content Validity Index of item relevancy and clarity and Modified Kappa 
agreement of Patient Rated Wrist/Hand Evaluation (PRWHE) 
Item 
Relevance Clarity Interpretation 
1. Pain subscale Agreement I-CVI* Pc** K*** Agreement I-CVI* Pc** K***  
Rate your pain: At rest 51/64 0.80 < 10 -5 0.80 50/53 0.94 < 10 -5 0.94 Excellent 
Rate your pain: When doing a task 
with a repeated wrist movement 
54/64 0.83 < 10 -5 0.83 49/53 0.92 < 10 -5 0.92 Excellent 
Rate your pain: When lifting a 
heavy object 
54/64 0.83 < 10 -5 0.83 50/53 0.94 < 10 -5 0.94 Excellent 
Rate your pain: When it is at its 
worst 
57/64 0.89 < 10 -5 0.89 49/53 0.92 < 10 -5 0.92 Excellent 
How often do you have pain? 50/63 0.79 < 10 -5 0.79 47/54 0.87 < 10 -5 0.87 Excellent 
2. Function          
A. Specific Activities          
Turn a doorknob using my affected 
hand 
53/63 0.84 < 10 -5 0.84 52/52 1.00 < 10 -5 1.00 Excellent 
Cut meat using a knife in my 
affected hand 
54/63 0.86 < 10 -5 0.86 53/53 1.00 < 10 -5 1.00 Excellent 
Fasten buttons on my shirt 51/63 0.81 < 10 -5 0.81 53/53 1.00 < 10 -5 1.00 Excellent 
Use my affected hand to push up 
from a chair 
50/63 0.79 < 10 -5 0.79 51/52 0.98 < 10 -5 0.98 Excellent 
Carry a 10lb object in my affected 
hand 
58/63 0.92 < 10 -5 0.92 52/53 0.98 < 10 -5 0.98 Excellent 
Use bathroom tissue with my 
affected hand 
50/63 0.79 < 10 -5 0.79 51/52 0.98 < 10 -5 0.98 Excellent 
B. Usual activities          
Personal care activities (dressing, 
washing) 
53/61 0.87 < 10 -5 0.87 50/53 0.94 < 10 -5 0.94 Excellent 
Household work (cleaning, 
maintenance) 
57/60 0.95 < 10 -5 0.95 49/53 0.92 < 10 -5 0.92 Excellent 
Work (your job or usual everyday 
work) 
52/60 0.87 < 10 -5 0.87 49/53 0.92 < 10 -5 0.92 Excellent 
Recreational activities 54/60 0.90 < 10 -5 0.90 51/53 0.96 < 10 -5 0.96 Excellent 
S – CVI/Ave 0.85 (95% CI: 0.82 to 0.88)  0.95 (95% CI: 0.93 to 0.97)   
NOTE: *I-CVI: item-level content validity index, **pc (probability of a chance occurrence) was computed using the 
formula: pc= [N! /A! (N -A)!] *.5N where N= number of experts and A= number of experts who agree that the item is 
relevant or clear, ***K(Modified Kappa) was computed using the formula: K= (I-CVI- PC)/(1- PC). Interpretation 
criteria for Kappa, using guidelines described in Cicchetti and Sparrow (1981): Fair=K of 0.40 to 0.59; Good=K of 0.60 







Table 7-4. Content Validity Index of item relevancy and clarity, and Modified 
Kappa agreement of the Thumb Disability Exam (TDX) 
Item 
Relevance Clarity Interpretation 
A. Please indicate your ability to 
perform these activities with the 
affected hand 
Agreement I-CVI* Pc** K*** Agreement I-CVI* Pc** K*** 
 
Turn a Key 54/61 0.89 < 10 -5 0.89 51/53 0.96 < 10 -5 0.96 Excellent 
Pick up a coin 52/61 0.85 < 10 -5 0.85 49/51 0.96 < 10 -5 0.96 Excellent 
Write 56/61 0.92 < 10 -5 0.92 51/54 0.94 < 10 -5 0.94 Excellent 
Squeeze Toothpaste 52/60 0.87 < 10 -5 0.87 51/53 0.96 < 10 -5 0.96 Excellent 
Hold a glass of water 50/61 0.82 < 10 -5 0.82 51/54 0.94 < 10 -5 0.94 Excellent 
Turn a doorknob 52/61 0.85 < 10 -5 0.85 51/53 0.96 < 10 -5 0.96  
Use a knife to cut food 54/61 0.89 < 10 -5 0.89 51/53 0.96 < 10 -5 0.96 Excellent 
B. Please indicate your ability to 
perform the following task while 
using both your hands 
         
Open a jar 57/61 0.93 < 10 -5 0.93 50/51 0.98 < 10 -5 0.98 Excellent 
Button a shirt/blouse 53/61 0.87 < 10 -5 0.87 49/50 0.98 < 10 -5 0.98 Excellent 
Tie your shoes 55/61 0.90 < 10 -5 0.90 50/51 0.98 < 10 -5 0.98 Excellent 
Wring a dishcloth/washcloth 53/61 0.87 < 10 -5 0.87 49/51 0.96 < 10 -5 0.96 Excellent 
II. The following questions refer to 
the level of pain in your thumb 
 
How often did you have pain in your 
thumb at rest?  
50/61 0.82 < 10 -5 0.82 40/52 0.77 < 10 -5 0.77 Excellent 
How often did the pain in your thumb 
interfere with your daily activities?  
49/60 0.82 < 10 -5 0.82 44/51 0.86 < 10 -5 0.86 Excellent 
How often did the pain in your hand 
interfere with recreational activities?  
51/60 0.85 < 10 -5 0.85 44/52 0.85 < 10 -5 0.85 Excellent 
How often did the pain in your thumb 
interfere with your sleep?  
47/60 0.78 < 10 -5 0.78 44/52 0.85 < 10 -5 0.85 Excellent 
How often did the pain in your thumb 
worsen your mood?  
51/60 0.85 < 10 -5 0.85 42/52 0.81 < 10 -5 0.81 Excellent 
III. The following questions ask 
about your satisfaction with the 
indicated hand or thumb over the 
past week.  
         
Motion in your affected thumb 48/58 0.83 < 10 -5 0.83 47/53 0.89 < 10 -5 0.89 Excellent 
Strength of your affected hand 54/57 0.95 < 10 -5 0.95 48/53 0.91 < 10 -5 0.91 Excellent 
Pain level of your affected hand 52/58 0.90 < 10 -5 0.90 48/53 0.91 < 10 -5 0.91 Excellent 
Overall function of your hand 53/58 0.91 < 10 -5 0.91 46/52 0.88 < 10 -5 0.88 Excellent 
S-CVI                                                          0.87 (95% CI: 0.85to 0.89)  0.91 (95% CI: 0.89to 0.94)   
NOTE: *I-CVI: item-level content validity index, **pc (probability of a chance occurrence) was computed using the 
formula: pc= [N! /A! (N -A)!] *.5N where N= number of experts and A= number of experts who agree that the item is 
relevant or clear, ***K(Modified Kappa) was computed using the formula: K= (I-CVI- PC)/(1- PC). Interpretation 
criteria for Kappa, using guidelines described in Cicchetti and Sparrow (1981): Fair=K of 0.40 to 0.59; Good=K of 0.60 






Table 7-5. Comparison of content validity index (S-CVI) of Relevance and Clarity 
Relevance   Clarity  

























AUSCAN p <0.001 p = 0.001        0.92 
(95% CI: 0.90-
0.94) 
AUSCAN p = 0.001 p = 0.002 0.99 
(95% CI: 0.98-
1.00) 
Paired t-Test: Student’s t-Test for Matched Pairs; Wilcoxon Signed Ranks: Wilcoxon Matched-Pairs Signed-Ranks; 






Chapter 7  
8 The Efficacy of a Joint Protection Program on Pain Intensity 
and Hand Function levels in People with Hand Osteoarthritis. 
A Protocol for a randomized controlled trial  
Trial Summary  
What is the principal research question? In patients with hand osteoarthritis does a joint 
protection program decrease pain intensity at 3 months compared to hand exercises.  
PICOT Format  
Population: Adult patients with primary type of hand osteoarthritis  
Intervention: Joint protection program 
Comparator: Hand exercises and joint protection 
Outcome: Pain Intensity levels  
Timeline: 1-year follow-up  
Outcome: Primary outcome: Pain intensity levels at 3-months will be our primary outcome 
(dependent variable) and will be investigated by the Visual Analog Scale (VAS). It consists 
of a unidirectional 10 cm responsiveness scale with two anchors at either end of the scale; 
0 - “no pain” and 10 - “worst possible pain”. Patients will be instructed to draw a vertical 
mark on the scale indicating their pain level. Secondary outcomes: Secondary outcomes 
that will be collected consist of the Global Rating of Change, quality of life with EQ-5D, 
the Australian/Canadian Osteoarthritis Hand Index (AUSCAN), the Patient-Rated 
Wrist/Hand Evaluation and hand grip strength that will be assessed with a handheld 
dynamometer  
Timeline: The maximum follow-up will be 1 year. The target of this trial is to demonstrate 
superiority of joint protection versus the exercise and joint protection on pain reduction at 
3 months follow-up.  
Study Design: This study will be a single center, investigator-blinded, randomized, 12-
month, parallel-group, superiority study  






8.1.1 Impact of Osteoarthritis  
Osteoarthritis (OA) is characterized as a degenerative joint disease that affects 
approximately 27 million adults in the USA and is one of the leading causes of disability.1 
Osteoarthritis affects 60-70% of the population above the age of 65 years, and is likely to 
increase further in the future.2,3 The most common site of OA is the hand and it typically 
involves the interphalangeal (proximal and distal) and first carpometacarpal joints.4 In a 
clinical setting, pain is a major symptom among patients with hand OA as it contributes to 
a reduction in joint function.1,4 Currently there is no cure for hand OA, but goals of 
treatment include maximizing long-term health-related quality of life, by controlling 
symptoms such as pain, prevention of structural damage and normalization of function. 
 
8.1.2 Age, Sex and Disease Progression in hand OA 
Approximately 60–70% of the population above the age of 65 seek medical attention for 
OA, and the majority of these are women.5–7 Hand OA has a strong genetic influence, 
indicating that if their mother had severe hand OA, they are likely to experience a similar 
disability.5,6 The biological mechanisms by which increases hand OA disability for 
females, is poorly elucidated. However, it may be a result of the smaller size of hand joints, 
hormonally regulated soft tissue laxity, pregnancy-induced laxity and sex-differences in 
pain.5–7 Gender may affect hand OA given the higher repetitive loading in paid and unpaid 
work tasks performed more often by women. However, men tend to be under-represented 
in studies of hand OA, so we may know less about how it manifests in men. Age has a 
pivotal effect to diseases as OA and at pain outcomes because of the degeneration nature 
of articular cartilage as we age.5–7 Additionally, pain intensity levels for people with hand 
OA may vary depending on the disease progression and the structural modification.7 This 
suggests that age, sex and disease progression must be considered in the design stage as 







8.1.3 Why Joint Protection and hand exercises are important?  
Joint protection programs (JPP) are a self- management strategy for patients living with 
arthritis to help preserve joint function and reduce pain.8 JPP involve training on “safer 
movement patterns, the use of adaptive devices (e.g. built up handles, hands free 
technologies) and behavior modifications (e.g. activities to avoid, pacing). Originally 
shown to be effective for rheumatoid arthritis, the concept has been expanded to treat 
patients with OA.9–11 Osteoarthritis causes excessive fluid to surround the joint, which 
when occurs for an extended period of time, causes the ligaments surrounding the joint to 
become elongated and no longer adequately stabilize the joint.12,13 Overtime, the cartilage 
weight bearing surfaces become eroded and patients experience pain especially with joint 
loading. Unlike the lower extremity where joint loading takes place through weight 
bearing, joint loading in the upper limb is determined by the tasks performed. The lack of 
soft tissue support makes joints in the hand susceptible to deformity during tasks of daily 
life.14 Muscle imbalance can further exacerbate deformity, and thus the kinematics of how 
tasks are performed are critical to cumulative loading. 
 
8.1.4 The need for a trial in hand OA 
Magni et al. has indicated clinically unimportant pain-relieving effects of hand exercises 
for people with hand OA.15 A subsequent study reported that it is unclear if a combination 
of hand exercises and joint protection program can provide better pain outcomes for people 
with hand OA.16 Both reviews15,16 highlighted the low-quality certainty that was associated 
for pain outcomes. The majority of the included studies were rated as high risk of bias 
mostly for: selection, performance and detection bias domains.17–19 Furthermore, problems 
with adherence to JPP and hand exercises were not documented. Hand dysfunction because 
of pain is a very common problem in hand OA. Hand exercises and joint protection are 
currently recommended in clinical practice but for people with rheumatoid arthritis only.20–
23 Also, these recommendations are not supported by high-quality evidence as 
recommended by Grading of Recommendations, Assessment, Development, and 





joint protection program in large group of people living with hand OA. As part of this 
evaluation, it is important to integrate strategies to maximize program adherence. The null 
hypothesis of the study is that there will be no difference in pain outcomes between the two 
arms at 3-months follow-up. It is unclear if a combination of hand exercises and joint 
protection program can provide better pain outcomes for people with hand OA.  
 
8.2 Objectives of the Study 
8.2.1 Primary Objective 
The first objective of this study is to assess if a JPP when compared to hand exercises and 
joint protection, can reduce pain intensity levels in people with hand osteoarthritis, at 3-
months follow up 
 
8.2.2 Secondary Objectives 
1. To assess if JPP when compared to hand exercises and joint protection, can improve 
hand function in people with hand osteoarthritis, at 6-months follow up 
 
2. To assess if JPP when compared to hand exercises and joint protection, can improve 
quality of life in people with hand osteoarthritis, at 12-months follow up 
 
8.3 Methods 
8.3.1 Study design  
This study will be a single center, investigator-blinded, randomized, 12-month, parallel-







This study will be conducted in a single center specialized tertiary hand clinic (Hand and 
Upper Limb Centre – HULC) in London Ontario Canada. Advertisements will be placed 
at regular intervals in local and regional newspapers and on social media platforms. This 
will be accompanied by regular posting of advertisements on hospitals, community 
noticeboards and in The Arthritis Society main webpage. Local health practitioners will be 
made aware of the study through information and advertising packages. Participants with 
hand OA will be contacted to schedule an initial visit at HULC. All participants who meet 
the eligibility criteria and provide an informed written signed consent, will be offered an 
opportunity to enroll in the study. Participants with hand OA will then complete a 
demographic data such as age, gender/sex, email address, height, weight, years of service, 
rank, educational level, use of NSAIDs and a set of outcome measures. 
  
8.3.3 Eligibility Criteria 
Our sample will include: 
1. Participants (males and females) between 18 and 85 years old 
2. Participants with primary type of hand osteoarthritis (non-traumatic) 
3. Radiographic findings of OA  
4. Meeting the ACR Classification criteria 
5. Individuals able to speak and write in English 
6. Have access to electronic devices (e.g. computer) and internet.  
Participants will be excluded if they have: 
1. Neurological disorders 
2. Rheumatoid arthritis or any other type of arthritis than hand osteoarthritis 
3. Dementia or any other cognitive condition that could interfere with the trial 
procedures 
4. Age less than 18 years 
5. Upper limb joint surgery, or fracture, in the previous 6 months 








Exercises and Joint Protection (Ex+JP) 
Participants that will be randomized to the Exercises and Joint protection (Ex+JP) arm will 
have a specific exercise program plus a joint protection that described above. The exercise 
program will include seven mobility exercises and four strength exercises against 
resistance. More specifically, they will perform: MCP flexion, tendon gliding, radial 
walking, eccentric wrist extension, gross grip, finger abduction and adduction, wrist 
circumduction and finger pinch. This intervention will involve a total of six sessions (1 
hour per session). Individuals will be provided with an exercise booklet containing pictures 
and instructions describing the program, as well as the resistance materials required. They 
will be asked to perform the program daily at home between clinic sessions, for a period 
of approximately 12 weeks. The dosage consists of 1 set and 10 repetitions for each 
exercise. Adherence to the exercise program is pivotal in ensuring that the dosage will be 
carried out. Patients adherence in home exercise programs is usually poor, but it will be 
enhanced through the use of exercise diaries. 
 
8.3.5 Joint Protection (JP) 
Joint protection will include patient education, problem-solving to promote behavior 
modification; energy conservation; and selective use of splints and adaptive devices and 
provision of The Arthritis Society booklets containing further advice. The following 
principles will be explained during the joint protection instruction: the need for balance 
between movement and resting a joint; dividing stress between as many joints as possible; 
using larger and stronger joints; using each joint in its most stable plane to reduce pressure 
on the joint; avoiding staying in one position; and avoiding vibrations for the finger joints. 
In addition, patients were trained to protect their joints, using assistive devices if necessary, 
to perform Activities of Daily Living (ADL). Patients were trained to do the following 





jars, cans, or boxes with Dycem; using a book holder for reading; and using a rocker or 
angled knife for cutting food. Patients will be encouraged to find examples for application 
of these principles in their own daily activities, which were discussed. Oral and written 
information will be provided. Participants that will be randomized to the JP arm will have 
individual appointments with a therapist (number of sessions dependent on clinical need 
up to a maximum of three sessions or 1.5 hours in total). They will be no resting splints 
provided, no explicit exercise prescription, no manual therapy (i.e. joint mobilizations) or 
electrotherapy, with assessment and treatment to be documented using a standardized log. 
 
8.3.6 Outcomes 
Pain intensity levels at 3-months will be our primary outcome (dependent variable) and 
will be investigated by the Visual Analog Scale (VAS).25 It consists of a bidirectional 10 
cm responsiveness scale with two anchors at either end of the scale; 0 - “no pain” and 10 - 
“worst possible pain”. Patients will be instructed to draw a vertical mark on the scale 
indicating their pain level.25 Secondary outcomes that will be collected consist of the 
Global Rating of Change26, quality of life with EQ-5D27, the Australian/Canadian 
Osteoarthritis Hand Index (AUSCAN)28, the PRWHE and grip strength.29 While several 
domains can be assessed in OA trials, the Outcome Measures in Arthritis Clinical Trials 
(OMERACT) expert group30 has identified 3 core variables (pain, function and global 
assessment) that require inclusions in OA studies.30 
 
8.3.7 Participant Timeline 
Outcome measures will be collected through Patient Reported Outcomes; at baseline (14-
30 days after randomization for all participants), at 3-months, 6-months and 12-months. 
8.3.8 Sample Size Estimation 
Response to treatment will be based on OMERACT-OARSI criteria.30,31 According to 
these criteria, a response has occurred if the patients experience a reduction of ≥50% from 





consider a 20% as a clinical important margin on VAS pain scale, 80% power at 5% 
significance level and assuming a scenario of 25% loss of follow-up a total sample size of 
347 patients will be needed (Figure 1) 
 
8.3.9 Recruitment 
Participants will be recruited through the email list of The Arthritis Society and from the 
Hand and Upper Limb Centre (HULC) at St. Joseph’s Health Care Hospital in London, 
Ontario. This will be conducted by contacting people who have previously expressed 
interest in participating in research initiatives through the organization. The Arthritis 
Society is a non-profit organization a with a well-established network and facilitates at the 
Federal and Provincial level to raise awareness and community engagement for people with 
arthritis in more than 40 communities across Canada. The HULC Centre is a respected, 
world renowned center of excellence in education, research, and treatment of patients with 
complex conditions affecting hands, wrists, elbows and shoulders requiring specialized  
care. Patients that are covered under OHIP have accessibility to the HULC clinic. One of 
the most common conditions that is treated at HULC is patients with arthritis. 
 
8.3.10 Allocation 
We will use block randomization with blocks of randomly selected sizes through a central 
web- based randomization system in a 1:1 ratio for the two arms. Central randomization 
will be conducted using a central randomization web-based program. The randomization 
process will be initiated by the trial coordinator who will access the web-based system and 
enter the patient’s information and confirmation of eligibility criteria. In order to secure 
the allocation concealment only once the participant will be registered in the trial then the 
random allocation will be generated by central randomization. Therefore, we will control 








To avoid performance bias, participants will be aware that two procedures (active 
treatments) are being compared. However, they will be unaware that one treatment is a 
control, as neither the consent forms nor the verbal explanations referred to the attention 
control intervention as a control treatment. Thus, participants could reasonably expect an 
improvement regardless of treatment received. All interventions will be delivered by 
physiotherapists who work at HULC which they are certified hand therapists. They will be 
independent of the recruitment and randomization procedures, and they will attend a 
training session delivered by the trial team. Participants will receive ongoing support and 
guidance regarding the intervention. Therapists will be trained to deliver both the 
experimental and control interventions without knowing which one it is. Contamination 
will be minimized through monitoring the treatment logs completed at each session. To 
protect against detection bias18, the outcome assessor will be blind to group allocation and 
independent of the treatment delivery. Participants will be requested not to disclose group 
allocation to the outcome assessor. If an outcome assessor will be unblinded, this will be 
recorded 
 
8.4 Data Collection 
8.4.1 Primary outcome 
Hand pain will be the primary outcome measure at 3 months, and it will be measured using 
a 100mmVAS by asking “on this line, where would you rate your pain, using the last 7 
days as a timeframe. It consists of a bidirectional 100 mm responsiveness scale with two 
anchors at either end of the scale; 0 - “no pain” and 10 - “worst possible pain”. Patients 
will be instructed to draw a vertical mark on the scale indicating their pain level.25 The 






8.4.2 Secondary Outcomes 
The Patient-Rated Wrist/Hand Evaluation (PRWE)is a self-administered questionnaire 
which has 2 subscales of pain (5-items) and function (10-items). The PRWE was originally 
developed and tested for people with distal radius fracture (DRF) and later validated as 
applicable to the wrist/hand for multiple conditions including arthritis as the PRWHE.45 
Each item is scored from 0 to 10 scale which 10 indicates the worst possible pain or 
disability.  
The Australian and Canadian Osteoarthritis Index (AUSCAN) is a 15-item self-reported 
disease specific questionnaire measuring pain (5-items), function (9-items) and stiffness 
(1-item) in the hand on a scale from 0 – none to 4 – extreme for all items.28  
Global rating of change (GROC) is patient-reported outcome that will be evaluated at 3-, 
6- and 12-months follow-up. Participants will be asked to rate their overall change in hand 
pain on a six- point Likert scale (completely recovered, much improved, improved, no 
change, worse, much worse). GROC has been used to evaluate outcomes in clinical trials 
of OA pain.26,35,36  
Hand grip strength will be evaluated at baseline, at 3-, 6- and 12-months follow-up with a 
Jamar hand-held dynamometer.29 The testing procedure for evaluating hand grip strength 
will use a standardized positioning with Jamar grip dynamometers that will be calibrated. 
Participants will be requested to complete three trials of hand grip strength bilaterally with 
a 15 s time break across the three measurements. The mean of the three trials will be 
calculated. For each trial, participants were seated comfortably in a chair, had their elbow 
flexed with the forearm and wrist in a neutral position. They will be asked to hold the grip 
for 2 to 3 s to ensure that the maximum hand grip strength had been achieved. Hand grip 
strength assessment has been found a valid and reliable procedure. Pooled results from a 
recent meta-analysis have indicated an ICC 0.95, 95% CI: -0.93 to 0.97 for upper extremity 
conditions.37 Regarding the minimum clinically important difference (MCID) of hand grip 
strength that was based on a distribution-based method indicated that MCID estimates are 






The standard format of the EQ-5D-5L descriptive classification system developed by the 
EuroQoL Group consists of five dimensions of health, each with three levels of problems. 
It is a brief self- reported generic measure of current health that consists of five dimensions 
(Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression), each 
with three levels of functioning (no problems, some problems, and unable to/extreme 
problems). The EQ-5D-5L appears to be a valid extension of the 3-level system which 
improves upon the measurement properties, reducing the ceiling while improving 
discriminatory power and establishing convergent and known-groups validity.38 
 
8.5 Data Management 
Data will single entered into the database by the study personnel. We will have 2 full-time 
clinical research coordinators and 2 research assistants with research-related duties that 
will include to prepare all study forms and materials, complete and maintain ethics 
approvals, maintain study databases, assist with data collection, database setup and 
management. The trial coordinator will be primarily responsible for subject recruitment 
and maintaining consent documentation, production of intervention tools (handbooks), 
maintaining and updating the trial policies and procedures manual, monitoring staff 
compliance with hospital research policies and certifications manual, updating participants 
in study processes and outcomes and support to the team conduct of the research. 
 
8.6 Statistical Methods 
8.6.1 Statistical Analysis 
Participants will be analyzed according to the treatment group to which they will be 
randomized (intention-to-treat analysis). Descriptive statistics will be used to summarize 
for the baseline characteristics. For the primary outcome, Generalized Linear Modeling 
(GLM) will test the between group differences over time, with age and gender as 
covariates. The magnitude of the treatments will be reported as effect sizes for the whole 





will also be calculated/reported for between- and within-group differences. The secondary 
outcomes will be analyzed in a similar manner to the primary outcome measure. In case of 
missing data, Multiple Imputation (MI) will be performed to resolve any missing data 
issues. 
 
8.7 Data Monitoring 
The data monitoring ethics committee (DMEC) will be independent of the trial and it will 
be tasked with monitoring ethical, safety and data integrity. The DMEC will be assembled 
by 1 rheumatologist, 1 physical therapist and 1 senior statistician. All adverse events 
occurring after entry into the study and until hospital discharge will be recorded. 
 
8.8 Auditing 
All sites will be visited to ensure smooth implementation of the interventions within the 
trial. This quality control process involved the same clinical research fellow auditing 
treatment logs and notes and observing experimental arm intervention sessions. 
 
8.9 Ethics and Dissemination 
8.9.1 Research Ethics Approval 
The protocol will be reviewed and approved by the institutional research ethical board 
(REB) with respect to scientific content and compliance with applicable research and 









8.9.2 Informed Consent Process 
All patients will provide written informed consent to participate in the study. If patients are 




Data collection will adhere to Health Insurance Portability and Accountability Act 
(HIPAA) guidelines. 
 
8.9.4 Declaration of Interests 
The authors declare no conflict of interest 
 
8.9.5 Access to Data 
Data will be stored at HULC lab which is very secure place and only authorized personnel 
have access to that area. Data can be available upon request to St. Joseph’s Hospital Health 
Care London. 
 
8.9.6 Ancillary and Post-trial Care 
No specific post-trial care will be required 
 
8.9.7 Dissemination and Policy 
The study results will be presented in the Osteoarthritis Research Society international 







Successful enrolment of the patients is always a potential pitfall of clinical research. At 
HULC we have enrolled in the past more than 2000 patients in our clinical studies and have 
(Canada Foundation for Innovation) CFI-funded patient testing infrastructure to complete 
this work. HULC is situated as one of the biggest upper extremity unit in Canada. Over 
14,000 patients visited annually this facility for therapy providing direct access to cohort 
of patients required for this work. Based on these experiences, we will develop an 
ambitious and impactful timeline that is reasonable given our expertise and resources. The 
cost will involve no special equipment, but only the payments of research and clinical 




While medications such as non-steroidal anti-inflammatory drugs and analgesics relieve 
musculoskeletal signs and symptoms; disease modifying drugs have shown to not be 
effective.3,39,40 Tumor necrosis factor inhibitors have a positive role in inflammatory 
arthritis41,42, but did not show any effect in reducing pain for hand OA. 43,44 Considering 
the lack of efficacy and the view of high costs of TNF inhibitors,45 self-management is 
fundamental to “living well while creating a future without arthritis”. Thus, it is important 
that research define strategies that are best to lessen pain and improve function and preserve 
joints. Our research will accomplish that aim in several ways. Most importantly, the 
exercise and the joint protection programs will be provided in an online version for open 
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Figure 8-1. Sample Size calculation
Outcome: Pain levels (0 – 10) Visual Analogue Scale. 
Alpha α error = 0.05; 
Beta β error = 0.2; 
N=size per group; 
zx= the z-score/standard normal deviate for a two-sided x; 
δ = a clinically acceptable margin; 


















Chapter 8  
9 General discussion and future directions 
9.1 Overview of this dissertation 
The purpose of this thesis was to provide evidence to better understand joint protection 
interventions for people with hand arthritis. Arthritis is mainly symptomatic and treatment 
strategies like joint protection may help to preserve joint function and mediate pain. There 
are several factors that may affect the efficacy of joint protection intervention and how 
these techniques are implemented into practice. To better understand these factors, we 
conducted a thorough literature to investigate existing gaps on joint protection programs to 
identify existing gaps in knowledge. We conducted 5 studies and we design a protocol for 
a superiority trial to test the efficacy of standardized updated joint protection techniques 
with hand exercises. 
The first study that we conducted was a scoping review to map all the available evidence 
in published and unpublished material around joint protection. This was an important step 
because we found many trials that were never synthesized and analyzed together. We also 
found that the most commonly reported responsible person for joint protection delivery 
was an Occupational Therapist. We mapped all the available joint protection principles 
from the grey literature, and we found that were many joint protection techniques that were 
never mentioned or it was unclear if were ever tested. 
The literature search from the first study enabled an evidence synthesis of all the available 
RCTs for people with rheumatoid arthritis and osteoarthritis in the hand. We assessed the 
efficacy of joint protection in three main outcomes (pain, function and grip strength) and 
we found that there was low quality certainty of small effects on pain outcomes that did 
not reach the clinically important margin for people with rheumatoid arthritis in the hand. 
For people with hand OA, we found that the effects of joint protection were unknown 
because there was lack of reporting and we were unable to calculate the effects.  
The third study was an overview of systematic reviews that was focused to gather the 





had findings in different directions. We assessed all included reviews and only 2 reviews 
were of high quality. The majority of the reviews were mainly repeating the results from 
the primary studies without re-analyzing and calculating the effects, but their 
recommendations were based mainly on statistical significance. Our overview identified 
that reviews used different critical appraisal tools and rarely these tools were taken into 
account when results were interpreted from the authors.  
The fourth study was a survey that aimed to understand individuals’ barriers, facilitators, 
expectations and preferences. An important finding was that the majority of the people that 
participated in the study never heard of joint protection. This a very important finding 
because it highlights that there is a major gap in implementation of JPP between research 
and clinical practice. Several barriers were identified such as cost of the program, time 
when the program was offered and work commitments.  Also, participants expressed their 
preferences about the joint protection components that they think are useful to them. More 
than 70% of respondents reported as extremely useful to find new ways to do tasks 
differently to reduce joint loading.  
The fifth study was a measurement study that tried to quantify the content validity of three 
self-reported outcomes that are commonly used for people with hand arthritis. In this study 
we used statistical methods to calculate the content validity index for each of item of the 
scale, for the overall scale and kappa agreement among the raters. We found very high 
content validity index for the three self-reported outcomes in terms of their relevancy and 
their clarity for people hand arthritis. This finding will further support the use of these three 
self-reported outcomes in clinical studies to measure the construct that the scales represent.  
The sixth study was a protocol design for a superiority trial. In this design, we considered 
all the previous findings that were identified in the systematic review, the survey and the 
measurement study of the three patient-reported outcomes. Our evidence synthesis found 
that no high-quality trials exist to test the efficacy of JP interventions in people with hand 
OA. Another important step was that we factored in the design of the trials the information 
that we gathered from our survey so the JPP can meet the patients’ expectations and 





patients are needed to demonstrate superiority of the experimental arm. The trial protocol 
adhered to the SPIRIT checklist guidelines.1  
 
9.2 Clinical and research implications 
In our systematic review we found low quality certainty evidence that joint protection did 
not improve pain and function scores by a clinically important amount. However, at mid - 
and long- term follow-up the effects of JP interventions were very close to be clinically 
meaningful for people with rheumatoid arthritis. The fact that the effects of JPP were 
unknown for people with hand OA further justifies the rationale of conducting a future trial 
with adequate power to detect if a real difference exists. In our systematic review, we were 
unable to extract specific information about JP therefore, we were uncertain what was 
actually implemented as joint protection programs.  
In our survey we identified that very few patients with arthritis were aware of or had 
participated in a joint protection program, given that there is systematic review evidence 
demonstrating the effectiveness of these programs both for patients with rheumatoid 
arthritis and osteoarthritis in the hand. Lack of awareness of JPP was greater than 
anticipated and potentially reflects lack of access to programs, lack or interest in 
participating and lack of awareness from clinicians who should be recommending JPP. 
Trends for patients with arthritis to engage in a broad array of conservative approaches, 
and their responses to this survey suggest patients would engage in JP if accessible 
programs were offered. Given the evidence supporting JPP as an important component of 
self-management of arthritis, this appears to be a substantial gap between research and 
clinical practice. Therefore, education of health care professionals about this option will 
potentially improve accessibility to programs and potentially improve clinical outcomes. 
In our measurement study we provided new information to support the conceptual 
foundations of the three selected patient reported outcome measures. The high content 
validity index of these self-reported questionnaires indicates that these measures can be 





relevance and clarity of all the individual items from each outcome measure by including 
patient input as experts is considered very important and was never quantified before.  
Our trial protocol design takes into account all the gathered information from survey, but 
most importantly results from our meta-analysis indicate that there is a need for a trial for 
people with hand OA. In this trial, we will implement standardized JP interventions and 
hand exercises in a specific and measurable way, and we will use strategies to maximize 
adherence. This trial can provide more useful and effective JPP for people living with hand 




In this dissertation we conducted 5 studies and we designed a protocol for a superiority 
trial to provide more useful and effective patient centered JPP. Although, we have some 
interesting findings our work has several limitations that need to be taken into account 
when interpreting our findings.  
First, the underlying methodology that was used to critically appraise the included RCTs 
as well as the half standard deviation units that was used as a cut-off score for clinically 
important benefit was a very conservative approach. We deem that even with a lower 
threshold the findings would have been inconclusive since the confidence intervals did not 
exclude even lower thresholds.  
Second, in our survey we did not collect further descriptive data such socioeconomic status, 
education, sex and gender and therefore, this limited our ability to explore potential 
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individuals with and without hand arthritis while swinging a golf club with the use of a 
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10.1 Appendix 2. Letter of Information/ Consent 
A Study of joint protection for hand arthritis exercise preferences in Osteoarthritis 
Principal Investigator: Dr. Joy Christine MacDermid  
Student Investigator:  
Co-Investigator: Pavlos Bobos 
School of Rehabilitation Sciences 
McMaster University  
Hamilton, Ontario, Canada 
 
• Purpose of the Study: 
You are invited to take part in this study about expectations from joint protection and 
preferences for exercise. We want to identify the key expectations and preferences for joint 
protection and the critical barriers and facilitator for exercise in people with arthritis. We 
are hoping to learn how to design better joint protection programs and exercise programs.  
 
• Procedures involved in the Research: 
You will find two questionnaires attached with this consent form. You will be asked to 
complete both questionnaires. The questions will include queries about your preferences 
for exercise and about your thoughts about joint protection. You will also be asked 
questions about your diagnosis and management of arthritis. You will also be asked for 
some demographic/background information like your age and area code. 
• Potential Harms, Risks or Discomforts: 
There are no foreseeable risks involved in participating in this study. You may feel worried 
about your responses. There are no right and wrong answers and your responses will be 
kept confidential, so you do not need to worry about this. You do not need to answer 
questions that you do not want to answer or that make you feel uncomfortable. 
 





We cannot promise any personal benefits to you for your participation in this study. The 
results from this study may benefit society and the scientific community by providing 
health care providers with a better understanding of barriers and facilitators for exercise 
and preferences for joint protection in people with arthritis. 
 
• Confidentiality 
Your data will not be shared with anyone except with your consent or as required by law. 
All personal information such as your name and e-mail address will be removed from the 
data and will be replaced with a number. A list linking the number with your name will be 
kept in a secure place separate from your file. The data, with identifying information 
removed will be securely stored in a locked office in the research laboratory. 
For the purposes of ensuring the proper monitoring of the research study, it is possible that 
a member of the Hamilton Integrated Research Ethics Board may consult your research 
data. However, no records which identify you by name or initials will be allowed to leave 
the hospital. By signing this consent form, you or your legally acceptable representative 
authorizes such access. If the results of the study are published, your name will not be used 
and no information that discloses your identity will be released or published without your 
specific consent to the disclosure. 
 
 
• Participation and Withdrawal: 
If you volunteer to be in this study, you may withdraw at any time. You have the option 
of removing your data from the study. You may also refuse to answer any questions you 
don’t want to answer and still remain in the study. The investigator may withdraw you 
from this research if circumstances arise which warrant doing so. 
 
• Information about the Study Results: 
If you would like to receive a summary of this study’s results, there is a provision for you 





Questions about the Study: If you have questions or need more information about the 
study itself, please contact me at:  
This study has been reviewed by the Hamilton Integrated Research Ethics Board (HIREB). 
The HIREB is responsible for ensuring that participants are informed of the risks associated 
with the research, and that participants are free to decide if participation is right for them. 
If you have any questions about your rights as a research participant, please call the Office 
of the Chair, Hamilton Integrated Research Ethics Board at  
 
• CONSENT 
I have read the information presented in the information letter about this study. 
I have had the opportunity to ask questions about my involvement in this study and to 
receive additional details I requested. 
I understand that if I agree to participate in this study, I may withdraw from the study 
at any time or up until September 1, 2019. 
I have been given a copy of this form. 
I agree to participate in the study. 
Signature: ______________________________________ Date: 
________________________ 
Name of Participant (Printed) ___________________________________ 
1. I agree to have my responses from this project used in future related projects. 
[ ] yes 
[ ] no 
2. [ ] Yes, I would like to receive a summary of the study’s results. 
Please send them to me at this email address 
______________________________________ 
_____________________________________________________ 
[ ] No, I do not want to receive a summary of the study’s results. 







[ ] Yes, please contact me at: 
__________________________________________________ 





10.2 Appendix 3. Survey Questionnaire 
Patient opinions on joint protection programs 
 
 
Start of Block: "Information about this survey" 
 
Q50 Patient opinions on joint protection programs 
This survey was developed to gain a better understanding of your priorities and goals, 
specific to joint protection. Your answers to these questions will help us to create more 
effective joint protection programs for patients living with arthritis in the future. 
 
o End of Block: "Information about this survey" 
 
Start of Block: Block 1 
 
Q1 Please select one of the following options 
o I have been diagnosed with hand osteoarthritis  (1)  
o I have been diagnosed with hand rheumatoid arthritis  (2)  
o I have been diagnosed with psoriatic arthritis  (3)  
o I have been diagnosed with some form of arthritis other than hand  (4)  
o None of the above  (5)  
 
Skip To: End of Survey If Please select one of the following options = None of the above 
 
 
Q2 Please indicate your age below 
▼ Under 18 (1) ... 85 or older (9) 
 
Skip To: End of Survey If Please indicate your age below = Under 18 







Q3 Please select one of the four following options 
o I am currently taking part in a joint protection program  (1)  
o I have previously taken part in a joint protection program  (2)  
o I have heard about joint protection but have not taken part in a program  (3)  
o I have not heard about any joint protection programs  (4)  
 
Skip To: End of Block If Please select one of the four following options = I have not 
heard about any joint protection programs 
Skip To: End of Block If Please select one of the four following options = I have heard 
about joint protection but have not taken part in a program 
 
 
Q4 Where did you attend the joint protection program? Check all that apply. 
▢ Inpatient- rehabilitation unit  (1)  
▢ Inpatient- hospital  (2)  
▢ Outpatient- hospital  (3)  
▢ Community recreation center  (4)  
▢ Home care  (5)  
▢ A rehabilitation centre/ clinic  (6)  








Q5 Who provided the joint protection program? Check all that apply. 
▢ Family physician or specialist  (1)  
▢ Occupational therapist  (2)  
▢ Physiotherapist  (3)  
▢ Hand therapist  (4)  
▢ Kinesiologist  (5)  





























(1)  o  o  o  o  o  o  o  




o  o  o  o  o  o  o  
Hand 
function 
(4)  o  o  o  o  o  o  o  
Swelling 


















Q8 What other harms, if any, did joint protection principles cause in your well-being? 









Q9 How often did you use joint protection principles after learning them? 
o Not at all  (1)  
o Occasionally (once a week or less)  (2)  
o Quite often (once a week at least)  (3)  















o End of Block: Block 1 
 
Start of Block: Block 1 
 
Q12 Where did you hear about joint protection program? Check all that apply. 
▢ From my family physician  (1)  
▢ From my therapist  (2)  
▢ From my specialist (e.g. rheumatologist, surgeon)  (3)  
▢ From my family or friends  (4)  
▢ From newspapers/ television/ internet/ radio  (5)  
▢ From my local community center  (6)  




Q11 Everyone has barriers and facilitators that affect their ability to participate in health 
programs. Please list up to three barriers that might make it difficult for you to participate 













Q13 Please list up to three factors that might make it easier for you to participate in a 












Q14 To what extent are the following factors a concern that would make it harder for you to participate in a joint protection 
program?   
 















Having the centre/clinic 
close to my house (1)  o  o  o  o  o  o  o  
Transportation to the 
centre where program is 
provided (2)  
o  o  o  o  o  o  o  
Cost of the program (4)  o  o  o  o  o  o  o  
Time when the program 
was offered (5)  o  o  o  o  o  o  o  
My work commitments 
(6)  o  o  o  o  o  o  o  
My personal 
commitments (7)  o  o  o  o  o  o  o  
Support from 





Having a friend to 
participate with (9)  o  o  o  o  o  o  o  
Research that shows joint 
protection works (10)  o  o  o  o  o  o  o  
Another patient finding 
joint protection helpful 
(11)  






Q15 Most joint protection programs have pieces that cover:1. Things that affect the loading of your joints2. Products that can be used 
to make tasks easier3. Pacing4. How to organize tasks to make it easier for your joints5. Ways to manage symptoms 6. How to get or 
use helpCovering all this information requires about 30 hours of teaching and demonstration. What schedule would you prefer for this 
type of program? Check one. 
o 3 hours, 5 times per week, for 2 weeks  (1)  
o 2 hours, 3 times per week, for 5 weeks  (2)  




Q16 How likely would you be to participate in a program if it is delivered in the following formats? Please rank the options below in 
order of preference (most preferred option at the top). Your can slide or place the option in it's order. 
______ Online (internet) (1) 
______ Videos (television, DVDs, YouTube etc) (2) 
______ Printed material mailed upon request (pamphlet, guidebook etc) (3) 
______ In clinic (4) 








Q17 Who would you like to teach you about joint protection? Check all that apply 
▢ Family physician or specialist such as rheumatologist  (1)  
▢ Occupational therapist  (2)  
▢ Physiotherapist  (3)  
▢ Hand therapist  (4)  
▢ Kinesiologist  (5)  
▢ Patients  living with arthritis  (6)  























Information on how 
joint positions can 
affect joint loading 
(1)  
o  o  o  o  o  o  o  
Ways to do tasks 
differently to reduce 
joint loading (2)  
o  o  o  o  o  o  o  
Feedback on if I am 
doing tasks correctly 
(3)  
o  o  o  o  o  o  o  
Information about 
pacing & organizing 
activities (4)  
o  o  o  o  o  o  o  
Advice from health 
professionals about 
joint protection (5)  





Advice from other 
patients with arthritis 
about what worked 
for them (6)  
o  o  o  o  o  o  o  
Demonstrations of 
how to do things 
better (7)  
o  o  o  o  o  o  o  
Time to discuss tasks 
that I am currently 
having difficulty with 
(8)  
o  o  o  o  o  o  o  
Sensors that I could 
wear to tell me how 
much different 
activities are loading 
my joints (9)  
o  o  o  o  o  o  o  
Information about 
assistive tools or 
devices that I could 
use to make daily 
tasks easier (10)  






where to find 
assistive tools or 
devices (11)  














Not at all important 
(5) 
Preventing joint 
deformity (1)  o  o  o  o  o  
Reducing pain (2)  o  o  o  o  o  
Improving hand 
function/ activity (3)  o  o  o  o  o  
Maintaining grip 








Q20 Would you like someone to contact you to see how you are doing after the joint protection program? 
o Yes  (1)  
o No  (2)  
 
Skip To: End of Block If Would you like someone to contact you to see how you are doing after the joint protection program? = No 
 
 
Q21 If you were to do it as a web-based program, how would you like to be contacted for follow-up? Rank these options from 1 to 3, 
with 1 being your most preferred option.  Your can slide or place the option in it's order. 
______ Twice per week (1) 
______ Once a week (2) 
______ Once every two weeks (3) 
______ Once early and once at 6 month (4) 




Q22 After a web-based or in-person program, would you like someone to contact you to discuss your progress? 
o Yes  (1)  






Skip To: End of Block If After a web-based or in-person program, would you like someone to contact you to discuss your pro... = No 
Q23 When would you like to be contacted after the completion of the program? 
o After a week  (1)  
o After two weeks  (2)  
o After a month  (3)  
o After two months  (4)  
o Every 6 months  (5)  




Q24 How would you like to be contacted for follow-up? Rank these options from 1 to 3, with 1 being your most preferred 
option. Your can slide or place the option in it's order. 
______ By telelphone (1) 
______ By email (2) 






Q25 Whom would you prefer to speak with at your follow-up meeting? Rank these options from 1 to 4, with 1 being your most 
preferred option. Your can slide or place the option in it's order. 
______ The person who provided the joint protection program (1) 
______ Another participant from the joint protection program who I had met (2) 
______ Any person living with arthritis who knows about joint protection (3) 
______ Any knowledgeable health professional (4) 
 
o End of Block: Block 1 
 
Start of Block: Block 4 
 
Q26 Would you participate in web-based forums about joint protection (like a posting board, Facebook group or email list)? 
o Yes  (1)  





Q27 How often do you use the following? 
 Never (1) Very rarely (2) Rarely (3) Occasionally (4) Frequently (5) Very frequently (6) 
Heat (1)  
o  o  o  o  o  o  
Cold (2)  
o  o  o  o  o  o  
Exercise (3)  
o  o  o  o  o  o  
Joint protection (4)  
o  o  o  o  o  o  
TENS machine or 
other electrical 
devices (5)  
o  o  o  o  o  o  
Splints (6)  
o  o  o  o  o  o  
Modified 
equipment (7)  o  o  o  o  o  o  
Other (8)  






Q28 Have you had surgery because of your arthritis? 
o Yes, please specify  (1) ________________________________________________ 
o No  (2)  
 
Skip To: End of Block If Have you had surgery because of your arthritis? = No 
o End of Block: Block 4 
 
Start of Block: Block 4 
 
Q29 How often do you use your medication? 
o Daily  (1)  
o When you feel pain  (2)  
o Other, please specify  (3) ________________________________________________ 
 
 














Q31 We are planning to develop a new joint protection program that would be updated and based on patient input.  Would you be 
interested in participating in the following? Check all that apply  
▢ Helping develop a new joint protection program  (1)  
▢ Participating in a study of a new joint protection program  (2)  
▢ Being a learner after the joint protection program has been tested  (3)  
 
 
Q32 If you would like to be contacted about the above, how would you prefer to be contacted? 
o By telephone  (1) ________________________________________________ 
o By post mail  (2) ________________________________________________ 







Q33 Would you like to receive a summary of the results this survey          
o if yes, please provide your email  (1) ________________________________________________ 
o No  (2)  
 
 
Q34 Would you be willing to answer a few more questions that would help us understand what outcomes we should be measuring in 
our research about hand arthritis? This will take another 5 minutes. 
o Yes  (1)  
o No  (2)  
 
Skip To: End of Survey If Would you be willing to answer a few more questions that would help us understand what outcomes w... = 
No 
o End of Block: Block 4 
 





Q35 "Instructions" and Items that could be listed on a patient questionnaire are listed below. In each section there is an instruction 
1st and then the items. For each item we would like you to tell us: (1) how relevant that item would be to you and other people living 
with arthritis, and (2) how clear that item is 

















very clear (4) 
Rate the amount 
of pain in your 
wrist - At rest (1)  
o  o  o  o  o  o  o  o  
Rate the amount 
of pain in your 
wrist - When 
doing a task with 
a repeated 
wrist/hand 
movement (2)  
o  o  o  o  o  o  o  o  
Rate the amount 
of pain in your 
wrist - When 
lifting a heavy 
object (3)  





Rate the amount 
of pain in your 
wrist - When it is 
at its worst (4)  
o  o  o  o  o  o  o  o  
How often do you 
have pain? (0 = 
never, 10 = 
always) (5)  







Q41 "Instructions" and Items that could be listed on a patient questionnaire are listed below. In each section there is an instruction 
1st and then the items. For each item we would like you to tell us: (1) how relevant that item would be to you and other people living 
with arthritis, and (2) how clear that item is 



















difficult it was 
doing the things 
listed below, this 
week - Fasten 
buttons on your 
shirt? (1)  
o  o  o  o  o  o  o  o  
"Rate how 
difficult it was 
doing the things 
listed below, this 
week - Cut meat 
(or vegetables) 
using a knife? 
(2)  
o  o  o  o  o  o  o  o  
"Rate how 





doing the things 
listed below, this 
week - Turn a 
door knob with 
your affected 
hand (3)  
"Rate how 
difficult it was 
doing the things 
listed below, this 
week - Use your 
affected hand to 
push up from a 
chair? (4)  
o  o  o  o  o  o  o  o  
"Rate how 
difficult it was 
doing the things 
listed below, this 
week - Carry a 
heavy object in 
your affected 
hand? (5)  
o  o  o  o  o  o  o  o  
"Rate how 





doing the things 
listed below, this 











Q42 "Instructions" and Items that could be listed on a patient questionnaire are listed below. In each section there is an instruction 
1st and then the items. For each item we would like you to tell us: (1) how relevant that item would be to you and other people living 
with arthritis, and (2) how clear that item is 
 Do you think the instruction or the item is? Do you think the instruction or the item is? 


















"Rate how difficult it was 
doing your usual 
activities, this week.  By 
usual activities, we mean 
what you did before you 
started having a problem 
with your wrist/hand." - 
Personal care activities 
(like dressing/washing) 
(1)  
o  o  o  o  o  o  o  o  
"Rate how difficult it was 
doing your usual 
activities, this week.  By 
usual activities, we mean 
what you did before you 
started having a problem 
with your wrist/hand." - 
Household work (like 





cleaning or maintenance) 
(2)  
"Rate how difficult it was 
doing your usual 
activities, this week.  By 
usual activities, we mean 
what you did before you 
started having a problem 
with your wrist/hand." - 
Work (your job or other 
work) (3)  
o  o  o  o  o  o  o  o  
"Rate how difficult it was 
doing your usual 
activities, this week.  By 
usual activities, we mean 
what you did before you 
started having a problem 
with your wrist/hand." - 
Recreational activities 
(4)  







Q44 "Instructions" and Items that could be listed on a patient questionnaire are listed below. In each section there is an instruction 
1st and then the items. For each item we would like you to tell us: (1) how relevant that item would be to you and other people living 
with arthritis, and (2) how clear that item is 
 Do you think the instruction or the item is? Do you think the instruction or the item is? 



















your ability to 
perform these 
activities with the 
affected hand."- 
Turn a Key (1)  
o  o  o  o  o  o  o  o  
"Please indicate 
your ability to 
perform these 
activities with the 
affected hand."- 
Pick up a coin (2)  
o  o  o  o  o  o  o  o  
"Please indicate 
your ability to 
perform these 
activities with the 
affected hand."- 
Write (3)  






your ability to 
perform these 
activities with the 
affected hand."- 
Squeeze 
Toothpaste (4)  
o  o  o  o  o  o  o  o  
"Please indicate 
your ability to 
perform these 
activities with the 
affected hand."- 
Hold a glass of 
water (5)  
o  o  o  o  o  o  o  o  
"Please indicate 
your ability to 
perform these 
activities with the 
affected hand."- 
Turn a Doorknob 
(6)  
o  o  o  o  o  o  o  o  
"Please indicate 
your ability to 
perform these 
activities with the 
affected hand."- 
Use a Knife to Cut 
Food (7)  






Q45 "Instructions" and Items that could be listed on a patient questionnaire are listed below. In each section there is an instruction 
1st and then the items. For each item we would like you to tell us: (1) how relevant that item would be to you and other people living 
with arthritis, and (2) how clear that item is 
 Do you think the instruction or the item is? Do you think the instruction or the item is? 




















"Please indicate your ability 
to perform the following task 
while using both your 
hands?" - Open a Jar (1)  
o  o  o  o  o  o  o  o  
"Please indicate your ability 
to perform the following task 
while using both your 
hands?" - Button a 
shirt/blouse (2)  
o  o  o  o  o  o  o  o  
"Please indicate your ability 
to perform the following task 
while using both your 
hands?" - Tie your shoes (3)  
o  o  o  o  o  o  o  o  
"Please indicate your ability 
to perform the following task 
while using both your 
hands?" - Wring a 
dishcloth/washcloth (4)  





"Please indicate your ability 
to perform the following task 
while using both your 
hands?" - How often did you 
have pain in your thumb at 
rest? (5)  
o  o  o  o  o  o  o  o  
"Please indicate your ability 
to perform the following task 
while using both your 
hands?" - How often did the 
pain in your thumb interfere 
with your daily activities? (6)  
o  o  o  o  o  o  o  o  
"Please indicate your ability 
to perform the following task 
while using both your 
hands?" - How often did the 
pain in your hand interfere 
with recreational activities? 
(7)  
o  o  o  o  o  o  o  o  
"Please indicate your ability 
to perform the following task 
while using both your 
hands?" - How often did the 
pain in your thumb interfere 
with your sleep? (8)  





"Please indicate your ability 
to perform the following task 
while using both your 
hands?" - How often did the 
pain in your thumb worsen 
your mood? (9)  







Q46 "Instructions" and Items that could be listed on a patient questionnaire are listed below. In each section there is an instruction 
1st and then the items. For each item we would like you to tell us: (1) how relevant that item would be to you and other people living 
with arthritis, and (2) how clear that item is 
 Do you think the instruction or the item is? Do you think the instruction or the item is? 
















"The following questions 
ask about your 
satisfaction with the 
indicated hand or thumb 
over the past week." - 
Motion in your affected 
thumb (1)  
o  o  o  o  o  o  o  o  
"The following questions 
ask about your 
satisfaction with the 
indicated hand or thumb 
over the past week." - 
Strength of your affected 
hand (2)  
o  o  o  o  o  o  o  o  
"The following questions 
ask about your 
satisfaction with the 
indicated hand or thumb 
over the past week." - 
Pain level of your 
affected thumb (3)  
o  
 





"The following questions 
ask about your 
satisfaction with the 
indicated hand or thumb 
over the past week."-  
Overall function of your 
hand (4)  





Q47 "Instructions" and Items that could be listed on a patient questionnaire are listed below. In each section there is an instruction 
1st and then the items. For each item we would like you to tell us: (1) how relevant that item would be to you and other people living 
with arthritis, and (2) how clear that item is 
 Do you think the instruction or the item is? Do you think the instruction or the item is? 


















"Rate your pain" - 
At rest (1)  
o  o  o  o  o  o  o  o  
"Rate your pain" - 
Gripping (2)  
o  o  o  o  o  o  o  o  
"Rate your pain" - 
Lifting (3)  
o  o  o  o  o  o  o  o  
"Rate your pain" - 
Turning (4)  
o  o  o  o  o  o  o  o  
"Rate your pain" - 
Squeezing (5)  
o  o  o  o  o  o  o  o  
"Rate your 
stiffness" - After 
first wakening in 
the morning (6)  





Q49 "Instructions" and Items that could be listed on a patient questionnaire are listed below. In each section there is an instruction 
1st and then the items. For each item we would like you to tell us: (1) how relevant that item would be to you and other people living 
with arthritis, and (2) how clear that item is  
 Do you think the instruction or the item is? Do you think the instruction or the item is? 


















"Rate your difficulty when" 
- Turning taps/faucets on 
(1)  
o  o  o  o  o  o  o  o  
"Rate your difficulty when" 
- Turning a round 
doorknob or handle (2)  
o  o  o  o  o  o  o  o  
"Rate your difficulty when" 
- Doing up buttons (3)  o  o  o  o  o  o  o  o  
"Rate your difficulty when" 
- Fastening jewellery (4)  o  o  o  o  o  o  o  o  
"Rate your difficulty when" 
- Opening a new jar (5)  o  o  o  o  o  o  o  o  
"Rate your difficulty 
when"- Carrying a full pot 
with one hand (6)  
o  o  o  o  o  o  o  o  
"Rate your difficulty when" 
- Peeling vegetables/fruits 
(7)  
o  o  o  o  o  o  o  o  
"Rate your difficulty 
when"- Picking up large 
heavy objects (8)  





"Rate your difficulty 
when"- Wringing out wash 
cloths (9)  
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